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QUILL ON SCALPEL
This section provides a medium through which 
Canadian surgeons can declare themselves, 
briefly and informally, on the day-to-day affairs of surgery.
Breast Lumps —  When Is a Cyst Not a 
Cyst?
Charles J. Wright, MB, ChB, MSc, FRCSC, FRCS, FRCS(Edin)
Member, Editorial Board, Canadian Journal o f  Surgery. Professor, Department o f Surgery,
University Hospital, University o f  Saskatchewan, Saskatoon, Sask.
O ne of the commonest problems encountered in the general sur­
geon’s office is that of breast cysts. 
Fortunately, women with breast 
cysts are no longer subjected to 
open biopsy for diagnostic pur­
poses. The diagnosis is made by 
aspiration, and a typical thin, 
yellow, brown, green or grey aspi­
rate followed by disappearance of 
the lump usually leads to a great 
sense of relief that the patient’s 
condition is benign. The ensuing 
conversation with the patient may 
go something like this:
“Mrs. Jones, I am pleased to see 
that this breast lump is just a cyst.”
“What does this mean then, doc­
tor?”
“It is simply a collection of fluid 
which is a benign condition.”
“So, it’s not a cancer, doctor?” 
“That’s right, but I would like to 
re-examine you in a month or so to 
make sure there’s no further prob­
lem.”
How confident are we that aspira­
tion represents appropriate manage­
ment? It is a “risk management” 
problem, since we know that breast 
cysts are most unlikely to be malig­
nant. The possibility of cancer can­
not be excluded, however, and how 
do we deal with the occasional
patient who pursues this conversa­
tion much further, wishing to know 
exactly what is the risk of a breast 
cancer in association with the cyst? 
We know that analysis and cytolog­
ic examination of the cyst fluid 
rarely give any useful information. 
The article by Devitt in this issue 
(pages 356 to 358) provides valu­
able information to help answer 
these questions. Dr. Devitt de­
scribes his extensive experience 
over the last 16 years, of 915 
women with breast cancer and 812 
with a breast cyst, to define the 
relationship between the two condi­
tions. The questions that his report
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helps to answer are those that often 
concern surgeons and women with 
breast problems alike. How often 
does a cyst actually turn out to be 
cancer? How often does a cancer 
present with a significant cystic 
component? How often does a can­
cer coexist with a breast cyst on 
presentation? Does cystic disease of 
the breast predispose to subsequent 
development of cancer?
In Devitt’s analysis four types of 
association of breast cysts and can­
cer were seen: cystic cancers, simul­
taneous cancers and cysts, cysts 
occurring after breast cancer and 
cancers occurring after breast cysts. 
Only 11 of the 915 patients with 
breast cancer had fluid aspirated 
from the lesion and it is noteworthy 
that in most of these either blood­
stained fluid was aspirated or there 
was a residual mass after aspiration. 
The data also demonstrate that this 
association occurs almost exclusive­
ly in older women. Concerning the 
likelihood of breast cancer develop­
ing after previous diagnosis of a 
breast cyst, Devitt found that, over 
16 years of follow-up of the 812 
patients with breast cysts (more 
than 5000 patient-years), a breast 
cancer (11 ipsilateral, 8 contralater­
al and 1 bilateral) subsequently de­
veloped in 20. This incidence of 
breast cancer falls within or close to 
the range of the expected incidence 
in the adult female population in
Canada. Analysis of these data in a 
slightly different way reveals that 
only 21 women out of 833 present­
ing with cysts had breast cancer at 
the time of presentation (11 had 
cystic cancers and 10 had simulta­
neous cysts and cancer). In other 
words, the “pretest probability” of 
having cancer in this population 
was only 2.5%, even without any 
diagnostic tests. After a thorough 
clinical examination, aspiration, 
fine-needle aspiration biopsy, mam­
mography and ultrasonography it is 
now unusual not to make a definite 
diagnosis.
Devitt’s paper is an excellent ex­
ample of how interesting and valu­
able a retrospective study can be 
when the number of patients is 
large enough, when the questions 
being asked are appropriate for the 
type of study and when the conclu­
sions reached are justified by the 
data. This study helps us to set 
aside the fear of occult cancer oc­
curring in a breast cyst, because 
this occurrence is extremely rare. 
The occasional carcinoma with a 
cystic component can be recognized 
by the blood-stained nature of the 
fluid in the cyst, by the persistence 
of a mass after aspiration or by 
rapid recurrence of the cyst. I agree 
enthusiastically with Devitt’s rec­
ommendations that all breast cysts 
should be aspirated, but that a 
localized mass still present after
aspiration should be excised. In 
recent years, fine-needle aspiration 
biopsy has enabled rapid and accu­
rate diagnosis of breast lesions in 
the office. Although not stated by 
Dr. Devitt because of the historical 
time period of his review, I would 
make a further recommendation 
that all breast lesions that do not 
contain fluid on aspiration should 
be subjected to fine-needle aspira­
tion biopsy. As to the relation be­
tween a breast cyst and the develop­
ment of cancer later in life, the risk 
is insignificant if it exists at all, and 
it would certainly not justify any 
special follow-up other than man­
agement of lumps detected by the 
patient herself. The hypothetical 
conversation described in the first 
paragraph is indeed appropriate, 
and women and their doctors can 
continue to feel the sense of relief 
when a breast lump is aspirated to 
reveal the typical fluid of a benign 
breast cyst. The remote possibility 
of cystic cancer or associated cyst 
and cancer will be covered by the 
repeat examination and subsequent 
follow-up if indicated. It is never 
possible to reassure a woman with 
absolute certainty that she does not 
have breast cancer, but this recom­
mended protocol is a reasonable 
compromise and represents appro­
priate management of the breast 
cancer risk in women with breast 
cysts. ■
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T h e  General Surgeon and Sepsis in the 
Critical Care Unit
Roger G. Keith, MD, FRCSC
Member, Editorial Board, Canadian Journal o f  Surgery. Associate Professor o f  Surgery,
University o f  Toronto, Division o f  General Surgery, St. Michael’s Hospital, Toronto, Ont.
In the critical care symposium that appears in this issue (pages 
319 to 336), Gregor and Prodger 
(pages 331 and 332) acknowledge 
that surgeons are becoming more 
involved in the management of pa­
tients in critical care units. More 
importantly, these authors stress 
the role of the general surgeon as a 
consultant in the intensive care unit 
to participate aggressively in the 
diagnosis and treatment of septic 
complications in critically ill pa­
tients. The use of this integrated 
approach through communication 
with the supervising intensive care 
physician is most valuable when 
sepsis occurs as a complication of 
abdominal surgery, abdominal trau­
ma or abdominal disease, causing 
an abrupt deviation from the antici­
pated course. Knowledge of the 
operative treatment, familiarity with 
relevant abdominal disease and clin­
ical acumen are assets for which the 
intensive care physician has no lab­
oratory substitute.
In another paper in this issue 
(pages 327 to 330), Hamilton has 
stressed the lethal consequences of 
untreated intra-abdominal sepsis in 
critically ill patients. The role of the 
surgeon or radiologist as the defini­
tive therapist for evacuating an ab­
scess is appropriately dealt with in 
the author’s description of the diffi­
culties of diagnosis, localizing the 
source of infection and the effects 
of delay of definitive therapy. 
Critically ill patients are often
immunocompromised, so it is im­
portant to differentiate between 
generalized peritonitis and localized 
abscess formation as the cause of 
the sepsis. The course of patients 
with generalized peritonitis will 
progress from septic shock to mul­
tiple organ failure and death more 
rapidly than that of patients who 
have a localized septic process in 
the abdominal cavity. Escherichia 
coli is frequently cultured from 
blood, sputum, urine and secretions 
of patients with sepsis. Growth of 
this organism alone may indicate 
translocation without a primary in­
tra-abdominal focus; however, when 
E. coli is one of a number of 
organisms cultured, the source of 
infection is most likely in the perito­
neal cavity. Given that all radiologic 
imaging techniques, including ra­
dionuclide scanning, require either 
a mass lesion or leukocyte aggrega­
tion in order to produce positive 
results from localization studies, at­
tempts at localization will likely be 
unsuccessful in patients with gener­
alized peritonitis. Prompt surgical 
intervention for peritonitis whose 
cause has been determined by clini­
cal features and results of cultures 
will increase survival substantially if 
treatment is initiated within 24 
hours of diagnosis.1 However, as 
Hamilton notes, when blind laparot­
omy is carried out for sepsis of 
indeterminate etiology and no intra­
abdominal focus is identified, mor­
bidity and mortality will be high.
The localization of intra-abdomi­
nal septic foci will reduce the rate 
of organ system failure. According 
to the thesis of Fry,2 respiratory 
failure occurred simultaneously 
with the onset of sepsis in such 
patients, but the subsequent devel­
opment of organ system failure 
ranged from 3 to 9 days. Thus, 
accurate localization will allow pre­
cise therapy to be instituted. Al­
though documentation is not well 
stratified, it seems that appropriate 
treatment of localized intra-abdomi­
nal sepsis can prevent further organ 
failure if only one system is com­
promised at the time of treatment.3
If intra-abdominal abscess is not 
identified by stepwise use of ul­
trasonography followed by comput­
ed tomography, then radionuclide 
scanning with indium-ill-labelled 
leukocytes is indicated. This study 
is technically complicated, expen­
sive and requires 24 hours to com­
plete. However, sonographic homo­
geneity on ultrasonography and 
equivalent tissue density on com­
puted tomography may give false­
negative results. When attention is 
directed to the retroperitoneum by a 
positive indium scan, dynamic com­
puted tomography will differentiate 
perfused from necrotic retroperito­
neal tissue. In such cases, abdomi­
nal surgery should include thor­
ough exploration of the re­
troperitoneum. If necrotic tissue is 
found, debridement and drainage 
are necessary, precluding the use of
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percutaneous catheter aspiration.
Several scoring systems have 
been introduced to evaluate the 
condition of these patients and indi­
cate the likely prognosis. Although 
each system has different defini­
tions and deficiencies, all are based
on prospective studies of large 
numbers of patients in multicentre 
trials and thus are valid. The gener­
al conclusion that in critically ill 
patients with sepsis, multiple organ 
failure and death will follow if no 
treatment is instituted is a logical
» A
one. However, acceptance of death 
as predicted by the various scoring 
systems should not be universally 
accepted. Organ failure has been 
reversed with eradication of the 
initiating disease process. There­
fore, continued aggressive therapy
1
An emerging 'X
m
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is indicated. Without surgical inter­
vention, death is assured.
As advised by the authors con­
tributing to the critical care sympo­
sium in this issue, the continuing 
education and training of general 
surgeons as consultants in critical
care facilities is mandatory to en­
sure appropriate and successful 
therapy.
References
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Reliability of Treadmill 
Exercise Test for Patients 
With Claudication
To the editors: In their article “A 
single treadmill exercise test does 
not accurately quantitate claudica­
tion” (Can J Surg 1987; 30: 446- 
448), Harris and Meads make a 
strong case for carrying out a series 
of three treadmill exercise tests to 
obtain an accurate assessment of 
the walking distance of patients 
with intermittent claudication due 
to peripheral vascular disease. In a 
recent study1 our group found the 
reliability of walking endurance 
high (r > 0.97, p < 0.0001) for 
three tests. The differences between 
our results and those of Harris and 
Meads may have been due to meth­
odology: our subjects were young 
and healthy but theirs had peripher­
al vascular disease; their treadmill 
test consisted of a single speed and 
grade (0.67 m /s, 12° incline), ours 
was incremental (beginning at 0.25 
m /s and 0% grade and increasing 
every 90 seconds in either speed or 
grade to a maximum of 2.75 m /s 
and 20% grade); they conducted 
five tests on the same day with 
30-minute rests between tests 
whereas the interval between tests 
for our subjects was 1 week; and 
they reported both the time to 
claudication and the maximum time 
walked (the former more variable 
than the latter) whereas our sub­
jects had no claudication and we 
reported only the maximum time 
walked. Although the average with- 
in-subject standard deviation in our 
study was only 23 seconds, this 
corresponds to a 95% confidence 
interval of about 92 seconds, which 
is of a magnitude similar to that 
associated with many of the report­
ed benefits of treatment on walking 
distance. Therefore, despite the 
slight differences in our methods
and findings, I agree with Harris 
and Meads that the limits of reliabil­
ity must be considered when con­
clusions are drawn from treadmill 
tests of walking distance.
R. Lee Kirby, MD, FRCPC
Department o f Medicine,
Dalhousie University,
Nova Scotia Rehabilitation Centre,
Halifax, NS 
B3H 4K 3
Reference
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To the editors: We thank Dr. Kirby 
for his interest in our paper.
We agree with his assessment 
that the differences observed may 
be largely related to methodology in 
our studies. We were able to record 
both the onset of muscle pain (in­
termittent claudication) and final 
muscle exhaustion related to re­
duced blood supply to the lower 
extremity. In all our patients we 
noted a reduction in substrate and 
oxygen delivery as measured by the 
ankle-brachial pressure index. In 
contrast, Dr. Kirby did not measure 
ankle pressures. It has been docu­
mented in the past, however, that 
there is no fall in limb perfusion 
with exercise in the normal sub­
ject.1 We must therefore question 
whether the end points measured 
reflect the same pathophysiologic 
mechanism.
Dr. Kirby’s patients walked for 
considerably longer (mean ± SEM 
991.4 ± 27.8 s) than our patients 
(252.4 ± 29.4 s), which may serve 
to minimize the variation seen in 
the walking distance. In addition to 
this, Dr. Kirby’s exercise test incor­
porates its own training curve with 
a slow, non-graded initial walk. Be­
Contributions to the Correspondence section 
are welcome. They should be typewritten 
and double spaced.
cause of the precarious blood sup­
ply in our patients, there is limited 
time for this within a single walk.
We agree with Dr. Kirby’s view 
that the reliability of the treadmill 
test must be assessed individually 
for each laboratory. However, we 
believe that we were assessing dif­
ferent parameters in an entirely dif­
ferent population and that extrapo­
lation of one set of data from the 
other may not be appropriate.
K.A. Harris, MD, FRCSC 
G.E. Meads, MD, FRCSC
St. Joseph's Health Centre,
268 Grosvenor St.,
London, Ont.
N6A 4V2
Reference
1. Strandness DEjr: Exercise testing in 
the evaluation of patients undergoing 
direct arterial surgery. J Cardiovasc Surg 
(Torino) 1970; 11: 192-200
Fecal Diversion in Pelvic 
Fractures
To the editors: In the March issue 
(pages 90 to 92) Dr. N.V. Christou 
discussed the use of fecal diversion 
in pelvic fractures only in conjunc­
tion with associated rectal injuries. 
This is surprising. Trunkey1 stated 
that fecal diversion is necessary in 
all open pelvic fractures to prevent 
perineal soiling and sepsis even if 
the rectum is not injured. He re­
ported that the routine use of fecal 
diversion in patients with open pel­
vic fractures lowered the death rate 
from 50% to 25%.
Rothenberger and colleagues2 
also reported a death rate of 50% in 
open pelvic fractures not treated by 
immediate total fecal diversion. In 
their series of 22 patients with open 
pelvic fractures, three of eight 
deaths directly attributable to the
*
n
*
r
4 ^ 4
304 VOL. 31, NO. 5 SEPTEMBER 79SS/CJS
CORRESPONDENCE
pelvic fracture were due to sepsis. 
In addition, 4 of the 11 survivors 
had infectious complications.
Of the five patients who under­
went colostomy immediately, three 
survived; the two who died had no 
evidence of pelvic infection.2 Simi­
larly, Maull and colleagues3 recom­
mended total diverting colostomy 
with rectal irrigation for all deep 
perineal lacerations associated with 
pelvic fracture, regardless of wheth­
er the rectum was intact, and de­
scribed a rapid, simple method of 
performing this procedure. Kus- 
minsky and associates4 also recom­
mended a diverting colostomy with 
all open pelvic fractures.
The rationale for this more ag­
gressive approach is to prevent peri­
neal wound contamination from 
feces and to avoid missing small 
rectal injuries in the extensively 
traumatized patient.
D. Ross, MD 
Resident,
Department o f Surgery,
Dalhousie University,
Halifax, NS
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Percutaneous Gastrostomy
To the editors: The article by Deitel 
and colleagues in the March issue 
(pages 102 to 104) is interesting in 
that the “introducer” technique is
virtually the same as that used for 
percutaneous nonendoscopic gas­
trostomy.
Percutaneous gastrostomy, per­
formed as an interventional radi­
ologic technique, is a safe and rapid 
method for gastric or jejunal feed­
ing or obtaining decompression and 
is associated with minimal morbidi­
ty.1'2 This method of gastrostomy 
has the advantages of requir­
ing only one operator — the inter­
ventional radiologist — and can 
be performed in patients with high- 
grade esophageal obstruction, in 
which case a fine angiographic 
catheter can be maneuvered into 
the stomach under fluoroscopic 
control for air insufflation. A modi­
fication of the standard method, 
using balloon inflation of the stom­
ach, has also been described for use 
in patients with a partial gastrecto­
my.3 Ascites is still a contraindica­
tion.
For most purposes, the Gray-St. 
Louis modification of the Wills— 
Oglesby gastrostomy set (Cook, 
Markham, Ont.), which is designed 
for gastrojejunal feeding or decom­
pression, is adequate and avoids the 
problem of gastroesophageal reflux. 
Wills and Oglesby4 have supplied an 
excellent description of the tech­
nique of percutaneous gastrostomy.
Richard N. Rankin, MB, ChB, DMRD, 
FRCR,FRCPC
Associate Professor,
Department o f Diagnostic Radiology, 
University Hospital,
University o f Western Ontario.
London, Ont.
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To the editors: The radiologic per­
cutaneous nonendoscopic gastros­
tomy is a useful technique. Howev­
er, the percutaneous endoscopic 
gastrostomy has the advantage that 
the light of the scope can be visual­
ized, positioned precisely and pal­
pated against the anterior abdomi­
nal wall (further confirmed by visu­
alizing endoscopically an indenta­
tion made on anterior gastric wall 
by the surgeon’s finger), ensuring 
that the catheter is indeed inserted 
into stomach. Furthermore, we 
have sometimes noted on endosco­
py that the balloon or mushroom 
was not against the anterior gastric 
wall when the abdominal surgeon 
felt resistance and believed that 
there was no further “ give”; the 
endoscopist then directed a further 
pull, which apposed and sealed the 
stomach against the anterior ab­
dominal wall. The balloon or mush­
room must be visualized against the 
anterior gastric wall to prevent peri­
tonitis and infusion of diet into the 
peritoneal cavity. All techniques 
have their complications, and we 
are aware of nonendoscopic inser­
tion into interposed small bowel and 
also of gastric leak and peritonitis 
by one of the radiologists in Dr. 
Rankin’s references, subsequent to 
his quoted paper.1
Mervyn Deitel, MD, FRCSC, FACS
Professor,
Department o f Surgery and Department 
o f Nutritional Sciences,
University o f Toronto,
St. Joseph’s Health Centre,
Toronto, Ont.
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W ounds of the Abdomen.
Part 2: In Peace
A.C. Derby, MD, FRCSC
Until the mid 1960s in the United States, penetrating abominal wounds in civilians 
were badly handled and often fatal. Little attention was paid to the methods used and 
results reported by military surgeons in previous wars such as those in Korea and 
Vietnam. In 1966 the National Academy of Sciences, National Research Council 
Committee on Shock pointed out that there was an increasing incidence of severe 
civilian injuries associated with unacceptably high morbidity and mortality and that 
this was because of lack of organized civilian community care. As a result the 
Trauma/Emergency Medical Service (T/EMS) was formed. The initiators based the 
organization on the remarkable success of military concepts and techniques.
The improvement in the evacuation and treatment of penetrating abdominal 
wounds in peace from the inception of the T/EMS to the present is described in this 
paper. The methods used and results obtained through the T/EMS have made an 
important contribution to both civilian and military surgery — a unique event in 
peacetime.
Aux Etats-Unis, jusqu’au milieu des annees 1960, les plaies penetrantes abdomina- 
les subies en temps de paix etaient traitees de fa?on inadequate et elles etaient 
souvent fatales. On pretait peu d’attention aux methodes et aux resultats signales 
par les chirurgiens militaires au course des guerres precedentes. En 1966, les 
Comites sur le choc de l’Academie nationale des sciences et du Conseil national de 
recherche signalaient une augmentation de l’incidence des blessures graves chez les 
civils, lesquelles etaient accompagnees d’une morbidity et d’une mortality inaccepta- 
blement elevees, a cause du manque de soins communautaires bien organises chez 
les civils. En consequence, les services medicaux d’urgence pour traumatises furent 
constitues. Les promoteurs etablirent les fondements de cet organisme sur le succes 
des concepts et des techniques militaires.
On decrit l’amelioration des methodes d’evacuation et de traitement des blesses 
souffrant de plaies penetrantes abdominales, depuis la mise sur pied des services 
medicaux d’urgence pour traumatises a la fin des annees 1960, jusqu’a nos jours. II 
est demontre que les methodes et les resultats des services medicaux d’urgence pour 
traumatises ont contribue de fa?on importante a la chirurgie civile de meme que 
militaire, ce qui constitue un evenement exceptionnel en temps de paix.
Because of well-trained person­nel, adequate equipment and 
supplies, adherence to sound princi­
ples of military surgery and the 
introduction of such innovative 
measures as direct helicopter eva­
cuation from battlefield to hospital, 
97.5% of those wounded in the 
Vietnam War survived. This was 
not the case in the United States. 
Van Wagoner1 examined the hospi­
tal charts and autopsy reports of
606 American soldiers who were 
accidentally injured and died in hos­
pital during the years 1957 to 1959 
inclusive. The military kept good 
records, but the same cannot be 
said for the hospitals where they 
died. Moreover, the management at 
these hospitals was poor. One-sixth 
would have survived with the most 
basic prompt diagnosis and treat­
ment, a further sixth received such 
limited treatment that they too 
would likely have recovered with 
adequate care. Over one-half of the 
remainder died of uncomplicated 
head injuries.
Van Wagoner’s findings were 
confirmed by a number of autopsy 
studies related to fatal traffic ac­
cidents.2-5 Even allowing for the 
scanty records, Van Wagoner be­
lieved that the loss of life among 
healthy young men at that time was 
appalling and that a serious prob­
lem existed. The United States Na­
tional Academy of Sciences agreed. 
As a result, in the late 1960s, the 
Trauma/Emergency Medical Ser­
vice (T/EMS) was formed. This 
organization was based primarily on 
military experience. Since then the 
treatment of injured civilians has 
greatly improved.6-7 In this paper I 
review the improved facilities and 
treatment of wounds of the abdo­
men in civilians.
Prehospital Treatment and 
Patient Assessment
When helicopter service for the 
evacuation of the seriously injured 
was established, minimum stan-
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dards were set for personnel and 
equipment for ground and air am­
bulances. Paramedics were trained 
and certified as emergency medical 
technicians and had the ability to 
perform advanced life-saving mea­
sures under the direct supervision 
of skilled medical personnel by two- 
way radio. Aprahamian and col­
leagues8 and Jacobs and associates9 
reported on the effect of paramedics 
in reducing mortality in severe trau­
ma.
Hospitals were graded according 
to availability of equipment and 
supplies and the presence of medi­
cal and surgical specialists. To the 
best equipped and staffed hospitals, 
designated as trauma centres, the 
most seriously injured were evacu­
ated. Patients with minor problems 
were sent to hospitals with lower 
grading.
The pneumatic antishock gar­
ment (PASG) was introduced in the 
late 1960s, but its use is controver­
sial.1011 Its ability to improve ve­
nous return is in doubt and its use 
is associated with such complica­
tions as anterior compartment syn­
drome, crush syndrome and in­
creased intracranial pressure in 
those with head injuries. It is most 
beneficial in tamponading intra­
abdominal or retroperitoneal he­
morrhage and in splinting fractures.
Scales for measuring injury se­
verity now exist. The most popular 
is the injury severity score (ISS) 
developed by Baker and associ­
ates.12 Each injured area of the 
body is assigned a score on a scale 
of one (minor) to five (critical, sur­
vival uncertain). The three highest 
regional scores are then squared 
and added together for a maximum 
of 75 — the higher the total the 
more severe the trauma.
Recently Sacco and colleagues13 
have advocated a numerical trauma 
score. It is a physiologic measure of 
the severity of injury that incorpo­
rates the Glasgow Coma Scale and
the cardiovascular and respiratory 
systems. Standard numbers are as­
signed on a sliding scale. When 
combined with other information, 
the trauma score provides an accu­
rate indication of the patient’s sta­
tus and assists in triage. Since there 
is less room for variation of inter­
pretation, this scale should be of 
more value than earlier scoring sys­
tems.
Initial Care in Trauma Centres
Rapid assessment of the patient 
to ensure adequate airway, control 
of external hemorrhage and replace­
ment of blood volume loss is still 
the keystone in the resuscitation of 
the injured patient on arrival at the 
trauma centre. Immediate rapid in­
fusion of a balanced salt solution, if 
necessary, should be carried out 
through two to three ports until 
blood is available to expand not 
only plasma but also interstitial tis­
sue.14 Monitoring of central venous 
pressure, blood gas determinations, 
insertion of an arterial line and 
occasionally a Swan-Ganz catheter 
and a volume respirator will be 
indicated in the profoundly shocked 
patient. Dopamine15 and dobuta- 
mine, which improve cardiac output 
but do not increase peripheral vas­
cular resistance, are most advanta­
geous in low to medium doses.
The use of type 0  unmatched 
whole blood and packed cells is 
gaining popularity16 because both 
are immediately available and no 
recorded reaction or later develop­
ment of blood group antibodies has 
been noted; further, packed cells in 
saline can be warmed as can the 
blood.
Since the Vietnam War, when its 
use was limited, autotransfusion 
has continued to arouse inter­
est.1718 Autotransfusion obviates 
such problems as transmission of 
disease and provides a ready source
of blood when a blood bank is not 
available.
Surgical Management
Vascular Injuries
In previous wars, including Viet­
nam, the cause of early death in 
abdominal wounds was predomi­
nantly hemorrhage. Patients with 
abdominal wounds in profound 
shock who reached the advanced 
surgical centre alive frequently died 
in the resuscitation ward or in the 
operating room in spite of attempts 
to re-establish blood volume and to 
control bleeding. The most striking 
advance in the treatment of abdomi­
nal wounds by the T/EMS has been 
the heroic attempts to control 
major hemorrhage from the re- 
troperitoneum and to treat associat­
ed injuries to the duodenum, pan­
creas, kidney and other retroperito­
neal structures. The reported inci­
dence of abdominal vascular inju­
ries in civilians19 was much higher 
than in the military20 because civil­
ian handguns are less powerful than 
artillery and rockets and, therefore, 
more patients reached hospital 
alive. Furthermore, it has been 
proved that trained paramedics 
using advanced life-support meth­
ods have significantly increased the 
number of exsanguinating patients 
who reach hospital alive. If, in spite 
of rapid resuscitation with two or 
three units of Ringer’s lactate solu­
tion followed by two or three units 
of group 0  whole blood or packed 
cells through two or three ports, 
the patient’s condition remains un­
stable with a blood pressure of less 
than 80 mm Hg systolic, surgery is 
indicated. One of two procedures 
may be used — a left thoracoto­
my2122 with proximal temporary 
aortic occlusion followed by lapa­
rotomy or laparotomy to gain proxi­
mal control by a rapid generous left
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retroperitoneal exposure in the case 
of the aorta and its major branches, 
and the use of an abdominal com­
pressor.23-26 Occlusion clamps are 
placed precisely immediately proxi­
mal and distal to the injury. Repair 
is carried out mostly by lateral 
aortorrhaphy or patch grafting. Oc­
casionally, resection and end-to-end 
anastomosis or interposition graft­
ing is necessary. Major aortic 
branches, such as the superior mes­
enteric, on occasion are transplant­
ed further down the aorta.
Exposure of the vena cava or the 
portal vein is best obtained by mobi­
lizing the right colon, hepatic flex­
ure, duodenum and pancreas, dis­
placing them to the left.2728 In the 
majority of cases, once the site of 
bleeding is ascertained, the he­
morrhage can be controlled by fin­
ger pressure or a sponge stick 
followed by application of vascular 
clamps. Repair is possible in most 
cases by lateral venorrhaphy. A pos­
terior hole may be repaired through 
an elongated anterior injury prior to 
its repair. Suprarenal vena caval 
injuries may require innovative 
shunting techniques. Shunts may 
be inserted through the right atrial 
appendage or the infrarenal vena 
cava.
The death rate from wounds of 
the aorta has varied from 30% to 
70%, depending on the site of the 
wound and whether there were as­
sociated gastrointestinal or major 
vascular injuries.23-26 The death 
rate from wounds of the suprarenal 
aorta is high because of the vessel’s 
inaccessibility. Mattox and col­
leagues26 suggested that by mobiliz­
ing the left colon, spleen, left kid­
ney and tail of the pancreas upward 
and to the right, better exposure 
can be obtained. The line of Toldt is 
initially divided by sharp dissection 
followed by blunt dissection to ex­
pose the aorta from the esophageal 
hiatus to the iliac vessels.
In vena caval injuries, recovery
depends on the location of the 
injury. It varied from 70% in renal 
and infrarenal injuries27 to 0% to 
30% in suprarenal and intra- and 
suprahepatic injuries.27 Trauma to 
the portal vein system is associated 
with a mortality of 39%.29 These 
figures are remarkable considering 
that Rich and associates20 reported 
on 1000 major vascular repairs in 
Vietnam, of which only 9 were in 
cases of abdominal injury and all 
were no higher than the common 
iliac vessels. Hemorrhage is the 
overwhelming cause of death in 
major vascular injuries. Some inju­
ries are so extensive that, despite all 
efforts, exsanguination is inevitable. 
Other patients die as a result of 
slow oozing. Kashuk and col­
leagues30 suggested that the coagu­
lation defects were exaggerated by 
hypothermia and acidosis, leading 
to hemorrhage. They recommended 
administration of fresh-frozen plas­
ma with every 4 units of banked 
blood and platelet concentrates with 
the fifth unit and every subsequent 
10 units. If bleeding continued, 
fresh whole blood should be admin­
istered. Acidosis should be combat­
ted by restoring blood volume to 
normal, if possible, and maintaining 
pH at 7.2 with the use of sodium 
bicarbonate. Hypothermia should be 
controlled by preheating all intrave­
nous fluids and always keeping the 
patient warm. At operation, warmed 
fluids should be used for intracavi­
tary lavage (thoracic and abdomi­
nal) and heated moisturized oxygen 
administered with anesthesia.
Pancreatic, Renal and Hepatic 
Injuries
Control of massive bleeding is the 
top priority in pancreatic injury.3132 
Once it is controlled, the entire 
duodenum can be mobilized using a 
Kocher maneuver. The condition of 
the head and tail of the pancreas is 
assessed by entering the lesser sac.
The questions to be answered are: 
are the superior mesenteric artery, 
vena cava, portal vein and pancreat­
ic duct intact? Is the duodenum 
viable and intact, and are the unci­
nate process and the common duct 
spared? Minor pancreatic injuries 
such as contusions, capsular tears 
or lacerations with no involvement 
of the main duct system require 
only hemostasis and drainage. 
Major lacerations, extensive hema­
tomas or main duct disruption in 
the body or tail require distal pan­
createctomy with closure or Roux- 
en-Y drainage into a jejunal loop. 
Large hematomas, lacerations or 
disruptions of the head of the pan­
creas necessitate either pan- 
creatoduodectomy or duodenal di- 
verticulization. This procedure con­
sists of vagotomy, hemigastrecto­
my, tube duodenostomy and gas­
trojejunostomy. The results of 
major pancreatic, duodenal and 
combined injuries using this tech­
nique have reduced the death rates 
in the past 10 years from as high as 
33% to as low as 9%.33 34
The approach to the retroperito­
neal hematoma associated with kid­
ney damage35 has been upgraded in 
the past 15 years; 85% of cases can 
now be treated conservatively.35 An 
intravenous pyelogram or computed 
tomogram demonstrating extravasa­
tion of urine into Gerota’s fascia or 
a nonfunctioning kidney or pedicle 
injuries involving the renal vessels 
are the indications for surgery. At 
operation, it is imperative first to 
control the renal vessels at the 
pedicle with tapes before exploring 
the kidney. In the majority of in­
stances, repair or partial nephrecto­
my is possible. In this way, total 
nephrectomy seldom is indicated.
Published series36 on liver dam­
age in civilians have usually reflect­
ed a less severe injury than that 
sustained in military conflict — the 
death rate being between 12% and 
20%. The management of liver inju-
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ries adopted in the Vietnam conflict 
is still the accepted method of treat­
ment.37
Postoperative Care
The majority of patients with 
multiple trauma and high injury 
severity scores (ISS), particularly 
those with abdominal wounds and 
sepsis, die postoperatively of multi­
ple organ failure (MOF). It is postu­
lated38 that because of persistent 
hematomas, necrotic tissue, abscess 
formation, peritonitis, free pancreat­
ic enzymes and other prolonged 
complement activation, polymor­
phonuclear leukocytes are induced 
to release prostaglandins and toxic 
oxygen radicals. This leads to endo­
thelial damage and permeability 
edema that limit oxygen diffusion, 
not only to the primary site but to 
other vital organs, resulting in 
anoxia and organ failure.
Prevention is the first step. Car­
diovascular and renal failure can be 
reduced by early aggressive resusci­
tation to shorten the period of 
hypotension. Immediate control of 
hemorrhage when possible is essen­
tial. At the time of surgery debride­
ment must be adequate, hematomas 
must be drained, blood clots re­
moved from the abdominal cavity 
and fractures splinted.
The management of established 
MOF has two approaches: the un­
derlying cause must be treated and 
the failing organ must be support­
ed. Because sepsis will be responsi­
ble in 70% of cases39 therapy is 
directed toward control of infection. 
Antibiotics must be given before 
and after operation. At laparotomy, 
thorough examination of the abdo­
men is carried out and sound surgi­
cal principles are used to manage 
abdominal wounds.
Driver and colleagues40 found 
that in 70 of 782 patients with 
abdominal wounds requiring reoper­
ation, 45.5% had intra-abdominal
abscesses and 12.1% peritonitis. 
Clinical signs of abscess after sur­
gery for penetrating abdominal 
wounds are often unimpressive; 
awareness is usually the first step in 
diagnosing an intra-abdominal ab­
scess. Diagnosis is confirmed when 
possible by roentgenography, ul­
trasonography, sinography or com­
puted tomography. However, celi­
otomy may be indicated if tests are 
negative but organ dysfunction and 
the septic state continue.
Polk and Shields41 noted that 
death rates with surgical drainage 
of intra-abdominal abscesses post­
operatively ranged from 21% to 
50% in published reports. Even 
these figures indicate a salvage rate 
of 50% to 67% of patients who 
otherwise face almost certain death.
If ventilation problems are antici­
pated, controlled ventilation with a 
volume respirator should be contin­
ued postoperatively. Border42 dem­
onstrated a marked reduction in the 
death rate from adult respiratory 
distress syndrome by the immediate 
fixation of fractures, permitting 
early ambulation. Oliguria, despite 
adequate hydration, suggests post- 
traumatic renal insufficiency, which 
can be managed by hemodialysis.
Adequate cardiac output should 
be maintained, using inotropic 
agents early, such as isoproterenol, 
dopamine and epinephrine (a com­
mon denominator in multiple sys­
tem failure may well be a marginal 
cardiac output with a reasonable 
arterial pressure but inadequate 
organ flow).
The frequency of stress ulcer­
ation can be reduced by keeping the 
stomach empty and administering 
antacids through nasogastric tube 
to maintain a gastric pH between 6 
and 7.
Corrigan and associates43 have 
shown that patients with septicemia 
who are hypotensive have changes 
in the coagulation system compati­
ble with intravascular clotting. Hep­
arin is given in such cases to pre­
vent episodes of diffuse coagula­
tion. The need for immediate nutri­
tional support to prevent malnutri­
tion (catabolism and anergy) has 
been advocated.44-46
Comment
The overall mortality in penetrat­
ing wounds of the abdomen, as 
reported from trauma centres over 
the past 15 years, varies between 
7.4% and 12.7% (Moore EE: Per­
sonal communication, 1986).47-49 
These figures compare favourably 
with the rates of from 2.4% to 10% 
reported from the Vietnam War.37
With experience gained from the 
T/EMS, advances in the treatment 
of penetrating abdominal wounds 
do not have to await the experi­
ences gained through another war. 
The Ben Staub Hospital in Hous­
ton, Texas, reported receiving 1545 
trauma patients in 1979,50 81% of 
whom had penetrating wounds. 
Sixty percent of the penetrating 
wounds were caused by gunshots 
and over 50% of these were abdomi­
nal wounds that required laparoto­
my for management.
The military surgeon must keep 
abreast of peacetime advances in 
the treatment of trauma and partic­
ularly of gunshot wounds.
Freeark51 recently noted that ac­
cident hospitals in the US will be­
come semi-autonomous units treat­
ing only trauma patients and simu­
lating the “one hospital” concept 
so successful in Vietnam. He also 
suggested that the hospitals be 
staffed by a new kind of health care 
professional, a fulltime employee 
who will choose to devote his or her 
career to the care and rehabilitation 
of the injured. To maintain the high 
standard of military surgery in fu­
ture wars it may be imperative that 
our military surgeons be trained in 
traumatology. It could also have
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specific application to the surgeon 
who elects to work in isolated or 
small communities in Canada.
References
1. Van Waconer FH: A three year study of 
deaths following trauma. J Trauma 
1961; 1: 401-408
2. W est JG: An autopsy method for evalu­
ating trauma care. J Trauma 1981; 21: 
32-34
3. Perry JF jr, McLellan RJ: Autopsy 
findings in 127 patients following fatal 
traffic accidents. Surg Gvnecol Obstet 
1964; 119: 586-590
4. Gertner HR jr, Baker SP, Rutherford 
RB, et al: Evaluation of the management 
of vehicular fatalities secondary to ab­
dominal injury. J Trauma 1972; 12: 
425-431
5. Accidental Death and Disability: the Ne­
glected Disease o f  Modem Society, US 
National Academy of Sciences, National 
Research Council, Washington, DC, 
1966
6. Boyd DR, Cowley RA: Comprehensive 
regional trauma/emergency medical 
services (EMS) delivery systems: the 
United States experience. World J Surg 
1983; 7: 149-157
7. Roy PD: The value of trauma centres: a 
methodologic review. Can J Surg 1987; 
30: 17-21
8. Aprahamian C, Thompson BM. Towne 
JB, et al: The effect of a paramedic 
system on mortality of major open intra­
abdominal vascular trauma. J Trauma 
1983; 23: 687-690
9. Jacobs LM, Sinclair A, Beiser A, et al: 
Prehospital advanced life support: bene­
fits in trauma. J Trauma 1984; 24: 8-13
10. McSwain N: Pneumatic anti-shock gar­
ment — a useful adjunct in prehospital 
care (abstr). Paper presented at the 
American College of Surgeons 72nd 
Annual Clinical Congress. New Orleans. 
Oct. 19-21, 1986
11. Buchard KW: Pneumatic anti-shock 
garment versus Trendelenburg position 
— a hemodynamic assessment. Ibid
12. Baker SP, O ’Neill B, Haddon W jr, et 
al: The injury severity score: a method 
for describing patients with multiple 
injuries and evaluating emergency care. 
J Trauma 1974; 14: 187-196
13. Sacco WJ, Champion HR, Gainer PS, et 
al: The Trauma Score as applied to 
penetrating trauma. Ann Emerg Med 
1984; 13: 415-418
14. Lucas CE, Ledcerwood AM: The fluid 
problem in the critically ill. Surg Clin 
North Am 1983; 63: 439-454
15. Ruiz CE, W eil MH, Carlson RW: Treat­
ment of circulatory shock with dopa­
mine. Studies on survival. JAMA 1979; 
242:165-168
16. Schwab CW, Shayne JP, T urner J: 
Immediate trauma resuscitation with 
type O uncrossmatched blood: a two- 
year prospective experience. J Trauma 
1986; 26: 897-902
17. Thurer RL, Hauer JM: Autotransfusion 
and blood conservation. Curr Probl 
Surg 1982; 19: 97-156
18. Mattox KL, Beall AC jr: Autotransfu­
sion: use in penetrating trauma. Tex 
Med 1975: 71: 6 9 -7 7
19. Feliciano DV. Bitondo CG, Mattox KL, 
et al: Civilian trauma in the 1980s. A 
1-year experience with 456 vascular and 
cardiac injuries. Ann Surg 1984; 199: 
717-724
20. Rich NM, Bauch JH, Hughes CW: Acute 
arterial injuries in Vietnam: 1,000 cases. 
J Trauma 1970; 10: 359-369
21. Millikan JS, Moore EE: Outcome of 
resuscitative thoracotomy and descend­
ing aortic occlusion performed in the 
operating room. J Trauma 1984; 24: 
387-392
22. Ledcerwood AM, Kazmers M, Lucas 
CE: The role of thoracic aortic occlusion 
for massive hemoperitoneum. J Trauma 
1976; 16: 610-615
23. Buchness MP, LoGerfo FW, Mason GR: 
Gunshot wounds of the suprarenal ab­
dominal aorta. Am Surg 1976; 42: 1-7
24. Brinton M, Miller SE, Lim RC jr, et al: 
Acute abdominal aortic injuries. J Trau­
ma 1982; 22: 481-486
25. Allen TW, Reul GJ, Morton JR, et al: 
Surgical management of aortic trauma. 
J Trauma 1972; 12: 862-868
26. Mattox KL, McCollum W B, Beall 
AC JR, et al: Management of penetrating 
injuries of the suprarenal aorta. J Trau­
ma 1975; 15: 808-815
27. Turpin I, State D, Schwartz A: Injuries 
to the inferior vena cava and their 
management. Am J Surg 1977; 134: 
25-32
28. Graham JM, Mattox KL, Beall AC jr, 
et al: Traumatic injuries of the inferior 
vena cava. Arch Surg 1978; 113: 413— 
418
29. Graham JM, Mattox KL, Beall AC jr: 
Portal vein system injuries. J Trauma 
1978; 18: 419-422
30. Kashuk JL, Moore EE. Millikan JS, et 
al: Major abdominal vascular trauma — 
a unified approach. J Trauma 1982; 22: 
672-679
31. Lucas CE: Diagnosis and treatment o f 
pancreatic and duodenal injury. Surg 
Clin North Am 1977; 57: 49-65
32. Nance FC: Management of injuries to 
the stomach, duodenum and pancreas. 
In W orth MH jr (ed): Principles and 
Practice o f  Trauma Care, Williams & 
Wilkins, Baltimore, 1982: 136-140
33. Stone HH, Fabian TC, Satiani B. et al: 
Experiences in the management of pan­
creatic trauma. J Trauma 1981; 21: 
257-262
34. Moore JB, Moore EE: Changing trends 
in the management of combined pan­
creaticoduodenal injuries. World J Surg 
1984; 8: 791-797
35. Trunkey DD: Torso trauma. Curr Probl 
Surg 1987; 24: 209-265
36. Sheldon GF: Liver injuries (abstr). 
Paper presented at the American College 
of Surgeons 70th Annual Clinical Con­
gress, San Francisco, Oct. 21-26, 1984
37. Derby AC: Wounds of the abdomen. 
Part 1: In war. Can J Surg 1988; 31: 
213-218
38. Goris RJ, te Boekherst TP, Nuytinck 
JK, et al: Multiple-organ failure. Gener­
alized autodestructive inflammation? 
Arch Surg 1985; 120: 1109-1115
39. Fry DE, Pearlstein L, Fulton RL, et al: 
Multiple system organ failure. The role 
of uncontrolled infection. Arch Surg 
1980; 115: 136-140
40. Driver T, Kelly GL, Eiseman B: Reop­
eration after abdominal trauma. Am J 
Surg 1978; 135: 747-750
41. Polk H C jr, Shields CL: Remote organ 
failure: a valid sign of occult intra­
abdominal infection. Surgery 1977; 81: 
310-313
42. Border JR: Advances in the care o f  the 
patient with blunt multiple trauma. Bull 
Am Coll Surg 1984; 69: 7 -1 1
43. Corrigan JJ jr, Ray WL, May N: 
Changes in the blood coagulation sys­
tem associated with septicemia. N Engl 
J Med 1968; 279: 851-856
44. Moore EE, Jones TN: Benefits of imme­
diate jejunostomy feeding after major 
abdominal trauma — a prospective ran­
domized study. J Trauma 1986; 26: 
874-881
45. MacLean LD: Systemic antibacterial 
mechanisms in trauma. World J Surg 
1983; 7: 119-124
46. Abbott WC, Echenique MM, Bistrian 
BR, et al: Nutritional care of the trauma 
patient. Surg Gynecol Obstet 1983; 157: 
585-597
47. Taylor FW: Gunshot wounds of the 
abdomen. Ann Surg 1973; 177: 174- 
177
48. Nance FC, W ennar MH, Johnson LW, 
et al: Surgical judgment in the manage­
ment of penetrating wounds of the ab­
domen: experience with 2212 patients. 
Ann Surg 1974; 179: 639-646
49. Davidson 1, Miller E, Litwin MS: Gun­
shot wounds of the abdomen. Arch Surg 
1976: 3: 862-865
50. Rapaport A, Feliciano DV, Mattox KL: 
An epidemiologic profile o f urban trau­
ma in America — Houston style. Tex 
Med 1982; 78: 44-50
51. Freeark RJ: Scudder Oration on Trau­
ma — the accident hospital. Bull Am 
Coll Surg 1986; 71: 24-30
VOL. 31, NO. 5 SEPTEMBER 1988/U S 311
Dalacin C Phosphate Sterile Solution
(clindamycin phosphate)
Antibiotic
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by 
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections 
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic 
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium 
species and micro-aerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms 
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) 
when the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in 
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or 
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has not 
been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have 
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (in­
fants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy 
with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with 
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary, con­
tinued only with close observation. Significant diarrhea occuring up to several weeks post-therapy 
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes 
may respondtosimpledrugdiscontinuance.Moderatetoseverecases.includingthoseshowingulcera- 
tion or pseudomembrane formation, should be managed with fluid, electrolyte, and protein 
supplementation as indicated. Corticoid retention enemas and systemic corticoids may be of help in 
persistent cases. Anticholinergics and antiperistalticagents may worsen the condition. Other causes 
of colitis should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal 
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this 
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco­
mycin were administered orally four times a day for 5 -1 0  or more days, there was a rapid ob­
served disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be noted that serious relapses have occurred up to one month after apparently successful 
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with 
caution in atopic individuals. Dalacin C Phosphate must be diluted for intravenous administration. 
(See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly 
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the 
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic 
liver function tests should be performed during prolonged therapy. Blood counts should also be 
monitored,during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in 
patients with impaired hepatic function is greater than that found in normal patients, the dose of 
Dalacin C Phosphate should be appropriately decreased. Hemodialysisand peritoneal dialysis are not 
effective means of removing the compound from the blood. Periodic serum levels should be deter­
mined in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin 
phosphate) intramuscularly (with a solution containing 150 mg/ml), six (1.5%) demonstrated local 
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at 
the injection site and two developed sterile absesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion, 
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and 
one patient developed both superficial and deep thrombophlebitis. The majority of these cases 
developed inconjuctionwiththeuseofindwellingI.V.cathetersanditisdifficulttoknowhowmuchthe 
drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at 
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin 
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Number o f Patients
Rash.........................................................................................................................................................  7
Urticaria...................................................................................................................................................  1
Pruritus..................................................................................................................................................... 1
Fever, Leucocytosis.................................................................................................................................  1
Nausea, with or without vomiting..........................................................................................................  1
Diarrhea (See also under "Warnings').....................................................................................................  4
Hypotension.............................................................................................................................................  1
Hypertension............................................................................................................................................  1
Shortness of B'eath................................................................................................................................  1
Superinfection'.......................................................................................................................................  4
Cardiac arrest* * ......................................................................................................................................  1
Bad or bitter taste in mouth....................................................................................................................  5
Superinfection is a complication of antibiotic therapy in general and is not necessarily a true side 
effect of clindamycin phosphate.
** Due to underlying myocarditis in this patient.
Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate 
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology, 
urinalysis and liverand kidney function tests. Some of these tests were abnormal initially and returned 
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became 
abnormal,during therapy. Overall evaluation of clinical laboratory values in these patients does not 
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal 
systems. Transient elevations of serum transaminases have occured in some patients, but other liver 
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and 
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms and Treatment ot Overdosage: No cases of overdosage have been reported. No specific 
antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days 
have been given without adverse effects.
DOSAGE AND ADMINISTRATION 
Adults
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections of more than 
600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to 
I V. administration to a dilution of 300 mg in 50 mL of diluent (6mg/mL) or more, and infused in not less 
thanlOminutes. Administration of more than 1200mg inasingle 1 hourinfusionisnot recommended. 
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each 
infused over 20 minutes or longer.
Severe Infections: 1800to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over 
20 minutes or longer. In life-threatening infections, doses of 2700to 4800 mg/day by continuous drip or 
in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and infusion rates:
Dose Diluent Time
300 mg 50 mL 10 min.
600 mg 100 mL 20 min.
900 mg 150 mL 30 min.
1200 mg 200 mL 45 min.
Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
To maintain serum Rapid Maintenance
clindamycin levels infusion rate infusion rate
Above 4 mcg/mL 10mg/min.for30min. 0.75 mg/min.
Above 5 mcg/mL 15mg/min.for 30 min. 1.00 mg/min.
Above 6 mcg/mL 20 mg/min. for 30 min. 1.25 mg/min.
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2,3 or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each 
infused over 20 minutes or longer.
Severe infections: It is recommended that children be given no less than 300 mg/day regardless of body 
weight. (Dilute Dalacin C Phosphate Sterile Solution in the same manner as for adults.)
Dilution and Compatibility:
4 mL (600 mg) Dalacin C Phosphate when diluted with 1000 m t of the following commonly used in­
fusion solutions was found to be physically compatible and demonstrated no significant change in pH 
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection 
Dextrose 5% in water 
Dextrose 5% in saline 
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride 
Dextrose 21/2% in Lactated Ringer's Solution (Hartmann s Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is 
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins.
Supplied:
Dalacin C Phosphate contains the following per mL of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg 
Benzyl alcohol 5 mg 
Disodium edetate 0.5 mg 
Water for injection q.s.
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH 
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 mL and 4 mL ampoules.
NOTE: Do not store below 15°C.
Product Monograph available upon request.
8704 R E G IS T E R E D  T R A D E M A R K : D A L A C IN  « » « »
T R A D E M A R K : D A L A C IN  C  CE 1377.1C I I
U p j o h n
antibiotic THE UPJOHN COMPANY OF CANADA PAAB
RESEARCR  865 YORK MILLS ROAD/DON MILLS, ONTARIO I CCFP
CANADIAN CARDIOVASCULAR SOCIETY
A
*
r
>
V
s
*■
V-
Intraoperative Doppler Flow Studies: 
Emphasis on Colour Mapping
W.J. Duncan, MD, FRCPC;* M.J. Tyrrell, MB, BS, FACC, FRCPC;* B. Bharadwaj, MD, FRCSC;t 
S.K.S. Iyengar, MB, BS, FRCSCt
Colour Doppler flow imaging (CD) is a well-established method of assessing valvular 
and congenital disease of the heart. The technique has proven useful 
intraoperatively in patients undergoing valve repair or replacement or intracardiac 
reconstruction.
In 21 patients with various cardiac anomalies, colour Doppler flow imaging was 
used intraoperatively, before cardiac cannulation and again after cardiopulmonary 
bypass. Previously undisclosed features were demonstrated preoperatively in two 
patients and important residual defects after cardiopulmonary bypass in three 
others. Adequacy of valve replacement was confirmed in four patients and small 
leaks in ventricular septal defect patches were shown in another three. The 
procedure facilitated repair of complex cardiac fistulas in two patients. There were 
no apparent complications from CD.
As intracardiac repairs become more complex, the role of intraoperative CD will 
expand.
La visualisation couleur du debit sanguin par systeme Doppler est une methode 
reconnue devaluation des maladies cardiaques valvulaires et congenitales. Cette 
technique a demontre son utilite durant l’operation chez les patients qui subissent 
une valvuloplastie, un remplacement valvulaire ou une reconstruction cardiaque.
Chez 21 patients souffrant de diverses anomalies cardiaques, la visualisation 
couleur du debit sanguin par systeme Doppler a ete utilisee durant Tintervention, 
avant le catheterisme cardiaque ainsi qu’apres la circulation extracorporeile. Des 
caracteristiques prealablement inconnues ont ete demontrees preoperativement chez 
deux patients et des effets residuels importants ont ete deceles chez trois autres, 
apres circulation extracorporeile. La reussite du remplacement valvulaire fut 
confirmee chez quatre patients, alors que de petites fuites a partir des plaques 
refermant la paroi ventriculaire etaient revelees chez trois autres. Ce procede a 
facility la reparation de fistules cardiaques complexes chez deux patients. On n’a 
observe aucune complication apparente attribuable a la visualisation couleur du 
debit par systeme Doppler.
Avec la complexity toujours plus grande des reparations cardiaques, le role de la 
visualisation couleur par systeme Doppler est destine a s’etendre.
From the *Department o f Pediatrics and fDepartment of Surgery, University o f Saskatchewan, 
Saskatoon, Sask.
Presented at the 40th annual meeting o f the Canadian Cardiovascular Society, Edmonton, Alta., 
Oct. 28-31. 1987
Accepted for publication Mar. 21, 1988
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S ince the advent of open-heart surgery, cardiac surgeons have 
had to rely on postoperative studies 
to assess the efficacy of their opera­
tions. In the past, at the end of 
cardiopulmonary bypass, subjective 
observations on cardiac filling and 
contractility would be made. A 
search for thrills that could indicate 
a persistent regurgitation and a 
review of waveforms from indwell­
ing lines or temporary needle mea­
surements from various heart cham­
bers would follow. The results of 
such studies were vague and did 
not answer the important question, 
have we done the best operation 
technically possible for our patient? 
We review our experience with col­
our Doppler flow imaging, a new 
technique that can help to answer 
this question.
History
Several reviews1"8 have demon­
strated the applicability of intraop­
erative ultrasonography.
The use of M-mode (single crys­
tal) echocardiography in the operat­
ing room was reported as early as 
1972.1 With technical advances, 
two-dimensional imaging systems 
were introduced, providing useful 
anatomical information after in­
tracardiac repairs.2
The mating of Doppler flow infor­
mation to two-dimensional echocar­
diography supplemented intraopera­
tive knowledge because two impor-
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tant parameters of cardiac flow, 
velocity and output, could be deter­
mined noninvasively.3
In 1984 sophisticated imaging 
systems employing colour flow 
mapping were introduced commer­
cially; these gave cardiovascular 
surgeons a powerful new tool for 
intraoperative assessment of the 
heart.4-8
The Device
Colour Doppler flow imaging 
(CD) uses a computer-like device 
called an autocorrelator to separate 
and distinguish the minor ultra­
sound frequency shifts (Doppler 
shift) occurring over a defined area. 
These variations are depicted as
colours relative to the transmitted 
frequency. With the system used in 
this article, blood flowing toward 
the transducer is shown in red 
(positive Doppler shift), the con­
verse in blue. The colour flow infor­
mation provides an overlay to the 
cardiac walls and valves as depicted 
by amplitude imaging ultrasound 
signals (Fig. 1). The physics of this 
system, as in all pulsed Doppler 
systems, limits the measurable ve­
locity for a given depth and fre­
quency (Nyquist limit); hence, if the 
blood is flowing faster than the 
Doppler system can measure at a 
given setting, the colour will 
“alias” and the blood flow appear 
to have reversed direction. Turbu­
lent and very high velocity blood
flow will have a mosaic or confetti­
like appearance because of the 
swirling effect. A complete review 
of the instrument is beyond the 
scope of this article, but Omoto9 
and Duncan10 have discussed the 
technique in detail elsewhere.
Intraoperative Method and 
Results
We adopted a cost-effective meth­
od of intraoperative CD in 21 pa­
tients with various cardiac anoma­
lies. Instead of undertaking 24-hour 
gas sterilization of the transducer, 
which means buying two transdu­
cers or using a transesophageal 
transducer (costing approximately 
$30 000), we place the instrument 
inside a sterile bowel bag containing 
a generous amount of airless gel. 
The operator, scrubbed, gowned 
and gloved, places the bag directly 
on the epicardium to start the re­
cording. We frequently perform pre­
operative studies after cannulation 
but before initiating cardiopulmo­
nary bypass. A complete echocardi- 
ographic study is carried out using 
the standard technique.4 Views are 
obtained of all valves, septa, cham­
bers and cannulation sites. Any dis-
a
2 !H 
D  2  
O  O  
cn ta 
<  U
os >
E-< <  
J  &
D
TRANSDUCER
RECEIVER
AMPLITUDE
INFORMATION
(DOPPLER)
VELOCITY
INFORMATION
(DOPPLER)
CARDIAC 
WALLS AND 
VALVES
AUTOCORRELATOR 
COLOUR FLOW
RANGE-GATED 
PULSED DOPPLER
FIG. 1 — Schematic diagram of echocardiographic colour Doppler system.
Fig. 2a Fig. 2b
FIG. 2 — Case 2. (a) “Four-chamber equivalent” view showing blue jet (arrowheads) of systolic periprosthetic regurgitation 
passing from left ventricle (LV) to left atrium (LA), (b) After repair of third ventriculoatrial fistula, periprosthetic regurgitant jet 
is no longer seen. RA =  right atrium, RV = right ventricle, S =  interventricular septum.
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eased areas are videotaped and pho­
tographed for later comparison with 
the postoperative appearances.
When the surgical procedure is 
completed but before the cannulas 
are removed, surgical sites are re­
viewed by CD with respect to the 
following:
•  State of the surgical site (e.g., 
valve function, regurgitation, patch 
integrity).
•  Disease unrecognized preoper- 
atively.
•  Flow patterns and gradients.
•  Cardiac output and regional 
wall motion.
•  Placement and position of in­
dwelling catheters.
Only when the surgeon is satis­
fied with the situation is the study 
terminated and the operation com­
pleted.
Preoperative use of CD on two 
occasions yielded information that 
had been missed preoperatively by 
both invasive and noninvasive 
studies. Intraoperative use prevent­
ed possible reoperation in at least 4
of 21 patients and greatly facilitated 
the surgery in 3 others with com­
plex fistulas.
The following case reports are 
examples of the type of information 
CD studies can provide intraopera- 
tively.
Case Reports
Case 1
A 12-year-old boy had evidence 
of persistent mitral regurgitation 2
Fig. 3a Fig. 3b
FIG. 3 — Case 2. (a) “Four-chamber equivalent” view shows broad band of systolic mitral regurgitant flow (open arrows) and 
small amount of tricuspid regurgitation (small closed arrow). Asterisks represent plane of mitral valve leaflets, (b) After mitral 
valve replacement, only small band of tricuspid regurgitation (arrow) was identified passing from right ventricle to right atrium.
Fig. 4a Fig. 4b
FIG. 4 — Case 3. (a) “Four-chamber equivalent” view confirming left ventricular to right atrial jet (arrowheads), (b) As in (a) 
with slight tilt to right and shift of colour flow cone to right. Jet passes to lateral wall of right atrium and interiorly toward 
orifice of inferior vena cava (arrows).
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years after mitral valve replacement. 
Preoperative CD and cardiac cathe­
terization confirmed that there was 
residual mitral regurgitation.
Intraoperative CD performed 
after repair of two periprosthetic 
fistulas showed (Fig. 2a) a persis­
tent jet of blood passing from left 
ventricle to left atrium, beside the 
prosthesis.
The site was re-explored and a 
third fistula, concealed under the 
sewing ring, was discovered; this
was oversewn. Further CD con­
firmed an intact repair (Fig. 2b).
Case 2
A 12-year-old girl, who showed 
evidence of congestive heart failure, 
was found to have severe mitral 
regurgitation. A poor response to 
medical therapy prompted an at­
tempt at a mitral valve repair. In­
traoperative CD (Fig. 3a) showed 
severe systolic mitral regurgitation
passing across a broad front 
through the closed mitral leaflets. 
Attempted repair of the valve by 
suturing a “cleft” and placing a 
Carpentier ring in the annulus 
proved ineffective on subsequent 
CD, which demonstrated no sub­
stantial improvement over the pre­
operative recording. High left atrial 
pressures confirmed persistent mi­
tral regurgitation requiring mitral 
valve replacement. After valve re­
placement there was no mitral re­
gurgitation (Fig. 3b), but mild tri­
cuspid regurgitation persisted.
Case 3
A 53-year-old man who had un­
dergone aortic valve replacement 4 
years earlier, presented with fever, 
malaise and a new loud pansystolic 
murmur. Preoperative investiga­
tions confirmed a fistulous tract 
from the base of the aortic prosthe­
sis to both right ventricle and right 
atrium. After 4 weeks of antibiotic 
therapy, surgical repair was at­
tempted.
After cannulation but before in­
tracardiac repair, CD confirmed a 
high-velocity jet of blood flowing 
from the left ventricle and the base 
of the prosthesis to the right atrium
FIG. 5 — Case 3. Continuous wave Doppler spectral display showing continuous 
and systolic peaking high-velocity jet (3.6 m /s) of ventriculoatrial fistula.
Fig. 6a Fig. 6b
FIG. 6 — Case 6. (a) “Long-axis equivalent” view showing tumour mass (T) occupying mitral orifice in diastole. AO = aorta, (b) 
“Short-axis equivalent” view showing similar features. Unobstructed portion of mitral valve orifice (MVO) is indicated by arrow.
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(Fig. 4a). Angulation of the trans­
ducer confirmed that this jet was 
directed at the right atrial wall and 
deflected back toward the origin of 
the inferior vena cava (Fig. 4b).
Continuous wave Doppler study 
of the flow disturbance (Fig. 5) 
confirmed the continuous and peak­
ing patterns (3.6 m /s) of the ven­
triculoatrial jet.
At surgery, Dacron patches and 
pledgetted sutures were placed 
around the area of tissue break­
down. The septal leaflet of the 
tricuspid valve was detached and 
later resewn to the Dacron patch.
After bypass was discontinued,
CD confirmed an intact repair. The 
patient made a successful recovery.
Case 4
A 33-year-old woman with mul­
tisystem complaints and exertional 
dyspnea was found, on echocardiog­
raphy, to have a left atrial tumour. 
Intraoperative echocardiography 
was performed before and after tu­
mour resection.
From long axis (Fig. 6a) and 
short axis (Fig. 6b) views the tu­
mour was seen to fill most of the 
mitral valve orifice. The tumour, 
histologically identified as a myxo­
ma, was excised without difficulty 
and complete resection confirmed 
(Fig. 7) by CD.
Case 5
A 60-year-old woman with symp­
tomatic isolated mitral stenosis un­
derwent intraoperative Doppler as­
sessment. The mitral pressure half­
time, a measure of the degree of 
mitral stenosis, is normally less 
than 100 ms, range of severity from 
115 to 400 ms (Fig. 8a), but in this 
case it was greatly prolonged at 
375 ms (Fig. 8b) as measured by 
continuous wave Doppler recording 
across the valve.
The valve was visualized and 
photographed before (Fig. 9a) and 
after (Fig. 9b) an open commis­
surotomy performed using cardio­
pulmonary bypass.
After commissurotomy the pres­
sure half-time was reduced to 265 
ms (Fig. 10). There was no serious 
mitral regurgitation.
Follow-up echocardiographic 
studies 1 month later demonstrated 
a further improvement in mitral 
pressure half-time (190 ms).
Discussion
Intraoperative echocardiographic- 
Doppler techniques have justifiably 
earned a niche in the operating
FIG. 7 — Case 4. Post-resection long-axis view indicating complete removal of 
tumour.
Fig. 8a
Tj ” TQ - pressure 1/2 Ciae
Fig. 8b
FIG. 8 — Case 5. (a) Schematic method to calculate mitral pressure half-time, (b) Preoperative mitral valve pressure half-time. 
Peak inflow velocity [x] at time T0 is divided by V2 or 1.4 =  y at time Tx — T0 =  pressure half-time at 375 ms.
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Fig. 9b
FIG. 9 — Case 5. View of mitral valve 
(a) before commissurotomy, (b) after 
commissurotomy.
room. The initial elementary “wall 
and valve” information provided by 
the M-mode instrument has been 
upgraded to sophisticated colour 
flow imaging as demonstrated in 
the cases we have described. The 
ability of colour flow imaging to 
provide reliable, accurate and imme­
diate confirmation of surgical repair
has been reported.11’13 These proce­
dures, however, require a specific 
time commitment and a practical 
knowledge of the instrument. The 
surgeon must accept that an addi­
tional 10 to 15 minutes will be 
required for imaging, recording and 
photography. A longer procedure 
may slightly increase the risks of 
operation and anesthesia, but these 
risks are minimal and should be 
offset by potential benefits to the 
patient. We believe that this tech­
nique has and will continue to re­
duce the need for reoperation in 
many patients, particularly patients 
who undergo procedures other than 
those for coronary artery disease.
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1. Transport of Critically 111 Adult Patients
M.J. Girotti, MD, FRCSC; G. Pagliarello, MD, FRCSC
Interhospital transportation of critically ill patients over long distances is common 
in the tiered health care systems of North America. The authors describe their 
1-year experience with a physician-assisted transport system, operating out of the 
surgical intensive care unit at the Toronto General Hosptial. The application of a 
well-known severity of illness measure (therapeutic intervention scoring system) 
allowed them to correlate severity of illness, as assessed over the telephone before 
patient transfer, with eventual outcome after admission to the surgical intensive care 
unit. Their analysis of 107 critically ill patients transported by this system led them 
to conclude that the system is reliable and is associated with acceptable morbidity 
and mortality.
A cause de la structure etagee du systeme de soins de sante qui a cours en Amerique 
du Nord, il est frequent de transporter sur de longues distances des patients 
gravement malades qui doivent etre transferes d’un hopital a un autre. Les auteurs 
decrivent l’usage pendant 1 an, d’un systeme de transport avec support d’un 
medecin, fonctionnant a partir du service des soins intensifs du Toronto General 
Hospital. L’emploi d’un systeme bien connu de cotation de la gravite de la maladie 
(le systeme de cotation de Tintervention therapeutique) a permis d’etablir un rapport 
entre la gravite de la maladie, telle qu’on avait pu l’etablir par telephone avant le 
transfert du malade, et l’issue eventuelle apres son admission a l’unite de soins 
chirurgicaux intensifs. L’analyse de 107 patients gravement malades qui ont 
beneficie de ce systeme porte a conclure que le systeme est fiable et qu’il est lie a 
une morbidity et une mortality acceptables.
A ccess to medical and surgical intensive care units is a pre­
requisite in Canada’s tiered health 
care system. Transportation is cur­
rently designed to serve two pur­
poses: to evacuate patients from the
Accepted for publication Mar. 8, 1988
scene of injury to a base hospital 
and to transfer patients between 
hospitals. The former is based on a 
military model developed during the 
Vietnam War.1 Civilian application 
of such a system was pioneered by
physicians and politicians in West 
Germany who established and main­
tained extensive aeromedical facili­
ties for the resuscitation and trans­
port of critically ill patients. Before 
transport, patients should be stabi­
lized because the journey to reach 
the technology and personnel of­
fered by advanced critical care units 
may involve great distances. This 
report focuses on the transfer of 
critically ill patients between hospi­
tals.
Transport over long distances 
and for prolonged periods removes 
patients from a stable environment 
such as the emergency department 
or the intensive care unit and ex­
poses them to a less stable monitor­
ing system. The sending and receiv­
ing physicians must agree that the 
benefits outweigh the risks of trans­
port.
The components of an effective 
transport system include the follow­
ing:
•  Coordination and dispatch 
control
•  The transport vehicle
•  The driver or pilot
•  Resuscitation personnel and 
their equipment; this may include 
physician, nurse, paramedic and 
respiratory therapist.
Transport systems include 
ground ambulances staffed by basic 
or advanced life-support ambulance 
personnel, as available provincially. 
Aircraft are staffed by specially 
trained paramedics, nurses or physi­
cians. The method of transport is
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influenced by severity of the pa­
tient’s condition, vehicle availabili­
ty, distance and weather conditions. 
It is essential for institutions taking 
part in a transport system to moni­
tor their activities in an attempt to 
develop epidemiologic tools for 
more accurately estimating the 
risks of transport. This will enable 
them to match the patient’s needs 
to the available resources.
We summarize our experience at 
the surgical intensive care unit of 
the Toronto General Hospital over 1 
year (Feb. 1, 1986 to Jan. 31, 
1987) with the transport of 107 
patients by a physician-accompanied 
transport system (PATS).
The Transport System
The PATS is based in the surgi­
cal intensive care unit (SICU) at the 
Toronto General Hospital and is 
supervised by the staff members of 
the unit (four surgeons, one anes­
thetist). A physician wishing to ini­
tiate transfer of a critically ill pa­
tient contacts either the attending 
SICU specialist directly or the re­
ceiving surgical service which in 
turn contacts the SICU physician. 
Data on the patient’s condition are 
obtained by telephone and an esti­
mated severity of illness score, 
based on the therapeutic interven­
tion scoring system (TISS), for 
transport is generated.2 This score 
accurately reflects the number of 
interventions required to stabilize a 
given patient physiologically. Three 
separate severity of illness scores 
were generated: TISS-TEL, which is 
the TISS assessed over the tele­
phone before departure of the phy­
sician-accompanied transportation 
from the SICU; TISS-DEP, the 
TISS assessed before the patient’s 
departure from the referring institu­
tion and TISS-1, the standard TISS 
after 1 day of therapy at the Toron­
to General Hospital. On the basis of 
the distance, acceptable delay in
transfer and vehicle availability, the 
receiving physician then arranges 
for the appropriate vehicle — 
ground ambulance, helicopter, tur­
bo-propeller or jet aircraft — for 
patient transport. The transport 
team comprises a respiratory thera­
pist and an SICU resident, usually 
one with at least 2 years of post­
graduate training, who is skilled in 
all aspects of airway management 
and resuscitation. The team carries 
a resuscitation kit consisting of 
intravenous solutions, standard car­
diopulmonary drugs, and other 
pharmacologic agents or special 
equipment that may be necessary 
for individual patient resuscitation 
(e.g., a bronchoscope).
On arrival of the PATS team at 
the referring institution, the patient 
is assessed to determine suitability 
for transport. Measures needed to 
assure clinical stability are under­
taken before departure: these in­
clude intubation, insertion of chest 
tubes, establishment of intravenous 
routes for resuscitation or monitor­
ing and administration of appropri­
ate medications. Monitoring in tran­
sit is within the limitations of the 
transport medium. Physiologic 
changes and any interventions un­
dertaken are recorded on a specially 
designed data sheet and re-recorded 
on arrival at the Toronto General 
Hospital. The data are stored in a 
microcomputer database for future 
analysis.
All data were recorded as the 
mean ± the standard deviation. 
Two sample comparisons were done 
using an unpaired f-test.3 Group
means were compared by the 
Kruskal-Wallis modification of 
ANOVA.4 The a error for statistical 
significance was selected at 0.05.
Findings
The average age of the patients 
was 52 years (range from 16 to 86 
years). One hundred and seven pa­
tients were transported using the 
PATS; 21 because they were possi­
ble major organ donors and 86 for 
other reasons (Table I). The times 
for the transport of patients to the 
SICU are summarized in Table II. 
“Start-up time’’ was the time from 
initial phone call to departure of the 
transport team from the Toronto 
General Hospital. “Time to” was 
the time taken by the team to reach 
the referring hospital and the 
“pack-up” time was the time re­
quired for patient stabilization. The 
“time in” was the time needed to 
return to the hospital. The dis­
tances transported ranged from 1 to 
8000 km. A time to distance ratio is 
related to the final outcome (Table 
II). Of the 107 patients, 56% were 
transferred by land ambulance, 22% 
by helicopter, 15% by fixed wing 
aircraft and 7% by jet.
The majority of patients were 
intubated (82%) and required assis­
ted mechanical ventilation (71%). 
Vasopressor agents were used in 
27% of patients, and 24% needed 
both mechanical ventilation and 
vasopressors to maintain cardiopul­
monary stability.
Problems of a technical or logisti­
cal nature were encountered in the
T a b le  1-Transfer Diagnosis and Outcome from SICU Admission
D iagnosis O vera ll Survivors Nonsurvivors
Sepsis 24 14 10
Respiratory failure 17 12 5
Trauma 6 6 0
Gastrointestinal hemorrhage 19 12 7
Postaneurysmectomy (emergency) 9 4 5
Miscellaneous 11 7 4
Organ donor* 21 0 21
'Determined before transfer.
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transport of seven patients. These 
included vehicular breakdown (1), 
inappropriate vehicle (1) and avoid­
able delay (1). Weather conditions 
and patient condition necessitated a 
change in vehicles in the remaining 
four cases. At the referring institu­
tions, major resuscitative efforts 
were undertaken by the transport 
team in 21% of patients. This was 
reflected by an increase in TISS- 
DEP compared with TISS-TEL, of 
more than four points, which we 
regarded as significant, based on 
our experience with TISS in over 
1500 patients managed in an inten­
sive care unit.5 There was one 
death; this was in an elderly man 
with a rapidly expanding abdominal 
aortic aneurysm. Emergency resec­
tion could not be completed at the 
referring hospital for technical rea­
sons and a transport team was 
dispatched to retrieve the patient 
from the referring hospital 100 km 
away. Approximately 5 km from 
Toronto General Hospital the aneu­
rysm ruptured. During reoperation 
he unfortunately suffered myocardi­
al infarction with subsequent pro­
found myocardial failure from 
which he could not be resuscitated.
In our analysis of TISS-TEL, 
TISS-DEP and TISS-1 (Table III), 
comparison of donors and nondo­
nors revealed significant (p < 0.05) 
increases in both TISS-TEL and 
TISS-DEP in the donor population. 
In the nondonor group, survivors 
and nonsurvivors of SICU admis­
sion were further analysed. The 
nonsurvivors had higher TISS-TEL, 
TISS-DEP and TISS-1 values than 
survivors.
Comments
On the basis of our experience 
we believe that the transport system 
can handle critically ill patients for 
prolonged periods without major 
morbidity or mortality. The severity 
of illness scoring system (TISS) was 
a useful guide to the intensity and 
sophistication of equipment and 
personnel required for transport in 
each case.
Our data cannot be compared
with those of other transport sys­
tems with respect to the types of 
patients transferred, the nature of 
the transport team and the dis­
tances involved. Physician-accom­
panied transport systems have been 
described,16' 8 but the majority in­
volved the transport of neonatal or 
trauma patients and few addressed 
the transport of critically ill surgical 
patients. A recent report from the 
Stanford Medical Center reviewed 
retrospectively 200 physician- 
accompanied transfers over a 4-year 
period6 —- the majority of patients 
had cardiac-related diagnoses. Some 
interesting comparisons can be 
made between patients transported 
by our PATS and those in the 
Stanford group: only 36% of the 
latter required ventilation, and 
shock, necessitating vasopressors 
during transport, was present in 
only 14% of their patients, com­
pared with 71% and 27% respective­
ly in our series.
A number of questions arise from 
this type of analysis. First, what is 
the physician’s role in the transport
Table 11-Time and Distance Factors
Nondonors
Factor
Survivors 
(n =  55)
Nonsurvivors 
(n =  31)
Overall 
(n =  86)
uonors 
overall 
(n =  21)
Time, min 377 ±  240 288 ±  172* 345 ±  221 286 ±  356
Start up 144 ±  195 114 ± 126 133 ±  174 126 ± 231
Time to 97 ±  102 49 ± 32* 79 ± 87 55 ±  107
Pack-up 70 ± 45 71 ± 47 70 ±  45 45 ±  20
Time in 85 ± 64 52 ± 35* 73 ±  58 55 ±  99
Distance, km 45 ± 836 141 ±  180* 342 ±  692 519 ±  1738
Time: distance, m in/km 1.1 ±  1.3 2.4 ±  3.7* 1.6 ±  2.5 1.6 ±  0.9
*p < 0.05 for survivors versus nonsurvivors.
Table Ill-Severity of Illness for Nondonors and Donors Analysed by Score Over Telephone Before Departure (TISS-TEL), Score Before Patient Departure
(TISS-DEP) and After 1 Day at Toronto General Hospital (TISS-1)
Nondonors
Donors
Scoring Survivors Nonsurvivors Overall overall
type______________________________________________(n =  55)_________________ (n =  31)_________________ (n =  86) (n =  21)
TISS-TEL 15.4 ± 6 7  20.5 ± 6.8* 17.3 ±  7.1 22.2 ±  6 .5 t
TISS-DEP 15.8 ± 7.6 21.7 ± 7.1* 17.9 ±  7.4 22.7 ±  6 .0 t
TISS-1___________________________________________ 27.6 ± 10.5_____________ 40.3 ± 10.8*____________ 32.3 ±  12.2____________ - _________
*p < 0.05 for survivors versus nonsurvivors, 
tp  < 0.05 for donors versus nondonors.
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process? Many programs, notably 
the West German system, rely heav­
ily on physician participation in the 
transport of severely ill patients. 
Others, such as the privately oper­
ated systems in the United States, 
make extensive use of transport 
nurses and paramedics to provide 
for resuscitation and stabilization. 
No formal comparisons have been 
made between these and physician- 
assisted systems such as ours. Sec­
ond, how does the transport system 
ensure that patients are appropri­
ately triaged and managed accord­
ing to the severity of their illness 
and factors such as weather and 
distance of transport and can this 
be accomplished by a variety of 
scoring systems? The final question 
is one of efficiency. Are different 
systems required for different pa­
tients and can cost savings be real­
ized by eliminating the use of so­
phisticated transport systems and 
personnel except in appropriate 
subgroups of patients?
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ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bacteri­
cidal action of cefoxitin, a cephamycin derived 
fromcephamycin C, results from the inhibition 
of bacterial cell wall synthesis. Evidence 
suggests that the methoxy group in the 
7a position is responsible for the resistance of 
cefoxitin to degradation by bacterial beta- 
lactamases.
INDICATIONS AND CLINICAL USES
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - in tra-abdom ina l in fec tions such as
peritonitis and intra-abdominal abscess
2 - G yneco log ica l in fe c tio n s  such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and jo in t infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies 
should be performed to determine the sus­
ceptibility of the causative organism(s) to 
MEFOXIN*. Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available.
Organisms p a rticu la r ly  appropria te  for 
therapy with MEFOXIN* are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci 
Gram negative (beta-lactamase producing 
and non-producing strains)
E. coli
Klebsiella species (including K. pneumoniae) 
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN* may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria. 
MEFOXIN* is not active against Pseudomonas, 
most strains of enterococci, many strains of 
Enterobacter cloacae, and m ethicillin- 
res is ta n t s ta p h y lo c o c c i and L is te ria  
monocytogenes.
Clinical experience has demonstrated that 
MEFOXIN* can be administered to patients 
who are a lso rece iv ing  c a rb e n ic illin , 
gentamicin, tobramycin, or amikacin (see 
PRECAUTIONS and ADMINISTRATION). 
Intravenous Administration 
The intravenous route is preferable for 
patients with bacteremia, bacterial septicemia, 
or other severe or life-threatening infections, 
or for patients who may be poor risks because 
of lowered resistance resulting from such 
deb ilita ting  cond itions as m alnutrition, 
trauma, surgery, diabetes, heart failure, or 
malignancy, particularly if shock is present or 
impending.
PROPHYLACTIC USE
MEFOXIN* may be administered periopera- 
tively (preoperatively, intraoperatively and 
postoperatively) to patients undergoing 
vaginal or abdominal hysterectomy and ab­
dominal surgery when there is a significant 
risk of postoperative infection or where the 
occurrence of postoperative infection is 
considered to be especially serious.
In patients undergoing cesarean section, intra­
operative (after clamping the umbilical cord)
and postoperative use of MEFOXIN* may 
reduce the incidence of surgery related post­
operative infections.
Effective prophylactic use depends on the 
time of administration. MEFOXIN* usually 
should be given one-half to one hour before 
the operation. Prophylactic administration 
should usually be stopped within 12 hours. It 
has been generally reported that continuing 
adm inistration of any an tib io tic  beyond 
24 hours fo llow ing surgery increases the 
possibility of adverse reactions but, in the 
majority of surgical procedures, does not 
reduce the incidence of subsequent infection.
If signs of postsurgical infection should 
appear, specimens for culture should be 
obtained for identification of the causative 
organism(s) so that appropriate therapy may 
be instituted.
CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN* is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
sensitivity reactions to MEFOXIN*, cephalo­
sporins, penicillins or other drugs. MEFOXIN* 
should be given with caution to penicillin- 
sensitive patients.
There is some clinical and laboratory evidence 
of partia l c ro s s -a lle rg e n ic ity  between 
cephamycins and the other beta-lactam anti­
b iotics, pen ic illins  and cephalosporins. 
Severe reactions (including anaphylaxis) have 
been reported  w ith  most beta-lactam  
antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed 
with caution in individuals with a history of 
gastrointestinal disease, particularly colitis. It 
is important to consider a diagnosis of pseudo­
membranous colitis in patients who develop 
diarrhea in association with antibiotic use. 
While studies indicate that a toxin produced 
by Clostridium difficile is one primary cause of 
antibiotic-associated colitis, other causes 
should also be considered.
Any patient who has demonstrated some form 
of allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs, 
administration of the drug should be discon­
tinued. Serious hypersensitivity reactions may 
require treatment with epinephrine and other 
emergency measures.
PRECAUTIONS
The total daily dosage should be reduced 
when MEFOXIN* is administered to patients 
with transient or persistent reduction of 
urinary output due to renal insufficiency (see 
DOSAGE AND ADMINISTRATION) because 
high and prolonged serum antibiotic con­
centrations can occur from usual doses.
In patients treated with MEFOXIN* a false­
positive reaction to glucose in the urine may 
occur with Benedict’s or Fehling’s solutions 
but not with the use of specific glucose 
oxidase methods.
Using the Jaffe Method, falsely high creatinine 
values in serum may occur if serum concen- 
trationsof cefoxitin exceed 100/rg/mL. Serum 
samples from patients treated with MEFOXIN* 
should not be analyzed for creatinine if with­
drawn within two hours of drug administration. 
Increased nephrotoxicity has been reported 
fo llow ing concom itant administration of 
cephalosporins and aminoglycoside antibiotics. 
The safety of MEFOXIN* in the treatment of 
infections during pregnancy has not been 
es tab lished . If the  a d m in is tra tio n  of
MEFOXIN* to pregnant patients is considered 
necessary, its use requires that the anticipated 
benefits be weighed against possible hazards 
to the fetus. Reproductive and teratogenic 
studies have been performed in mice and rats 
and have revealed no evidence of impaired 
fertility or harm to the fetus due to MEFOXIN*. 
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug. 
Prolonged use of MEFOXIN* may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient's condition 
is essential and if superinfection occurs 
during therapy, appropriate measures should 
be taken. Should an organism become 
resistant during antibiotic therapy, another 
antibiotic should be substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN' (100mg/kg/day and 
above) have been associated with an 
increased incidence of eosinophilia and 
elevated SGOT
ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse 
reactions rarely required cessation of 
treatment and usually have been mild and 
transient.
Local Reactions
Thrombophlebitis has occurred with intra­
venous administration. Some degree of pain 
and tenderness is usually experienced after 
in tram uscu la r in je c tio n s  using water. 
Induration has occasionally been reported. 
Allergic
Maculopapular rash, urticaria , pruritus, 
eosinophilia, fever and other allergic reactions 
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported 
rarely.
Blood
Transient eosinophilia, leukopenia, neutropenia, 
hemolytic anemia, and thrombocytopenia 
have been reported. Some individuals, particu­
larly those with azotemia, may develop 
positive direct Coombs tests during therapy 
with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDH, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure 
has been reported rarely. The role of 
MEFOXIN* in changes in renal function tests 
is d ifficu lt to assess, since factors pre­
disposing to prerenal azotemia or to impaired 
renal function have often been present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN* can be 
eliminated by dialysis in patients with renal 
insufficiency.
DOSAGE AND ADMINISTRATION
MEFOXIN* may be administered intravenously 
or intram uscularly when required. (See 
complete monograph on ADMINISTRATION 
and RECONSTITUTION.)
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1 g or 2 g of 
MEFOXIN* every 6 to 8hours. Dosage and 
route of administration should be determined 
by severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
Type of Daily Frequency
infection Dosage and Route
Uncomplicated 3-4 g 1 g every 6-8 h
forms* of in- I.V. o r I.M.
fections such as
pneumonia,
urinary tract
infection, soft
tissue infection
Moderately 6-8 g 1 g every 4 h
severe o r severe o r
in fections 2g every 6-8h  I.V.
Infections 12 g 2 g every 4 h
com monly o r
needing anti- 3 g every 6 h I.V.
biotics in higher
dosage (e.g. gas
gangrene)
"Including patients in whom bacteremia is 
absent or unlikely
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infections should be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving 
a collection of pus, surgical drainage should 
be carried out where indicated.
Adults with Impaired Renal Function 
MEFOXIN* may be used in patients with 
reduced renal function but a reduced dosage 
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
After a loading dose, the following recommen­
dations for maintenance dosage may be used 
as a guide:
RENAL
FUNCTION
Mild
impairment
Moderate
impairment
Severe
impairment
Essentially
no function
CREATININE
CLEARANCE DOSE FREQUENCY
mL/min
50-30 1 -2  g every 8-12 h
29-10 1-2 g every 12-24 h
9-5 0.5-1 g every 12-24 h
<5 0.5-1 g every 24-48 h
In the patient undergoing hemodialysis, the 
loading dose of 1-2g  should be given after 
each hemodialysis, and the maintenance dose 
should be given as indicated in the Table 
above.
Neonates (Including Premature Infants), 
Infants and Children (See WARNINGS for 
Neonates under ADMINISTRATION in the 
complete monograph.)
Premature Infants 
with Body Weights 
Above 1500 g 20-40 mg/kg every 12 h I.V.
Neonates
0 - 1 week of age
1- 4 weeks of age
20-40 mg/kg every 12 h I.V. 
20-40 mg/kg every 8 h I.V.
Infants
1 month to 2 years 
of age
20-40 mg/kg every 6 h or 
every 8 h I.M. o r I.V.
Children 20-40 mg/kg every 6 h or 
every 8 h I.M. o r I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200 mg/kg, but not to exceed 12 g per day.
MEFOXIN* is not recommended fo r the
therapy of meningitis. If meningitis is sus­
pected, an appropriate antibiotic should be 
used.
At present there is in su ffic ie n t data to 
recommend a specific dosage for children 
with impaired renal function. However, if the 
administration of MEFOXIN* is deemed to be 
essential the dosage should be modified 
consistent with the recommendations fo r 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN* is recommended as follows.
Vaginal or abdominal hysterectomy and 
abdominal surgery
2g  administered intramuscularly or intra­
venously just prior to surgery (approximately 
one-half to one hour before initial incision).
The second and third 2g[doses should be 
administered at 2-6 hour intervals after the 
initial dose.
Cesarean Section
The first dose of 2g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2 g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
AVAILABILITY
MEFOXIN* is supplied as sterile powder in 
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca - 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored 
below 30° C.
PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST
*®T rademark
(425-a,6,87x)
I paab  I I CM» e l
M S P
MERCK
SHARft
DOHME
P.O. Box 1005, Pointe Claire 
Dorval, Quebec H9R 4P8
323
CANADIAN ASSOCIATION OF GENERAL SURGEONS
2. Complications of Monitoring Systems
Current invasive monitoring techniques, although valuable in the care of critically 
ill patients, also have disadvantages. Complications of these techniques include 
errors in interpretation of measurements and complications of venous access and 
indwelling lines. To prevent these, the author recommends a standard routine for 
inserting and changing catheters, regular calibration of transducers and insertion of 
Swan-Ganz catheters with the balloon inflated with 1.0 to 1.5 ml of air.
Les techniques invasives de monitorage presentement utilisees peuvent etre utiles 
chez les patients gravement malades, mais elles presentent aussi des inconvenients. 
Parmi les complications de ces techniques, on compte les erreurs d’interpretation de 
mesure et les complications des entrees veineuses et des catheters a demeure. Afin 
de les eviter, l’auteur propose une procedure d’usage pour poser et changer les 
catheters, la calibration reguliere des transducteurs et l’insertion de catheters de 
Swan-Ganz dont le ballonnet est gonfle avec de 1.0 a 1.5 ml d’air.
Thomas R. Todd, MD, FRCSC
T he advent of elaborate, invasive monitoring in intensive care 
units allows us the luxury of a 
physiology laboratory at the pa­
tient’s bedside. There is no question 
that these systems are beneficial in 
the management of critically ill pa­
tients. As with all interventions, 
however, they also introduce their 
own complications which are de­
scribed in this paper. The principal 
complications of invasive monitor­
ing systems are: errors in interpre­
tation, complications of venous ac­
cess and complications of indwell­
ing lines.
Accepted fo r publication Mar. 8, 1988
Errors in Interpretation
Errors of interpretation adversely 
affect the outcome. The commonest 
ones are associated with transducer 
malalignment. This instrument 
measures the hydrostatic pressure 
at the tip of the attached catheter 
and the height of the transducer 
from the catheter tip. Thus, if it is 
not referenced to the atmosphere or 
is incorrectly positioned relative to 
the left or right atrium, the mea­
sured preload (central venous or 
pulmonary wedge pressure) will be 
inaccurate. Frequently the trans­
ducer falls off the bed or is posi­
tioned on top of the patient, result­
ing in wide fluctuations of mea­
sured pressure. When recordings 
are made from low-pressure sys­
tems, the patient must be fully 
supine and the transducer properly 
aligned. It is not uncommon to see 
a nurse record sequential pulmo­
nary artery pressures from a moni­
tor with the patient supine, in Fowl­
er’s position or on either side and, 
unfortunately, these pressures are 
accepted by physicians. Arterial 
pressure is less affected by trans­
ducer malalignment. Malalignment 
will, however, augment the upswing 
of the arterial pressure tracing so 
that recorded pressure will be erro­
neously high. Nurses should rou­
tinely check the monitor reading 
against sphygmomanometer pres­
sure assessment. A physician may 
sometimes be alerted to artifactually 
high arterial pressure tracings by 
noticing that the upstroke of the 
arterial pressure curve is abrupt and 
that the peak is exceptionally nar­
row.
Another error in interpretation is 
a failure to monitor the pulmonary 
artery wave form during measure­
ment of wedge pressure. When a 
balloon is inflated, the pulse pres­
sure decreases and the mean pres­
sure falls. However, if the balloon 
should force the catheter tip against 
the arterial wall, the mean pres­
sure, although initially decreasing, 
may then increase — so-called high- 
pressure wedging which is often 
higher than diastolic pressure. A 
useful double check of the accuracy 
of these measurements is to ensure 
that recorded wedge pressure is
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always less than or equal to pulmo­
nary diastolic pressure. A third 
cause of artificially high wedge 
pressure recordings is failure to 
record pressure at end expiration. 
In the patient with exaggerated 
respiratory effort or in situations 
where peak airway pressure is high, 
respiratory artifacts can be substan­
tial. Digital monitors display an 
electrical mean across a sweep of 
the screen; hence, a pronounced 
increase in wedge pressure during 
inspiration will artificially elevate 
the mean pressure. This phenome­
non can be overcome by recording 
the pressure on the diastolic mode 
to ensure that only the end-expira­
tory pressure contributes to the 
mean pressure recorded on the 
monitor.
A fourth cause of erroneously 
high recording of wedge pressure is 
the development of a zone 2 phe­
nomenon in the lung about the 
catheter. Several years ago, West 
and colleagues1 described three 
zones in the lung, based on the 
relationship between the pressures 
in the pulmonary artery (PAP), left 
atrium (PLA) and pulmonary alveo­
lus (PALV). The first two are 
low-pressure systems, subject thus 
to changes along the hydrostatic 
gradient created by gravity. The 
gradient will alter the relationship 
between the pressures, depending 
on the distance above or below the 
heart where the recordings are 
made. In zone 2, PAP is greater 
than either PLA or PALV, but 
PALV is greater than PLA. When 
the balloon of the Swan-Ganz cath­
eter is inflated, flow stops and the 
catheter tip cannot sense the pres­
sure in the left atrium. Zone 2 thus 
can be achieved by hypovolemia 
with a low left atrial pressure or by 
increased alveolar pressure. The 
higher the tip of the catheter above 
the left atrium, the more frequent is 
the abnormal observation.2 Results 
of experiments undertaken in venti­
lated patients in our intensive care 
units have suggested that the phe­
nomenon is unusual with a positive 
end-expiratory pressure less than or 
equal to 1.3 kPa.
Complications of Venous 
Access
Complications of central venous 
catheterization (Table I) are well 
known to all intensive care physi­
cians. The most common are he­
morrhage and pneumothorax. The 
former is fortunately uncommon in 
the absence of coagulopathy, but 
when coagulopathy is present, 
venepuncture must be carried out 
with particular care. Pneumothorax 
can be prevented by ensuring the 
patient is disconnected from posi­
tive-pressure ventilation as the nee­
dle is inserted under the clavicle or 
into the internal jugular vein. Ar­
rhythmias are frequent. Ventricular 
tachycardia dictates immediate 
withdrawal of the catheter. Ventric­
ular premature beats are common 
but fortunately disappear once the 
pulmonary artery is entered. How­
ever, the presence of a left bundle 
branch block should preclude pul­
monary artery catheterization with­
out pacemaker standby.
Complications of Indwelling 
Lines
Indwelling central venous lines 
may cause several problems. Sub­
clavian or vena caval thrombosis is 
unusual and can be managed expe­
ditiously with anticoagulation. Pen­
etration of the vena cava occurs 
during insertion. Penetration of the 
atrium or ventricle, with cardiac 
tamponade, can occur with time if 
catheters are rigid or if they are not 
correctly positioned in the vena 
cava or pulmonary artery. Thus, 
chest x-ray films should be carefully
checked for line position and rigid 
introducers or firm catheters should 
not be used. Infection is uncommon 
within the first 72 hours after inser­
tion. All central lines should be 
changed every 72 to 120 hours, 
depending on the clinical circum­
stances. These lines can be changed 
over guidewires if access sites are 
not themselves superficially in­
fected. Otherwise, completely new 
sites should be found. A fever that 
occurs on 2 successive days without 
an obvious cause suggests that all 
lines be removed. Knots in pulmo­
nary artery catheters are rare. If the 
catheter has been inserted through 
the internal jugular vein, removal is 
not difficult, because direct surgical 
access is possible in the intensive 
care unit. If the route is via the 
subclavian vein, removal may be 
facilitated by tightening the knot as 
much as possible. This is not al­
ways possible. In such cases, a 
skilled angiographer can cut the 
line and extract the catheter 
through a separate peripheral ac­
cess site.
Pulmonary artery disruption is 
uncommon but when it occurs, usu­
ally during line insertion, it can be 
devastating. Patients likely to suffer 
this complication are elderly and 
may have pulmonary hypertension. 
The commonest site is the right 
middle lobe, and endobronchial he­
morrhage is the presenting sign. 
Although the hemorrhage may ap­
pear profuse, these patients do not 
die of blood loss unless there is 
further bleeding into the pleural 
space. They die of asphyxiation
Table I -  Complications of Central Venous 
Lines
Pneumothorax 
Local hemorrhage 
Knots
Venous thrombosis 
Arrythmias 
Pulmonary infarction 
Pulmonary artery disruption 
Sepsis
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from airway obstruction. In any 
patient with significant airway he­
morrhage, use of the rigid broncho­
scope is essential because the air­
way is rarely cleared effectively by 
suctioning or fiberoptic bronchos­
copy. Adequate ventilation could be 
supplied by the Venturi effect or 
high frequency ventilation. It is im­
portant to remember that the sys­
tem is a low pressure one, and thus 
the initial hemorrhage is usually 
temporary. Should the bleeding 
continue however, the use of a rigid 
bronchoscope also facilitates the in­
sertion of a balloon catheter into 
the damaged side. Double-lumen 
tubes may be used at this point, but 
never as the initial treatment, since 
suctioning is difficult or impossible. 
If rupture occurs during insertion,
Table II -  Precautions Against Errors in 
Interpretation
Check transducer alignment 
Check catheter position radiologically 
Remember that wedge pressure must be 
< pulmonary artery diastolic pressure 
Remember the effects of ventilation on 
wedge pressure
Table III -  Management of Indwelling Lines. 
Precautions Against Complications of 
Insertion
Sterile, careful insertion 
Always insert Swan-Ganz catheter with 
balloon inflated 
Never use >  1.5 ml 
of air in balloon 
If <  1.0 ml of air is required, 
readjust catheter 
Watch position 
on x-ray
Remove catheter if repeated 
spontaneous wedging occurs 
Change catheters every 72 to 120 h
do not remove the catheter, as 
radiologic verification of its position 
may be the only indication as to 
which side is affected. Hyperinfla­
tion of the balloon to tamponade 
the hole in the artery is to be 
condemned because it may further 
damage the thin-walled pulmonary 
artery, and the bleeding almost al­
ways stops spontaneously.
Unfortunately there are no satis­
factory guidelines to determine 
which patients should undergo tho­
racotomy when pulmonary artery 
disruption occurs. Frequently no 
further sequelae develop and con­
servative management is satisfac­
tory. However, a second endobron­
chial hemorrhage or perforation of 
the pleural space may occur, which 
in our experience is usually fatal. 
The literature3’4 and our experience 
suggest a thoracotomy should be 
performed when there is continued 
hemorrhage, an intrapulmonary he­
matoma (as opposed to the alveolar 
flooding of bronchial hemorrhage) 
or a hemothorax.
Comment
Prevention of monitoring compli­
cations is clearly the mainstay of 
successful intensive care (Tables II 
and III). It is suggested that a 
routine be established for line inser­
tion and changes (Seldinger tech­
nique) and removal of central ve­
nous apparatus, using sterile tech­
nique. All transducers should be 
calibrated by the nurse once per 
shift and the blood pressure record­
ings double-checked using a sphyg­
momanometer. Swan-Ganz cathe­
ters should be inserted with the 
balloon inflated with 1.0 to 1.5 ml 
of air, not just to achieve flotation 
into the primary artery, but to en­
sure that the catheter is passed into 
the wedge position thus avoiding an 
insertion so distal that perforation 
of the artery may occur. These 
catheters alter position so it is im­
portant to ensure that each subse­
quent measurement uses at least 1 
ml of air for balloon inflation. Oth­
erwise the catheter must be read­
justed.
The monitoring of physiologic 
variables has improved our inten­
sive care management of critically 
ill patients. All interventions, how­
ever, carry their own set of compli­
cations and errors. Their recogni­
tion and the appropriate education 
of intensive care unit staff will 
prevent most of these problems.
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Action
In vitro studies indicate that the bacterial action ol CLAFORAN (cefotaxime sodium) 
a semi synthetic cephalosporin antibiotic, results from inhibition of cell wall 
synthesis.
Indications and Clinical Uses
Treatm ent: CLAFORAN (cefotaxime sodium) may be indicated for the treatment 
of infections caused by susceptible strains of the designated micro organisms 
in the diseases listed below.
Lower respiratory tract in fe c tio n s : pneumonia and lung abscess caused by 
Streptococcus pneumoniae (formerly Diplococcus pneumoniae), other streptococci 
(excluding enterocci, e.g. S. faecalis), Straphylococcus aureus (penicillinase and 
non-penicillinase producing), Escherichia coli, Hemophilus influenzae, (including 
ampicillin resistant strains) and unspecified Klebsiella species.
Urinary trac t in fec tions: caused by Escherichia coli, unspecified Klebsiella 
species (including K. pneumoniae), Proteus mirabilis, indole positive Proteus, Ser­
rate marcescens and Staphylococcus epidermidis. Also, uncomplicated gonor­
rhea caused by N. gonorrhoeae including penicillin resistant strains. 
B ac te rem ia /S e p ticem ia : caused by Escherichia coli, unspecified Klebsiella 
strains and Ser/ate marcescens.
Skin in fe c tio n s : caused by Staphylococcus aureus (penicillinase and non­
penicillinase producing, S. epidermidis, Group A streptococci, Escherichia coli, 
Proteus mirabilis and indole positive Proteus.
Intra-abdominal in fections: caused by Escherichia coli, and unspecified Kleb­
siella species.
Gynecological in fec tions: including pelvic inflammatory disease, endometritis 
and pelvic cellulitis caused by E. coli, Group A streptococci and Staphylococcus 
epidermidis, anaerobic bacteria including unspecified Peptococcus and Peptostrep- 
tococcus strains and some strains of Bacteroides tragihs. In several cases, although 
clinical cures were achieved, bacteriological follow up was not available. 
Clinical experience with CLAFORAN in anaerobic infections is limited. CLAFORAN 
has been used with some success in wound and intra-abdominal infections against 
some strains of unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against some strains of Pseudomonas. 
In the treatment of infections encountered in immunosuppressed and granulo­
cytopenic patients, results of therapy with CLAFORAN have not been impressive. 
CLAFORAN should not be considered in the treatment of enterococcal infections, 
i.e. Streptococcus faecalis.
Specimens for bacteriologic culture should be obtained prior to therapy in order 
to isolate and identify the causative organisms and to determine their suscep­
tibilities to CLAFORAN. Therapy may be instituted before results of susceptibility 
studies are known; antibiotic treatment should be re-evaluated once these results 
become available.
Prophylactic U s e : The administration of CLAFORAN perioperatively (preoperative 
ly, intraoperatively and postoperatively) may reduce the incidence of certain infec 
(ions in patients undergoing elective surgical procedures (e.g. abdominal or vaginal 
hysterectomy, gastrointestinal and genitourinary tract surgery) that may be classified 
as contaminated or potentially contaminated.
In patients undergoing caesarian section who are considered to be at increased 
risk of infection, intraoperative (after clamping the umbilical cord) and postoperative 
use of CLAFORAN may also reduce the incidence of certain postoperative infections 
Effective use for elective surgery depends on the time of administration (see Dosage 
and Administration).
For patients undergoing gastrointestinal surgery, preoperative bowel preparation 
by mechanical cleansing as well as with a non absorbable antibiotic (e.g. neomycin) 
is recommended.
If there are signs of infection, specimens for culture should be obtained for iden­
tification of the causative organism so that appropriate therapy may be instituted.
Contraindications
CLAFORAN is contraindicated in patients who have shown hypersensitivity to 
cefotaxime sodium, the cephalosporin or the penicillin groups of antibiotics.
Warnings
Before therapy with CLAFORAN is instituted, it must be carefully determined whether 
the patient has had previous hypersensitivity reactions to cefotaxime, 
cephalosporins, penicillins or other drugs CLAFORAN should be given with caution 
to patients with Type 1 hypersensitivity reactions to penicillin. Antibiotics, including 
CLAFORAN should be administered with caution to any patient who has 
demonstrated some form of allergy, particularly to drugs. If an allergic reaction 
to CLAFORAN occurs, the drug should be discontinued and the patient treated 
with the usual agents (eg. epinephrine, antihistamine, pressor-amines or 
corticosteroids).
Pseudomembranous colitis has been reported with the use of cephalosporins 
(and other broad spectrum antibiotics); therefore, it is important to consider its 
diagnosis in patients who develop diarrhea during the administration of CLAFORAN. 
This colitis can range from mild to life-threatening in severity.
Treatment with broad spectrum antibiotics, such as CLAFORAN, alters the nor­
mal flora of the colon and may permit overgrowth of Clostridium difficile or other 
Clostridia. It has been established that a toxin produced by Clostridium difficile 
is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to discontinuation of CLAFORAN and replace­
ment with a suitable specific antibiotic. Moderate to severe cases should be manag­
ed with fluid, electrolyte and protein supplementation as indicated. When the colitis 
is not relieved by discontinuance of CLAFORAN administration or when it is severe, 
an antibiotic specifically effective in antibiotic-associated pseudomembranous colitis 
(eg. vancomycin) or other suitable therapy may be indicated. Other possible causes 
of colitis should also be considered (see Averse Reactions).
Precautions
CLAFORAN (cefotaxime sodium) should be prescribed with caution in individuals 
with a history of lower gastrointestinal disease particularly colitis.
The safety of CLAFORAN in pregnancy has not been established. Consequently, 
use of the drug in pregnant women requires that the likely benefit from the drug 
be weighed against the possible risk to the mother and fetus.
Use of CLAFORAN in women of child-bearing potential requires that the anticipated 
benefits be weighed against the possible risks.
Cefotaxime is excreted in human milk in low concentrations. Caution should be 
exercised when the drug is administered to nursing mothers.
Prolonged use of CLAFORAN may result in the overgrowth of nonsusceptible 
organisms. Constant evaluation of the patient’s condition is essential. If super­
infection occurs, therapy should be discontinued and appropriate measures taken. 
Although CLAFORAN rarely produces alterations in kidney function, evaluation 
of renal status is recommended, especially in severely ill patients receiving high 
doses.
Patients with markedly impaired renal function should be placed on the special 
dosage schedule recommended under Dosage and Administration, because nor­
mal dosage in these individuals is likely to produce excessive and prolonged serum 
antibiotic concentrations.
Positive direct Coomb's test is known to develop in individuals during treatment 
with the cephalosporin group of antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur with reducing 
substances but not with the use of specific glucose oxidase methods. 
Adverse Reactions
The most frequent adverse reactions with their frequency of occurrence are: 
Hypersensitivity (1.8%): Rash, pruritus, fever. Local (5%): Injection site inflam­
mation with intravenous administration. Pain, induration and tenderness after in­
tramuscular injection. Gastrointestinal (1.7%): Colitis, diarrhea, nausea and 
vomiting. Symptoms of pseudomembranous colitis can appear during or after 
CLAFORAN treatment. Hemic and Lymphatic System ( <  1%): Mild, reversi­
ble leukopenia, granulocytopenia and thrombocytopenia have been reported. Some 
patients developed positive direct Coomb's test during treatment with CLAFORAN. 
Genitourinary System ( <  1%) . Moniliasis, vaginitis. Liver ( <  1%): Transient 
elevations in SGOT, SGPT, serum LDH and serum alkaline phosphatase levels 
have been reported. Kidney ( <  1%): Increased serum creatinine and BUN have 
occasionally been observed. Central Nervous System (0.2%): Headache. 
Symptoms and Treatment of Overdosage 
Since no case of overdosage has been reported to date with CLAFORAN, no 
specific information on symptoms or treatment is available. Treatment of over­
dosage should be symptomatic.
Dosage and Administration
CLAFORAN (cefotaxime sodium) may be administered intramuscularly or in­
travenously after reconstitution (see Table with recommended mode of reconstitution 
according to route of administration).
Dosage
Adults
The dosage of CLAFORAN should be determined by susceptibility of the causative 
organisms, severity of the infection and condition of the patient.
Guidelines for Dosage of CLAFORAN (cefotaxime sodium)
Type of Infection
Daily Dose
(g) Frequency and Route
Uncomplicated
Gonorrhea
1 1 g IM (single dose)
Uncomplicated
infections
2 1 g every 12 hours 
IM or IV
Moderately 
severe to severe 
infections
3-6 1-2 g every 
8 hours IM or IV
Very severe 
infections (e.g. 
septicemia)
6-8 2g  every 
6-8 hours IV
Life-threatening
infections
up to 12 2g  every 
4 hours IV
To prevent postoperative infection in contaminated or potentially contaminated 
surgery, recommended doses are as follows.
(a) 1 g IM or IV administered Vs to 1 Vs hours prior to the initial surgical incision 
to ensure that adequate antibiotic levels are present in the serum and tissues 
at the start of surgery
(b) 1 g IM or IV administered 1V2 to 2 hours following the first dose; for lengthy 
operative procedures, additional intraoperative doses may be administered, if 
necessary, at appropriate intervals (IV 2  to 2 hours) during surgery
(c) 1 g IM or IV administered within 2 hours following completion of surgery 
The total cumulative prophylactic dose should not exceed 6 g in a 12 hour period. 
Caesarian Section Patients
The first dose of 1 g is administered IV as soon as the umbilical cord is clamped. 
The second and third doses should be given as 1 g IM or IV at 6 and 12 hours 
after the first dose.
Neonates, Infants, and Children
The following dosage schedule is recommended:
Neonates: 0-1 week of age 50 m g/kg  IV q 12 h
1-4 weeks of age 50 m g/kg  IV q 8 h
Infants and children (1 month to 12 years). For body weights less than 50 kg, 
the recommended daily dose is 50 to 100 mg / kg IM or IV of body weight divid­
ed into 4 to 6 equal doses, or up to 180 m g/kg /day for severe infections. 
For body weights 50 kg or more, the usual adult dosage should be used.
The maximum daily dosage should not exceed 12 grams.
Administration of CLAFORAN should be continued for a minimum of 48 to 72 
hours after the patient defervesces or after evidence of bacterial eradication has 
been obtained; a minimum of 10 days of treatment is recommended for infec­
tions caused by Group A beta-hemolytic streptococci in order to guard against 
the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical 
appraisal is necessary during therapy of chronic urinary tract infections and may 
be required for several months after therapy has been completed; persistent in­
fections may require prolonged treatment. Doses less than those recommended 
should not be employed.
Dosage for Patients with Impaired Renal Function
In patients with estimated creatinine clearance of less than 20 mL / min / 1.73m2 
the dose of CLAFORAN should be halved (see Precautions).
If serum creatinine values alone are available, the following formula (based on 
sex, weight, and age of the patient) may be used to convert these values into 
creatinine clearance.
M ales: Weight (kg) x  (140 -  age) Females: 0.85 x above value 
72 x  serum creatinine
Administration
Intram uscular: CLAFORAN should be injected well within the body of a relatively
large muscle such as the upper outer quadrant of the buttock (i.e. gluteus max- 
imus); aspiration is necessary to avoid inadvertent injection into a blood vessel. 
Intravenous: The intravenous route is preferable for patients with bacteremia, 
bacterial septicemia, or other severe or life-threatening infections, or for patients 
who may be poor risks because of lowered resistance resulting from such 
debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure, 
or malignancy, particularly if shock is present or impending.
For bolus administration a solution containing 1 or 2 g of CLAFORAN can be 
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3. Monitoring and Investigation 
of Intra-abdominal Sepsis
Stewart M. Hamilton, MD, FRCSC
Diagnosis and management of intra-abdominal sepsis continue to be major problems 
in critically ill patients. Multiple system organ failure secondary to intra-abdominal 
sepsis continues to cause serious morbidity and death. The first step in management 
is to recognize the infection, while providing careful supportive therapy. A number 
of radiologic investigations, including ultrasonography and computed tomography, 
will help to diagnose a potential source of infection, which can be positively 
identified by fine-needle aspiration and culture. The septic focus must be drained 
either percutaneously or, if this fails, surgically. Use of specific antibiotics is 
imperative. Delay in diagnosis and surgery increases the death rate, so all available 
diagnostic modalities should be utilized, but these should not replace careful 
ongoing clinical assessment.
Le diagnostic et le traitement des sepsies intra-abdominales represented toujours 
des problemes majeurs chez les patients gravement malades. Les defaillances 
plurisystemiques secondaires aux sepsies intra-abdominales sont encore la cause 
d’une serieuse morbidity et de deces. Le premier pas de la marche a suivre consiste a 
identifier l’infection pendant qu’on assure une therapie de soutien. Un certain 
nombre d’examens radiologiques, dont l’echocardiographie et la tomodensitometrie, 
aident au diagnostic des sources possibles d’infection; l’identification positive peut 
etre faite par ponction-biopsie et mise en culture. Le foyer d’infection doit etre 
draine, soit par voie percutanee ou, si cela s ’avere insuffisant, par voie chirurgicale. 
L’utilisation d’antibiotiques specifiques s ’impose. Les delais de diagnostic ou les 
retards a operer augmentent la mortalite. Tous les moyens diagnostics doivent done 
etre mis en oeuvre, sans toutefois que ceux-ci remplacent une evaluation clinique 
soigneuse.
A n attempt to address all the abnormal manifestations of ab­
dominal sepsis is beyond the scope 
of this paper. Prevention is the best 
form of management, but when 
intra-abdominal sepsis is suspected, 
the first step is to establish its
presence. In this paper I shall focus 
on clinical aspects and laboratory 
values that are altered in sepsis and 
on x-ray studies that may help to 
localize the source. I shall attempt 
to define the role of percutaneous 
aspiration and drainage of septic
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foci in the abdomen and to address 
the complex issue of the diagnostic 
laparotomy in the critically ill pa­
tient.
Infection within the abdomen 
may range from a single unilocular 
walled-off abscess, often the sequela 
of appendicitis, to a systemic pro­
cess resulting in multiple organ 
system failure. The sequence of 
events, which starts as a local in­
flammatory reaction and may prog­
ress to hemodynamic instability 
with failure of the respiratory, he­
patic, renal and coagulation sys­
tems, is poorly understood and is 
the subject of much research. The 
ability of an infective process to 
activate the immune response, caus­
ing the release of vasoactive media­
tors that affect distant organs, is a 
concept that has been developed 
over the past 10 to 15 years. Re­
cent investigations to isolate a com­
mon mediator have been directed 
toward the white blood cell, specifi­
cally tissue macrophages and their 
ability to release tissue necrosis 
factor (cachetin). This substance 
has now been isolated and been 
found, in animal studies, to produce 
the septic shock syndrome.1
The cause of this syndrome is 
multifactorial, and nosocomial in­
fection is the most common factor. 
In hospitalized patients the bacteri­
al environment is altered by medical 
practice, invasive monitoring de­
vices and surgery, leading to coloni­
zation by gram-negative bacteria. 
The patients’ host defences may be 
blunted by major trauma, anesthe­
sia, neoplasia or underlying chronic
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medical disease. With the interplay 
of these factors, sepsis can result 
from minor infectious processes. 
The development of septic shock 
syndrome can be catastrophic, with 
a death rate of more than 90% in 
critically ill patients with intra­
abdominal sepsis.2 The occurrence 
of organ system failure (renal, he­
patic and respiratory) as a function 
of time and number of systems 
involved, correlates directly with a 
poor prognosis.3' 5
Other factors that can adversely 
influence outcome in the septic pa­
tient include antecedent use of anti­
biotics, antimetabolites and cor­
ticosteroids, the presence of con­
gestive heart failure, azotemia or 
diabetes mellitus. Hospital-acquired 
infections are much more likely to 
result in morbidity and mortality 
than community-acquired infec­
tions.3 Patients older than 60 years 
are at increased risk.6
Local factors that increase mor­
bidity and mortality include multiple 
abscesses, lesser sac abscesses, pos­
itive blood cultures and recurrent or 
persistent abscesses.6 From a surgi­
cal perspective the development of 
peritonitis postoperatively is the 
factor of most concern and out­
weighs all others, including age.5 
The diagnosis of sepsis postopera­
tively is difficult and for this reason 
reoperation is often delayed. More­
over, many of the changes sought 
in laboratory and x-ray studies that 
are diagnostic of sepsis are altered 
by the initial surgical procedure.
Clinical and Laboratory 
Manifestations
The alert patient with an abdomi­
nal infection usually complains of 
abdominal pain associated with a 
localized tenderness and guarding. 
There is a rise in body temperature, 
and a leukocytosis usually greater 
than 12.0 X 109/L ; however, pro­
found neutropenia with more than
20% band forms also indicates an 
overwhelming infectious process. 
Blood cultures from such a patient 
not previously on antibiotics will 
frequently be positive within 24 
hours. The clinical and laboratory 
changes that accompany progres­
sion of the localized process to the 
septic shock syndrome are initially 
subtle, but may be rapid.
Mental confusion, tachypnea and 
intestinal ileus accompanied by a 
coffee-ground aspirate from the na­
sogastric tube are early signs of 
sepsis. There is usually a bounding 
pulse and a warm flushed skin with 
sluggish capillary perfusion. The 
blood pressure may drop precipi­
tously, so that the patient requires 
infusion of a large volume of fluid. 
Rectal or core temperature is often 
greater than 39°C. The platelet 
count may be less than 100 X 
109/L . Arterial blood gases drawn 
during this phase will show hypo­
capnia as a compensatory mecha­
nism for the metabolic acidosis of 
septic shock. Initially hyperventila­
tion maintains adequate oxygena­
tion, but the situation can deterio­
rate rapidly in unchecked sepsis 
associated with aggressive fluid re­
suscitation.
Invasive hemodynamic monitor­
ing is not always necessary for 
assessing the progress of septic 
shock. However, in patients who 
are profoundly unstable after initial 
fluid resuscitation or have a history 
of respiratory insufficiency or cardi­
ac disease, a flow-directed pulmo­
nary artery catheter will help in the 
administration of fluids. Should 
such a catheter be in place, findings 
usually indicate a hyperdynamic 
cardiovascular system with an ele­
vated cardiac output and low sys­
temic vascular resistance. Measure­
ment of mixed venous oxygen ten­
sion reveals peripheral shunting and 
poor peripheral oxygen extraction. 
The initial hyperdynamic cardiac re­
sponse may deteriorate to low cardi­
ac output, high peripheral resist­
ance and hypoperfusion of the pe­
riphery as manifested by poor uri­
nary output and a worsening meta­
bolic acidosis.23
Although they do not indicate 
the source of sepsis, abnormal liver 
function measurements occur in a 
patient with overwhelming infec­
tion. The serum albumin and cho­
lesterol levels fall; the serum alka­
line phosphatase and serum aspar­
tate aminotransferase levels may be 
elevated.7 Blood cultures that reveal 
a polymicrobial bacteremia in the 
absence of a burn wound, an ampu­
tation or pulmonary aspiration, al­
most certainly indicate an intra­
abdominal septic process. The pre­
dominant organisms cultured in­
clude Enterococcus, Escherichia 
coii, Bacteroides fragiiis, Klebsiella 
sp, and Pseudomonas sp.8
The best prognostic indicator of 
sepsis is the presence of shock 
itself. Additional measurements that 
help in assessing prognosis include: 
arterial lactate levels, which are 
higher in septic patients (the over­
lap with normals is too great to 
allow adequate sensitivity9); metabo­
lites of the cyclo-oxygenase system, 
which are abnormally high (this test 
is not readily available3) and fi- 
bronectin levels, which are often 
depressed in septic patients (the 
wide range of levels lacks sensitivi­
ty3’10).
Radiologic Investigations
When clinical and laboratory 
findings suggest a septic focus 
somewhere in the body, the chal­
lenge is to localize the site. Over 
the past 10 to 15 years, improve­
ments in diagnostic imaging tech­
niques have made this task consid­
erably easier. However, the abdomi­
nal cavity remains a relatively diffi­
cult area to evaluate radiologically, 
and the decision to re-explore fre­
quently must be based on a combi-
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nation of suggestive physical and 
laboratory findings and radiologic 
evidence.
In the critically ill patient when a 
history cannot be obtained, the in­
vestigation of intra-abdominal sep­
sis must also rule out other sites of 
infection. Culture material from the 
sputum, urine and blood should be 
examined routinely to determine if 
colonization or active infection is 
present. A recent infiltrate seen on 
the chest x-ray film, associated with 
a leukocytosis and fever, suggests 
pneumonia.
If the physical findings suggest 
an intra-abdominal infection, a thor­
ough radiologic investigation of the 
abdomen is warranted. Although 
the findings are frequently nonspe­
cific, abdominal films may reveal 
gastric dilatation, a gas pattern sug­
gestive of obstruction or an ady­
namic ileus. Sometimes, extralumi­
nal gas may be visualized in a 
stippled pattern or as an air-fluid 
level — both signs of an intra­
abdominal abscess. Pneumoperito­
neum can be detected on a left 
lateral decubitus film. This may 
represent perforation of a hollow 
viscus, but in the mechanically ven­
tilated patient with high airway 
pressures, intraperitoneal gas can 
occur secondarily to the ventilation.
Contrast x-ray studies of the 
upper or lower gastrointestinal 
tracts may show perforation or 
signs of spasm and mucosal irregu­
larity suggestive of an inflammatory 
process. When intraperitoneal leak­
age is suspected, a water-soluble 
contrast agent should be used.
More sophisticated radiologic in­
vestigations of intra-abdominal sep­
sis include ultrasonography, com­
puted tomography and radioisotope 
scanning. Ultrasonography is gener­
ally available and frequently is the 
investigation used first to localize 
fluid collections and to look for 
visceral disease (e.g., cholelithiasis, 
biliary obstruction, liver abscess,
splenic abscess). False-positive diag­
noses occur with sterile fluid collec­
tions or fluid-filled bowel loops that 
are thought to be a loculated collec­
tion of fluid. False-negative exami­
nations result from an inability to 
demonstrate the lesion, more so in 
the postoperative patient with a 
large abdominal incision, multiple 
drain sites, obesity and overlying 
loops of bowel filled with gas. All of 
these conditions compromise the 
effectiveness of ultrasonography.11
Radioisotope scanning requires 
special equipment and technical 
staff. A HIDA scan of the biliary 
tree is helpful in diagnosing acalcu- 
lous cholecystitis. Scanning for a 
focus of infection has recently be­
come more sensitive and specific 
with the advent of leukocyte scan­
ning using the radioisotope indi­
um-111. This test has supplanted 
gallium scanning, particularly for 
intra-abdominal sepsis, because 
85% of the gallium is excreted in 
the colon, making interpretation 
difficult. Leukocyte scanning has 
the major advantage of covering the 
entire body. Preparation for the 
scan takes approximately 2 hours 
as the leukocytes must be with­
drawn in a 30-ml blood sample, 
labelled and then reinjected. False­
positive results are obtained when 
other inflammatory lesions, such as 
inflammatory bowel disease or ar­
thritis exist in conjunction with a 
septic process. Accessory spleens 
also will localize the isotope. False­
negative results occur in abscesses 
with no leukocytes (e.g., fungi, tu­
berculosis), in chronic infections 
when the polymorphonuclear leuko­
cyte response has been blunted, in 
patients who have been on long­
term antibiotic therapy and in situa­
tions in which leukocyte function 
may be compromised, such as hype­
ralimentation, hemodialysis and hy­
perglycemia.11
Although availability may be a 
problem, computed tomography of
the abdomen remains the most sen­
sitive and specific diagnostic test for 
intra-abdominal sepsis. In numerous 
studies it has been associated with a 
diagnostic accuracy of more than 
90%, whether used in conjunction 
with other modalities, or alone.211' 15 
This degree of accuracy can also be 
achieved in the post-laparotomy 
state. False-positive diagnoses can 
occur in patients with concomitant 
necrotic tumours, thick-walled 
cysts, seromas or hematomas and 
where a bowel loop may simulate a 
lesion, a situation usually rectified 
by the use of contrast in the bowel 
loops. A potential lesion simulating 
a loop of bowel or fluid collections 
that are identified and subsequently 
turn out to be sterile may give rise 
to false-negative diagnoses. A fur­
ther advantage of computed tomog­
raphy is that its accuracy and ana­
tomical detail frequently permit per­
cutaneous drainage or a localized 
drainage procedure.1113
Percutaneous Aspiration and 
Drainage
When a potential source of infec­
tion is identified by computed to­
mography the specific content can 
be identified. In the absence of a 
coagulopathy, aspiration can be 
performed for Gram’s staining and 
culture (aerobic and anaerobic). 
Fine-needle aspiration poses rela­
tively few risks except when the 
location of the collection requires a 
complicated approach. Transgress­
ing the lumen of the colon or small 
bowel may invalidate the culture 
result or, more importantly, infect a 
sterile fluid collection. In general, 
however, fine-needle aspiration 
poses minimal risk especially with 
accurate mapping by computed to­
mography.14' 16
The ability to aspirate a potential 
source of infection also enables the 
radiologist to place a catheter for 
definitive drainage. If the abscess
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cavity is unilocular and not very 
large, it should be possible to drain 
it percutaneously. With experience, 
increasingly larger catheters, in­
cluding double-lumen tubes, have 
been placed using the modified 
Seldinger technique. Patients not 
eligible for this mode of drainage 
are those with extensive abscess 
cavities that are anatomically inac­
cessible, those with extremely viscid 
material in the abscess and those 
with a coagulopathy. When there is 
no favourable response to percuta­
neous drainage after 24 to 48 
hours, open surgical drainage is 
necessary.14-16
Laparotomy
In assessing the role of laparoto­
my as a diagnostic and therapeutic 
modality in intra-abdominal sepsis, 
it is helpful to use the terms direct­
ed and nondirected procedures. For 
a time, the nondirected or “blind” 
laparotomy was considered a diag­
nostic test that could be used liber­
ally with an acceptable morbidity 
and mortality. This concept has 
been refuted by a number of 
studies25'1718 demonstrating high 
death rates with this technique in 
critically ill patients. However, in 
the critically ill patient, manifesting 
symptoms and signs of infection, 
and with no source identified, a 
nondirected laparotomy must be 
considered. In a recently published 
series of such cases2 the procedure 
resulted in 58% positive findings 
but when another focus of infection 
was already identified, the rate fell 
to zero. Delaying the procedure 
until sepsis was present increased 
diagnostic accuracy but decreased 
the survival.2
The directed laparotomy is used 
when clinical and x-ray evidence 
points to an infective process within 
the abdominal cavity. Its accuracy 
improves as the evidence for an 
intra-abdominal septic focus hard­
ens. More than 90% of patients with 
septic shock and a positive blood 
culture who have a definitive lesion 
on computed tomography were 
found to have sepsis at laparoto­
my.2 Unfortunately with this degree 
of positive findings, the mortality 
associated with the septic process 
approaches 95%.2
Comments
Diagnosis and localization in the 
critically ill patient with a possible 
intra-abdominal focus of infection 
remains a problem. The first step is 
to recognize that infection is pres­
ent, and while the source of infec­
tion is being localized, careful sup­
portive therapy must be provided. 
Specific antibiotic therapy is imper­
ative. A recent study19 concluded 
that steroids have no role in such 
patients. Fibronectin, on the other 
hand, may have a beneficial ef­
fect.10'20
Delay in diagnosis and surgical 
intervention are associated with in­
creased death rate. In the absence 
of a highly sensitive diagnostic test, 
an aggressive approach using all 
available modalities must be under­
taken. The availability of the newest 
techniques should not replace care­
ful ongoing clinical assessment by 
experienced observers (at least one 
study18 found physical examination 
to be as reliable as the sophisticated 
radiologic procedures).
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4. Abdominal Crisis in the Intensive Care 
Unit
Paul Gregor, MD, FRCSC; J. Dwight Prodger, MD, FRCSC
Abdominal crises are common in critically ill patients who are admitted to the 
intensive care unit for problems unrelated to the abdomen. General surgeons may be 
asked to assess these patients for such reasons as pain, distension, possible sepsis, 
radiologic or laboratory abnormalities. Since many of the diagnostic signs and 
symptoms of acute abdomen are blunted or absent in critically ill patients who may 
be comatose or have been given analgesics or steroids, frequent thorough physical 
examination and close cooperation with the service admitting the patient are 
necessary to ensure early diagnosis and aggressive treatment of the abdominal 
crisis.
Les abdomens aigus sont frequents chez les patients gravement malades qui sont 
re?us aux soins intensifs pour des raisons autres qu’abdominales. Le chirurgien 
general peut etre appele a evaluer ces patients pour des raisons telles que douleurs, 
distension, sepsie possible, anomalies radiologiques ou biologiques. Plusieurs des 
signes et symptomes diagnostiques sont emousses ou absents chez ces patients 
gravement malades qui peuvent etre comateux ou sous l'influence d’analgesiques ou 
de steroi'des. II est done necessaire de pratiquer des examens physiques complets et 
frequents et d’etablir une etroite collaboration avec le service responsable de 
l’hospitalisation afin d’assurer un diagnostic precoce et un traitement vigoureux de 
l’abdomen aigu.
In this paper I shall discuss how 
abdominal crises present in the in­
tensive care unit, but I shall not 
consider specific surgical diagnoses 
or postoperative care.
Surgeons are asked to participate 
in the management of patients in 
the intensive care unit for various 
reasons, such as when the patient 
has abdominal pain or distension, 
sepsis, or when a radiologic or 
laboratory abnormality is found that 
raises the possibility of an abdomi­
nal crisis. Modern pharmacologic 
and physiologic manipulation, inter­
action and complications of drug 
therapy must be well understood by 
the surgeon who sees patients with 
abdominal crises in the intensive 
care unit.
O ver the past 10 years, intensive care medicine has grown faster 
than the other medical subspecial­
ties. Sophisticated methods of inva­
sive and noninvasive monitoring 
can provide crucial information to 
identify numerous pathophysiologi­
cal aspects of critical illnesses. The 
influence of surgeons in the inten­
sive care unit has now become so 
important in the ongoing care of
severely ill patients that they are 
sharing in the coordination of inten­
sive care units. Thus, more patients 
with advanced age and stage of 
disease are being admitted to inten­
sive care units and operated on. The 
complication rate is correspondingly 
higher, but so is the survival of 
patients who would not previously 
have been considered candidates for 
surgery.
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Diagnostic Signs
The surgeon must be aware that 
pain in these patients may be mod­
erated or even absent, despite the 
abdominal crisis, because the pa­
tient is obtunded or comatose or is 
being treated with analgesics or 
steroids. Thus, signs and symptoms 
of acute abdomen are useful only if 
they can be verified. Similarly, the 
signs of peritonitis may be reduced 
or absent.
Abdominal distension or an ileus 
in a critically ill patient, although 
nonspecific, may be the first indica­
tor of an intra-abdominal crisis. 
Difficult perioperative intubation or 
reintubation after respiratory dis­
tress may cause a large amount of
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air to be introduced into the stom­
ach, resulting in both gastric and 
intestinal distension. However, 
other causes are often responsible, 
such as fluid and electrolyte imbal­
ance, drug interaction or toxicity, a 
worsening neurologic condition, 
perforated viscus, the presence of 
intra-abdominal sepsis or the devel­
opment of pancreatitis. Poor cardiac 
output with low flow not leading to 
frank ischemia, but sufficient to 
cause dysfunction in the gastroin­
testinal tract, is a not uncommon 
complication of ileus. The develop­
ment of ileus may be so subtle as to 
be suggested initially by the pa­
tient’s intolerance to enteric feed­
ing.
Jaundice, alone, is seldom a sign 
of severe abdominal crisis, the 
cause of which is usually multifac­
torial. Measurement of the serum 
bilirubin and liver enzyme levels 
may clarify the situation; ul­
trasonography and HIDA scanning 
are occasionally required.
The diagnosis of hemorrhage is 
usually obvious (Table I), but the 
bleeding site may be obscured in 
patients with a ruptured spleen, 
torn liver or bleeding from intercos­
tal vessels due to fractured ribs 
associated with resuscitation after a 
cardiac arrest. Rupture of an ab­
dominal aortic aneurysm can occur 
in the intensive care unit. The obvi­
Table I -  Diagnosis of Hemorrhage
Gastrointestinal tract 
Upper 
Lower
Cryptogenic origin 
Anticoagulants 
Postcardiac arrest 
Ruptured spleen 
Torn liver
Ruptured abdominal aneurysm
ous upper and lower gastrointesti­
nal hemorrhage, common in the 
past, is now seen less frequently. 
The introduction of H2 antagonists 
and aggressive antacid therapy has 
reduced the occurrence of stress 
ulceration to low levels.
Frequently the general surgeon is 
asked to see patients who have 
sepsis of unknown origin, as evi­
denced by unexplained spiking of 
body temperature or, more unusual­
ly, by positive blood culture, sug­
gesting that the gastrointestinal 
tract is the source. Causes would 
include intra-abdominal abscesses, 
cholangitis, acalculous cholecystitis 
(predominantly in critically ill pa­
tients), perforated viscus, ischemic 
bowel or an infected aortic graft. 
Uncontrolled sepsis will lead to mul­
tiorgan failure, with subsequent 
death of the patient if the cause is 
not identified early and treated ag­
gressively.
When radiologic investigations 
yield unexpected results a surgical 
consultation may be necessary. 
X-ray films may reveal the presence 
of free air on an upright view of the 
chest, suggesting a perforated vis­
cus, or air in the biliary tree may 
suggest biliary tract sepsis. Com­
puted tomography has become com­
mon in the investigation of intra­
abdominal disease. It may reveal 
free fluid within the abdomen, pan­
creatitis, ischemic bowel or unsus­
pected intra-abdominal abscesses. 
Computed tomography has low sen­
sitivity in the diagnosis of acalcu­
lous cholecystitis.
The presence of metabolic acido­
sis may suggest a life-threatening 
sepsis or ischemic bowel. Determi­
nation of serum lactate and phos­
phate levels may not be helpful
because of their low sensitivity and 
specificity. Plain abdominal roent­
genography, angiography and com­
puted tomography have all been 
used to help differentiate between 
sepsis and ischemic bowel in a low 
flow state due to poor cardiac out­
put. Peritoneal lavage is useful in 
diagnosing ischemic bowel disease. 
To rule out other causes of meta­
bolic acidosis, the anion gap is 
determined; if the gap is increased, 
the presence of drug-induced and 
diabetic acidosis must be eliminat­
ed.
Hyperamylasemia is being discov­
ered more frequently in critically ill 
patients and it is important to dif­
ferentiate between the pancreatic 
and nonpancreatic forms. Clinical 
and radiologic examinations with 
the addition of isoenzyme determi­
nation can help in the differential 
diagnosis.
Summary
It is important to realize that the 
signs and symptoms of intra­
abdominal catastrophes developing 
in the intensive care unit are fre­
quently blunted or even absent, 
making diagnosis difficult. Frequent 
and full physical examinations of 
patients are mandatory to detect 
early abdominal crises and to pre­
vent further complications. Close 
cooperation with staff members of 
the service admitting the patient to 
the intensive care unit will lead to 
better understanding, quicker diag­
nosis and earlier discharge. It is 
important that the general surgeon 
take an aggressive approach to 
whatever diagnostic investigations 
are required.*
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5. The Diagnosis and Management of 
Common Soft-Tissue Infections
A.J. Davison, MD; O.D. Rotstein, MD, FRCSC
Soft-tissue bacterial infections range from the superficial, relatively benign form, 
readily treated by oral administration of antibiotics, to the highly lethal variety 
which requires extensive surgical debridement, administration of broad-spectrum 
antibiotics and patient monitoring in the intensive care unit. The key to patient 
survival in the latter group is early diagnosis and treatment. Those at risk of 
serious infections include diabetic and cirrhotic patients and trauma victims who 
have been treated either surgically or medically. In addition to awareness of the 
possibility of serious infection, x-ray films of the soft tissue to show gas, aspiration 
of fluid collections for Gram’s staining and local incision of the tissue to inspect 
fascia and muscle are all useful aids in diagnosis. This review attempts to classify 
soft-tissue infections and to recommend an approach to diagnosis and management.
Les infections bacteriennes des tissus mous peuvent prendre une forme superficielle 
et relativement benigne qui se traite facilement par l’administration d’antibiotiques 
oraux; elles peuvent toutefois etre d’une variete gravissime qui exige un debride­
ment chirurgical large, l’administration d’antibiotiques a large spectre et la mise 
sous surveillance du patient aux soins intensifs. Dans ce dernier cas la cle de la 
survie reside dans un diagnostic et un traitement precoces. Les patients exposes a 
des infections serieuses sont les diabetiques et les cirrhotiques, et les traumatises 
qui ont re?u un traitement chirurgical ou medical. En plus d’etre aux aguets des 
possibility d’infections serieuses, la recherche radiographique de gaz dans les 
tissus mous, la ponction des epanchements liquidiens pour coloration Gram, et 
l’incision locale des tissus pour examen des aponevroses et des muscles represented 
des outils utiles au diagnostic. Cet article propose une classification des infections 
des tissus mous et recommande une marche suivre pour leur diagnostic et leur 
traitement.
Because of the durability of its keratinous layer, the skin is 
generally resistant to infection. Dis­
ruption of this layer or the presence
Accepted for publication Mar. 8, 1988
of a foreign body, such as suture 
material or soil, renders the soft 
tissues susceptible to infection by a 
relatively small bacterial inoculum.
Diabetes mellitus, vascular insuffi­
ciency and venous stasis also en­
hance susceptibility of soft tissues 
to infection.
Classification
Soft-tissue infections can be clas­
sified according to the anatomic 
level affected: the skin and subcuta­
neous tissues, the fascia and the 
muscle layers. Because these layers 
are in close apposition, infection in 
one layer may initially appear to 
involve another. For example, nec­
rotizing fasciitis due to Streptococ­
cus pyogenes may present with cu­
taneous gangrenous changes due to 
thrombosis of superficial vessels as 
they traverse the infected fascial 
layer. Generally, however, clinical 
examination and a few basic tests 
will lead to the correct diagnosis. 
The purpose of this paper is to 
review the clinical presentation, di­
agnosis and management of com­
mon bacterial soft-tissue infections.
Common Bacterial Infections of 
the Skin and Subcutaneous 
Tissue
Impetigo, erysipelas and folliculi­
tis are the most common superficial 
infections of the skin and subcuta­
neous tissues. These infections gen­
erally require no drainage or 
debridement but occasionally may 
resemble noninfectious lesions and 
require biopsy for diagnosis.
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Impetigo, initially vesicular, pus­
tulates and ruptures to form the 
characteristic golden crusting.1 The 
common epidemic variety appears in 
infants and children during the 
warm, humid months. Minor trau­
ma or insect bites predispose to this 
highly communicable infection. The 
responsible agent initially is Group 
A Streptococcus, but rapid superin­
fection by Staphylococcus aureus 
follows. Gram’s staining shows 
gram-positive cocci, and culture of 
vesicular fluid or exudate confirms 
the diagnosis. Good hygiene and 
topical use of antibiotics are help­
ful, and penicillin may reduce the 
incidence of glomerulonephritis as a 
sequela. Erythromycin is an alterna­
tive in mixed infections with penicil­
linase-producing staphylococci.
Erysipelas is a distinctive superfi­
cial cellulitis characterized by a 
painful, red, indurated area sharply 
demarcated by an advancing border. 
High fever and leukocytosis are 
common. Erysipelas often occurs in 
the lymphedematous extremity fol­
lowing radical mastectomy and 
chest wall irradiation. Streptococ­
cus pyogenes is the usual causative 
agent, so penicillin is the drug of 
choice. Three to 4 days of parenter­
al antibiotic therapy are usually 
necessary before the signs and 
symptoms resolve.
Folliculitis is a pyoderma located 
within hair follicles, usually caused 
by S. aureus.2 Extension of this 
infection into the subcutaneous tis­
sues with involvement of several 
hair follicles results in the develop­
ment of a furuncle; further exten­
sion produces a carbuncle which 
causes subcutaneous abscesses with 
multiple draining tracts along hair 
follicles. This lesion usually occurs 
at the back of the neck, on the back 
or thighs, and systemic toxicity is 
common. Carbuncles and furuncles 
associated with cellulitis and fever 
should be treated with an antista- 
phylococcal drug, since S. aureus is
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almost always the infecting organ­
ism. Surgical drainage and under­
mining through cruciate incisions 
are necessary for large, fluctuant 
furuncles and all carbuncles.
Cellulitis and subcutaneous ab­
scesses are deeper extensions of the 
superficial infections and involve si­
milar pathogens. Classic cellulitis 
due to S. pyogenes is painful and 
appears most commonly on an ex­
tremity as a poorly demarcated area 
of erythema and edema and pain; it 
is usually associated with fever, 
chills and malaise.
Factors predisposing to cellulitis 
are minor trauma or an underlying 
skin lesion, although there may be 
no apparent break in the skin. 
Local skin necrosis and occasionally 
abscess formation and gram-nega­
tive superinfection may complicate 
the condition. Lymphangitis, 
lymphadenitis and bacteremia are 
common. Cellulitis associated with 
diabetic ulcers, decubitus ulcers or 
chronic venous insufficiency is al­
most always polymicrobial, contain­
ing a mixture of gram-positive cocci 
and both gram-negative aerobes and 
anaerobes.
Standard management for celluli­
tis is immobilization, elevation and 
parenteral antibiotic therapy which 
should include penicillin, usually in 
combination with a penicillinase- 
resistant penicillin such as cloxacil- 
lin to cover S. aureus. Cellulitis 
associated with diabetic or decubi­
tus ulcers requires initial treatment 
with broad-spectrum antibiotics 
such as an aminoglycoside plus 
clindamycin or an advanced-genera­
tion cephalosporin. When underly­
ing suppuration is signalled by fail­
ure of the infection to respond to 
antibiotic therapy, incision and 
drainage should be carried out with­
out delay.
Subcutaneous abscesses fre­
quently complicate folliculitis, cellu­
litis and trauma.3 Patients have pain 
and swelling; systemic toxicity is
less prevalent than with cellulitis, 
but lymphangitis and regional ade­
nopathy may be present. While fluc­
tuation is the sine qua non of 
suppuration, it sometimes occurs 
late, particularly with perineal and 
breast infections. In these cases, the 
indication for surgical drainage is 
based on the presence of overlying 
inflammatory change alone.
Under suitable anesthesia and 
sterile conditions, the abscess is 
drained and probed digitally. Thor­
ough irrigation and loose gauze 
packing of the abscess cavity are 
important; packing is removed after 
48 hours. Antibiotic use is con- 
toversial but indicated in the follow­
ing circumstances: in a clinically 
septic patient with tachycardia and 
fever, in facial or mastoid abscesses, 
in systemic conditions such as rheu­
matic heart disease and in im- 
munosuppressed patients. Extremi­
ty abscesses often result from S. 
aureus infection alone, those of the 
axilla and trunk frequently contain 
a mixture of aerobes, and abscesses 
below the umbilicus invariably yield 
a mixture of aerobes and anaerobes. 
Final culture results should dictate 
the antibiotic therapy used.
Gangrenous Infections of 
Subcutaneous Tissue and 
Fascia
Gangrene of the skin with under­
lying infection is a manifestation of 
vascular thrombosis at the level of 
the subcutaneous tissues, fascia or 
muscle. Hence, the clinical finding 
of gangrene is not diagnostic of 
infection at any particular level, but 
rather an indication for further in­
vestigation. An x-ray film of the 
soft tissues for the presence of gas 
is mandatory. Air in the tissues 
usually means the presence of gas­
forming organisms such as Es­
cherichia coli or anaerobic bacteria 
and is an absolute indication for
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surgical intervention. Initially a 
small incision should be made down 
to the level of the fascia for direct 
inspection. In necrotizing fasciitis, 
the fascia appears grey and stringy 
and an instrument can easily be 
passed along the deep fascial plane. 
Through the same incision, under­
lying muscle can also be inspected. 
Aspiration of fluid for Gram’s stain­
ing and culture may help in the 
choice of antimicrobial therapy.
Meleney’s synergistic gangrene is 
an ulcerating necrotic lesion of the 
skin and subcutaneous tissues 
caused by the synergistic action of 
microaerophilic streptococci and S. 
aureus.4 It usually starts around a 
foreign body such as a retention 
suture and is characterized by an 
ulcer surrounded by a ring of pur­
plish-coloured skin, erythematous 
at the periphery. Treatment in­
cludes removing the foreign body, 
excising the necrotic ulcerated tis­
sue and providing appropriate anti­
biotic therapy.
Clostridial anaerobic cellulitis, a 
necrotizing subcutaneous infection, 
does not involve deep fascia or 
muscle. The associated extensive 
crepitus and dark foul-smelling 
drainage occur typically in traumat­
ic wounds and areas contaminated 
by fecal flora. Nonclostridial anaer­
obic cellulitis is a similar infection 
in which mixed anaerobic flora pre­
dominate.
Necrotizing fasciitis is the gener­
ic name for any infection causing 
necrosis of the fascia. Systemic 
manifestations vary, but usually the 
patient is extremely toxic and has a 
fever and hypotension. Pain may be 
minimal because cutaneous sensa­
tion is lost. Streptococcal gangrene 
is a rare fulminant type of necrot­
izing fasciitis caused by Group 
A streptococci. Characteristically, 
there is extensive skin necrosis re­
sulting from thrombosis of the su­
perficial vascular plexus. Dusky 
patches and large bullae appear
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within 2 to 4 days, followed by 
cutaneous gangrene and a burn-like 
eschar. Subcutaneous gas is un­
common. Gram-positive cocci are 
found in the bullae. Bacteremia, 
metastatic abscesses and death may 
occur if prompt, radical, surgical 
debridement is not carried out and 
parenteral penicillin therapy is not 
initiated.
The usual form of necrotizing 
fasciitis is a synergistic bacterial 
infection involving a combination of 
aerobes and anaerobes, including 
gram-positive cocci and gram-nega­
tive bacilli.5 It is an uncommon type 
of infection, generally introduced 
through a break in the skin or 
through the gastrointestinal tract. 
Diabetes, cardiovascular disease and 
renal disease predispose to the de­
velopment of necrotizing fasciitis. 
“Fournier’s gangrene”, a necrotiz­
ing fasciitis of the scrotum, is char­
acterized by extensive cutaneous 
gangrene.6 It is frequently associat­
ed with ischiorectal abscesses or 
penetrating rectal cancers. The tes­
ticles are usually spared. Cultures 
usually grow facultative organisms 
(E. coli, Klebsiella sp and enterococ­
ci) and anaerobes (Bacteroides sp, 
Fusobacterium sp, Clostridium sp, 
anaerobic or microaerophilic strep­
tococci).
Management of necrotizing fas­
ciitis consists of surgical debride­
ment of necrotic tissue, control of 
the underlying disease and appro­
priate antibiotic therapy. Incision of 
the skin and subcutaneous tissue 
should extend to healthy fascial 
planes. Necrotic fascia should be 
completely debrided and the wound 
packed open to permit further exci­
sion if necessary. For infections of 
the perineum, buttock and thigh, 
broad-spectrum antibiotic therapy, 
effective against anaerobic and aer­
obic bacteria, is required. A defunc­
tioning colostomy is necessary 
when the anorectal region is in­
volved. The prognosis depends on
the age of the patient, site of the 
infection and the presence of under­
lying disease such as diabetes or 
renal failure; for example, elderly 
debilitated patients with perirectal 
infections have a much greater 
death rate than young drug addicts 
with extremity infections.
Myonecrosis
In clostridial myonecrosis (gas 
gangrene), a rapidly progressive 
toxemic infection of muscle, Clos­
tridium perfringens is the responsi­
ble organism in about 90% of 
cases.7 Important factors in the 
pathogenesis of this infection are 
clostridial contamination of devital­
ized tissue from the gastrointestinal 
tract or soil and the presence of 
foreign material in the wound. 
These may occur in both surgical 
and nonsurgical trauma. Character­
istically, severe pain, not in keeping 
with the relatively benign appear­
ance of the wound, is an early sign 
of the disease. The patient rapidly 
becomes sweaty and hypotensive 
and experiences tachycardia; deliri­
um, shock and renal failure follow.
Initially the wound is edematous 
and tender and Gram’s staining of 
the serosanguineous discharge 
shows typical gram-positive bacilli 
but few leukocytes. Tissue crepita­
tion, blisters filled with dark fluid, 
skin necrosis and x-ray films show­
ing gas in the muscle are all late 
signs.
To improve the poor prognosis 
the condition must be diagnosed 
early and necrotic muscle radically 
debrided; a number of operations 
are frequently necessary to accom­
plish satisfactory debridement. Am­
putation may be required and fasci- 
otomies are occasionally necessary 
to decompress and drain adjacent 
muscle compartments. High intra­
venous doses of penicillin are essen­
tial and an aminoglycoside may be
335
DAVISON & ROTSTEIN
added for patients with traumatic 
wounds. Hyperbaric oxygen therapy 
is a useful adjuvant but is not a 
substitute for surgical debridement 
and antibiotic therapy.
Anaerobic streptococcal myone­
crosis is a similar disease with a 
longer incubation period and a less 
fulminant course. Pain is less prom­
inent and toxemia a later develop­
ment. Synergistic nonclostridial an­
aerobic myonecrosis is a necrotizing 
fasciitis involving muscle. In mixed 
infections B. fragilis is the key 
pathogen; combinations of antibiot­
ics and extensive debridement are 
required.
Unusual Soft-Tissue Infections
Prophylaxis against infection is 
the key to management of human 
bite wounds. This is accomplished 
by debridement of devitalized tissue 
and foreign particles, and primary 
repair of divided tendons, nerves 
and blood vessels, in addition to 
antibiotic and antitetanus therapy. 
Superficial wounds are left open. In 
bite wounds to the hand, it is 
crucial to recognize any hidden in­
jury to the extensor tendon and 
metacarpophalangeal joint capsule; 
oral bacteria thrive in the avascular 
tendon tissues and may produce 
mixed infections presenting as cel­
lulitis, lymphangitis, necrotizing 
fasciitis or osteomyelitis.8 Drainage, 
debridement and parenteral penicil­
lin are required for these estab­
lished infections. Animal bites are 
managed similarly. Pasteurella mul- 
tocida inoculated by animal bites 
can cause cellulitis, ulceration and 
lymphadenopathy progressing to 
necrosis and abscess formation. 
These infections will respond to 
pencillin.
The diabetic foot is subject to 
soft-tissue infections due primarily 
to peripheral neuropathy.9 Repeated 
painless trauma to the pressure 
points on the foot leads to ulcer­
ation and secondary infection, 
which typically is polymicrobial; an 
average of five to six aerobic and 
anaerobic species are usually cul­
tured. Slow healing is aggravated 
by peripheral vascular disease. Vari­
ous diabetic skin lesions and fungal 
infections may also predispose to 
secondary bacterial invasion. Cellu­
litis should be treated with broad- 
spectrum antibiotics (cefoxitin or 
gentamicin plus clindamycin). Con­
trol of the diabetes, drainage of 
abscesses and debridement of ne­
crotic tissue may aid ulcer healing 
and avoid amputation. X-ray films 
of the soft tissues may indicate the 
proximal spread of these undermin­
ing infections along fascial planes. 
As a preventive measure, podiatric
advice should be sought to recom­
mend appropriate foot care and 
shoes for diabetics.
We thank Miss Christina Wareham for 
preparing the manuscript.
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SESAP V Question
136. Laboratory data supporting the diagnosis of systemic sepsis include all of the following EXCEPT
(A) hypoxemia with a normal chest roentgenogram
(B) platelet count 600,000/cu mm
(C) serum fibrin split products present in > 1:40 dilution
(D) blood glucose 480 mg/dl
(E) cardiac output 11.6 L/min
For the incomplete statement above select the one completion that is best of the five given.
For the critique of Item 136 see page 345.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and Self-Assessment Program No. 5. 
For enrolment in the Surgical Education and Self-Assessment Program No. 5, please apply to the American 
College of Surgeons, 55 East Erie St., Chicago, IL 60611.) _________
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The increasing fear of acquired immune deficiency syndrome and other 
blood-transmissible diseases and increasing blood-bank shortages prompted a study 
of the safety and feasibility of a commercially available hand-held unit for collecting 
and reinfusing blood. The device was used on nine patients undergoing aortic 
surgery and permitted a mean saving of 2.6 units of banked blood. The reinfusion of 
collected blood did not result in any coagulation disturbances or changes in renal 
function. The hemoglobin and platelet levels were comparable to those in a group of 
patients receiving only banked blood. The unit does not require additional personnel 
or technical training for its use. The authors conclude that this autotransfusion 
device is a safe and feasible method of reducing the requirement for banked blood 
during aortic surgery.
La peur croissante d’attraper le syndrome d’immunodeficience acquise ou d’autres 
maladies transmissibles par transfusion sanguine ainsi que les penuries de plus en 
plus frequentes dans les banques de sang, sont a l’origine de cette etude portant sur 
la securite et la possibility d’utiliser un appareil portatif, disponible dans le 
commerce, pour prelever et retransfuser le sang. L’appareil a ete utilise chez neuf 
patients soumis a une chirurgie aortique et il permit d’epargner, en moyenne, 2.6 
unites de sang prises sur les banques de sang. La transfusion du sang preleve n’a 
entralne aucune perturbation de la coagulation ou modification de la fonction renale. 
L’hemoglobine et les plaquettes etaient comparables aux taux mesures chez un 
groupe de patients qui rejurent seulement du sang provenant de la banque de sang. 
L’appareil n’exige pas, pour son utilisation, de personnel additionnel ou d’une 
formation technique speciale. Les auteurs concluent que cet appareil d’autotransfu- 
sion represente un moyen sur et applicable pour reduire les demandes a la banque 
de sang durant les chirurgies aortiques.
The increased public awareness of acquired immune deficiency 
syndrome (AIDS) and frequency of
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blood-transmissible diseases have 
sparked another surge of interest in 
autologous blood collection and
reinfusion. Autotransfusion was 
first reported by Duncan in 18861 
during an amputation of the lower 
extremity for a crush injury. Lock- 
wood2 first reported its use in North 
America when he reinfused blood 
collected during splenectomy for 
Band’s syndrome. Since then, tech­
niques have improved, and equip­
ment has become more sophisticat­
ed and costly.34 Cell collection and 
washing with immediate reinfusion 
is possible but requires special 
equipment and trained personnel, 
putting this technique out of the 
reach of many institutions. A Euro­
pean group5 recently reported their 
experience with a simple self-con­
tained unit not requiring personnel 
trained in its use. Because of in­
creasing public concern and fre­
quent blood-bank shortages, we 
used a similar commercially avail­
able unit, the Solcotrans unit 
(Solco Basle Inc., Boston, Mass.), 
to assess the feasibility and 
safety of autotransfusion by this 
means.
Patients and Methods
Nine patients scheduled to under­
go elective aortic reconstruction 
were selected for the study. Eight 
had abdominal aortic aneurysms 
and one required an aortobifemoral 
graft. The aorta was exposed 
through a midline incision. After 
the vessel was controlled proximally 
and distally, the indicated graft re-
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placement was performed according 
to the surgeon’s usual practice. 
Five thousand units of heparin 
were administered intravenously, 
then the Solcotrans unit was con­
nected to wall suction set at 80 mm 
Hg and suspended vertically over 
the operative field. A suction tip 
was connected to the unit using 45 
cm of large-bore polyvinyl chloride 
tubing which permitted excellent 
freedom of movement. Citrate phos­
phate dextrose (40 ml) was aspir­
ated into the unit, then pooled 
blood was withdrawn from the oper­
ative field until the heparin effect 
was reversed. The unit was agitated 
intermittently during the procedure 
to encourage mixing of blood with 
the anticoagulant. A 170 /rm in-line 
filter was used between the suction 
tip and the unit.
The unit (Fig. 1) comprises a 
rigid plastic container with an inner 
polyvinyl chloride lining bag into 
which the blood is aspirated. When 
the bag is full (500 ml) the tubing is 
clamped and disconnected, and the 
unit is passed to the anesthetist 
(average time less than 1 minute); 
another unit may then be set up if 
needed. The anesthetist inverts the 
unit, attaches a 40 mm filter and 
reinfuses the blood through the exit 
port. A separate valve between the 
inner bag and rigid plastic box 
permits safe reinfusion under pres­
sure. The unit is not reusable.
The following blood analyses 
were carried out before surgery, at 
the end of infusion, 1 hour postop- 
eratively and on postoperative day 
1: hemoglobin level, platelet count, 
prothrombin, activated partial 
thromboplastin and thrombin clot­
ting times, creatinine and urea ni­
trogen levels and a qualitative anal­
ysis of free plasma hemoglobin. For 
comparison, 12 consecutive pa­
tients who previously underwent 
aortic aneurysm procedures and re­
ceived only banked blood (control 
group) were retrospectively re­
viewed. Results were compared 
using the unpaired Student’s t-test.
Results
The nine patients received a 
mean (± SD) of 2.4 ± 1 .3  units of 
autotransfused blood and 1.0 ± 0.9 
units of banked packed red cells 
perioperatively. Over the same peri­
od the control group received 3.6 ± 
2.2 units of packed cells. The mean 
hemoglobin level fell from 131 ± 
16 g /L  preoperatively to 116 ± 16 
g /L  on postoperative day 1, a dif­
ference that was not significantly 
different from that in the control 
group (132 ± 19 g /L  to 124 ± 18 
g/L). Although there was a signifi­
cant fall in the platelet count (243 
± 39 X 109/L  to 184 ± 41 X 
109/L), the levels remained within 
the reference range for our labora­
tory and did not differ from the fall 
in the control group (304 ± 78 X
109/L  to 232 ± 61 X 109/L). 
There was no significant change in 
renal function although six of the 
nine patients showed signs of a 
short-lived rise in free plasma he­
moglobin lasting less than 24 
hours. Changes in coagulation sta­
tus (Fig. 2, Table I) showed that the 
preoperative and postoperative lev­
els were within normal ranges. 
Changes occurring intraoperatively 
corresponded appropriately to the 
administration of heparin. Fibrino­
gen levels remained normal 
throughout the study. No ill effects 
could be directly or indirectly attri­
buted to the auto transfusion. Three 
patients received no banked blood 
and three received only one unit.
Discussion
None of our findings suggested 
that the Solcotrans unit for collect­
ing and reinfusing autologous
FIG. 1 — (A) Unit is contained within sterile field suspended from anesthetic 
screen, 80 mm Hg wall suction is applied and aspiration port is used to remove 
pooled blood from operative field. (B) After unit is full, entire device is passed to 
anesthetist who attaches blood filter and uses pressure infusion port to reinfuse 
blood. Inner lining bag prevents air infusion.
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blood was unsafe, and the simplicity 
of operation coupled with its low 
cost makes it available to all hospi­
tals. Units previously described 
have involved collection, washing 
and reinfusion of red cells.34 The 
equipment required for this is avail­
able in centres doing cardiopulmo­
nary bypass but not in other hospi­
tals. At least two units of blood 
must be salvaged to make auto­
transfusion with cell washing cost- 
effective.4 The original unit cost, 
the ongoing expense of personnel, 
tubing and so on and the inability 
to predict operative blood loss reli­
ably all make this approach imprac­
tical in many centres. The device 
described in this study may be 
stored on a shelf, is readily available 
at any time and does not require 
special personnel or training. Each 
unit of blood has a self-contained 
cost factor and therefore even the 
salvage of 500 ml may be practical 
if infusion of banked blood can be 
avoided.
Although whole, unwashed blood 
was infused, no disseminated in­
travascular coagulation or major 
clotting abnormalities were identi­
fied. The 170 /urn aspiration filter 
and the 40 /tm reinfusion filter 
served to rid the blood of much
FIG. 2 — Changes (± SD) in prothrombin time (hatched bars), activated partial 
thromboplastin time (white bars) and thrombin clotting time (dotted bars) demon­
strating preoperative and postoperative levels. They were within reference range 
for laboratory. Rise in activated partial thromboplastin time and thrombin clotting 
time is in keeping with intraoperative heparin dose.
T a b le  1 -  Changes in Results of Coagulation Studies
Prothrom bin
A ctivated  p a rtia l 
th rom bop lastin
Throm bin
clotting
tim e , s tim e , s tim e , s
(8 .8  -  1 2 .4s *) (2 4  -  4 2 s *) (6 .6  -  9 .9 s * )
Preop
Study group 10.8 ± 0 .2 31.4 ±  3.6 9.1 ±  0.8
Control 11.1 ± 0 .5 28.9 ± 1.2 9.3 ± 0.8
Postop
Study group 11.7 ± 0 .5 33.9 ± 3.6 9.7 ± 0.7
Control 11.9 ± 0 .6 42.1 ± 23.8 13.0 ± 7.7
Postop day 1
Study group 11.6 ± 0 .6 34.6 ±  1.5 8.9 ±  0.8
Control 12.0 ± 1.2 33.3 ± 4.8 9.6 ± 1.2
'Normal ranges for our laboratory.
debris. The use of low wall suction 
and polyvinyl chloride tubing limit­
ed damage to the red cells. If frag­
mentation or collection of debris is 
unavoidable then the blood may be 
washed in the blood bank by stan­
dard techniques. At present the au­
totransfusion unit, like the more 
expensive cell savers, cannot be 
recommended for use in con­
taminated fields or when malignan­
cy is suspected.
There are several disadvantages 
to the unit: the low pressure wall 
suction may not remove blood from 
the field as quickly as portable 
suction; it is therefore suggested 
that two intraoperative suction de­
vices be available, one for blood 
that is to be salvaged and one for 
blood to be discarded. The Solco- 
trans unit works best at recovering 
pools of blood rather than continu­
ous small quantities since larger 
volumes are drawn directly into the 
chamber containing anticoagulant, 
preventing coagulation within the 
tubing. Because of the lower suc­
tion used with these units to pre­
vent red cell damage they may be 
less useful in a situation of massive 
hemorrhage than in one of predict­
ed blood loss. Units can be changed 
quickly, but necessitate a short (less 
than 1 minute) break in the opera­
tion which may occur at an inop­
portune time. The maximum num­
ber of units that may safely be 
reinfused has not been studied. 
With continued use one readily 
adapts to these inconveniences.
We believe that the Solcotrans 
unit is safe to use in aortic recon­
struction where there is predictable 
blood loss, and its self-contained 
nature makes it applicable in hospi­
tals where cardiopulmonary bypass 
equipment and trained personnel 
are not available.
Summary
The self-contained hand-held Sol-
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cotrans unit provides a safe and 
feasible method of collecting and 
immediately reinfusing autologous 
blood during aortic surgery. Small 
decreases in hemoglobin levels and 
platelet counts were identified, but 
they remained within the reference 
range and did not differ significant­
ly from the control group. Clotting 
abnormalities were not identified. 
Although free plasma hemoglobin
BOOK REVIEW S
ACUTE PANCREATITIS. Research 
and Clinical Management. Edited by 
Hans G. Berger and Markus Buchler. 
394 pp. Illust. Springer-Verlag, New 
York, 1987. Price not stated. ISBN 
0-387-17534-2.
This publication is the product of an 
international congress held in Ulm, Ger­
many in the spring of 1987. Contribu­
tions from European and American in­
vestigators are organized into sections. 
Those dealing with morphology, ep- 
demiology, pathophysiology, diagnosis 
and prognosis describe laboratory ap­
proaches to pancreatitis and attempt to 
stratify disease severity. Few of the 
methods present any new information; 
the various contributors do not reach a 
consensus, but rather maintain the es­
tablished directions of their own cen­
tres. The aim of investigators to find a 
common acceptable standard that corre­
lates with clinical disease prognosis is 
not achieved through the tutorials pre­
sented in this book.
The next sections deal with the clini­
cal course of acute pancreatitis, biliary 
pancreatitis and conservative treatment. 
The last two suffer from repetition 
through multiauthor descriptions of si­
milar material. Nonsurgical therapies 
presented include pharmaceutical and 
endoscopic management, peritoneal la­
vage and parenteral nutrition. The con-
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was evident for a short time in some 
patients it had no adverse effects on 
renal function. Further study may 
result in the use of this unit during 
many aortic reconstructions.
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sepsis and reducing morbidity and mor­
tality will arouse criticism from those of 
conservative persuasion.
Overall, this textbook presents a sur­
gical orientation to severe pancreatitis. 
The issues presented are at the leading 
edge of controversy in management. 
The book does not allow conclusions to 
be drawn from tutorials as presented in 
this book by selected authorities in the 
field of acute inflammatory disease of 
the pancreas.
Roger G. Keith, MD, FRCSC, FRCS, 
FACS
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Division o f General Surgery,
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ANAESTHETIC MANAGEMENT OF 
CAROTID ENDARTERECTOMY. 
Leonard C. Jenkins and David W.H. 
Wong. 179 pp. Illust. Lloyd-Luke 
(Medical Books) Ltd., London, 1987. 
Price not stated. ISBN 0-85324-204-6.
Twenty years have passed since Jen­
kins’ review “Anaesthetic consider­
ations for carotid thrombo-endarterecto- 
my” appeared in the Canadian Anaes­
thetists Society Journal. This new book
continued on page 367
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Review of the Surgical Management of 
Recurrent Hiatal Hernia: 5-Year Follow-up
Robert D. Henderson, MB, FRCSC;* Gary Marryatt, RNA; Robert F. Henderson
Symptoms in patients with hiatal hernia often respond to treatment consisting of 
diet and medication. Operative procedures, designed to control gastroesophageal 
reflux and avoid surgically induced problems, are reserved for those with intractable 
symptoms. When these operative procedures fail, reoperation may be necessary. The 
reoperative procedure is often technically complex because of esophageal and gastric 
scar fixation. The authors reviewed the surgical management of recurrent hiatal 
hernia in 168 patients followed up for 5 years or more; 43 of them had undergone 
gastric surgery previously.
Radiologically, 97% of patients studied (142 of 146) had no evidence of anatomic 
recurrence or reflux postoperatively. Manometric studies postoperatively in 114 
patients showed that the mean tone of the high pressure zone was within the normal 
range and lower esophageal disordered motor activity was decreased by 34.5% from 
the preoperative level. Symptoms of recurrent hiatal hernia were abolished by 
operation in 88% of the patients; only 4.8% had serious or recurrent symptoms.
Chez les patients souffrant de hernie hiatale, les symptomes repondent souvent a un 
traitement reposant sur le regime alimentaire et la medication. Les interventions 
chirurgicales destinees a empecher le reflux gastro-oesophagien et a eviter les 
problemes provoques par la chirurgie, sont reservees aux personnes presentant de 
symptomes irreductibles. Quand ces interventions echouent, il peut etre necessaire 
de reoperer. Cette seconde operation est souvent techniquement complex a cause des 
cicatrices gastriques et oesophagiennes. Les auteurs ont passe en revue le 
traitement chirurgical de hernies hiatales recidivantes chez 168 patients qui ont ete 
suivis pendant 5 ans ou plus; 43 d’entre-eux avaient subi des chirurgies gastriques 
precedemment.
A la radiographie, 97% des patients etudies (142 sur 146) n’avaient aucun signe 
postoperatoire de recidive ou de reflux. Chez 114 patients, des etudes manometri- 
ques postoperatoires ont montre que le tonus moyen de la zone de pression elevee 
etait a l’interieur des limites normales et que l’activite motrice dereglee de 
l’oesophage inferieur etait reduite de 34.5% par rapport au niveau preoperatoire.
Les symptomes de hernie hiatale recidivante ont ete elimines par l’operation dans 
88% des cas; seulement 4.8% des patients ont presente des symptomes serieux ou 
recurrents.
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Gastroesophageal reflux, a com­mon cause of indigestion, oc­
curs at all ages and with varying 
degrees of severity. Although re- 
flux-induced symptoms in the ma­
jority of patients respond well to 
minor dietary changes and medica­
tion, some require H2 blockers. Sur­
gery is reserved for those with 
severe symptoms not responding to 
appropriate medical management. 
Operations are designed to control 
reflux and avoid surgically induced 
problems.
In this paper the term recurrent 
hiatal hernia is used to describe 
recurrence o f symptoms and major 
reflux. Some patients with recur­
rent hernia also suffer dysphagia 
and overcompetence produced by 
their initial operation.1
Surgical management o f a recur­
rent hiatal hernia is technically 
complex because o f esophageal and 
gastric scar fixation. Detailed pre­
operative investigation must evalu­
ate the gastroduodenal disease and 
problems created by the original 
operation.
Reports o f the surgical manage­
ment o f recurrent hernias are limi­
ted2-4 and none have a follow-up of 
as long as 5 years. Most papers on 
esophageal surgery do not refer to 
the management o f previous associ­
ated gastric surgery.5-8 We there­
fore reviewed the surgical manage­
ment of patients who had recurrent 
hiatal hernia and were followed up 
for 5 years, with reference also to 
those who had undergone previous 
gastric surgery.
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Patients and Preoperative Studies
Our study was based on 168 
consecutive patients (58 men, 110 
women) with recurrent hiatal hernia 
who were referred for surgery from 
other centres and physicians. The 
mean age of the patients was 47.2 
years (range from 19 to 72 years) 
and mean duration of symptoms 
was 7.7 years. The patients were 
investigated preoperatively by histo­
ry (Table I) and radiologic, mano- 
metric, acid perfusion and common 
cavity pH studies and by eso- 
phagogastroduodenoscopy.
Good quality radiologic studies 
were available for review in 160 
patients. An anatomic hiatal hernia 
recurrence was demonstrated in 86 
(53.7%) patients, reflux only in 32 
(20%) and neither in 42 (26.3%).
Manometric studies were con­
ducted in 166 patients, 1 could not 
tolerate the procedure and a second 
patient had a bleeding esophageal 
polyp. The average tone of the high 
pressure zone (HPZ) was 12.7 cm 
H20  and disordered activity was 
present in 45.8% of lower esopha­
geal motor waves. Two patients had 
clinical and manometric evidence of 
scleroderma. Acid perfusion studies 
performed on 148 patients were 
positive in 131 (88.5%).
All patients underwent eso- 
phagogastroduodenoscopy and 
were found to have disease in the 
stomach as well as the esophagus. 
Sixteen (9.5%) had esophageal stric­
tures, 6 (3.6%) had severe and ex­
tensive ulcerative esophagitis and 
17 (10.1%) had moderate ulcerative 
esophagitis. One patient (0.6%) had 
a bleeding granulation tissue polyp. 
Twenty patients (11.9%) had mild to 
moderate gastritis, 2 had gastric 
bezoars and 1 a bleeding gastritis. 
One had a pyloric stenosis, one had 
a pyloric ulcer and two had gastric 
ulcers.
In addition to esophageal hernia
repair, 43 patients had undergone 
gastric surgery: vagotomy and
drainage (20), Billroth I gastrec­
tomy (5), Billroth II gastrectomy 
(14), Billroth II gastrectomy with 
Roux-en-Y anastomosis (3) and 
esophagogastrostomy (1).
Operative Procedure
The operation in all cases was a 
thoracoabdominal total fundoplica- 
tion gastroplasty (TFG).910 In the 
absence of previous gastric surgery, 
a pyloromyotomy was added to im­
prove gastric emptying.
The thoracoabdominal incision, 
started immediately below the xy- 
phoid, extends 10 to 15 cm into 
the chest and 5 cm into the abdo­
men. It may be further extended in 
either direction to improve expo­
sure in obese patients or those with 
major scar problems. The costal 
margin is divided, removing 1 cm of 
cartilage directly beneath the xy- 
phoid. The diaphragm is incised 
circumferentially, preserving the 
phrenic nerve and 1 cm of attach­
ment to the chest wall. The esopha­
gus is mobilized circumferentially 
to the level of the inferior pulmo­
nary vein and then along its pericar­
dial and mediastinal pleural surfaces 
to the inferior margin of the aortic 
arch; lateral aortic attachments are 
preserved to maintain blood supply 
and reduce the risk of vagal nerve 
injury. Scar tissue in the vicinity of 
the hiatus is now divided.
The diaphragm is elevated and 
sutured to the upper edge of the 
incision, giving excellent exposure 
for the subdiaphragmatic dissection 
which is usually the longest part of 
the operation because scar fixation 
is often intense. Important aspects 
of the operation include: entering 
the lesser sac, exploring and pre­
serving the crural surfaces, protect­
ing both main vagi and the hepatic 
branch of the vagus nerve, minimiz­
ing injury to liver and spleen and 
avoiding muscular injury or fenes­
tration of the scarred esophagus 
and stomach. It is essential to rec­
ognize that previous sutures in the 
esophagus or stomach may have 
included mucosa and, when divided, 
a small opening may result and 
must be closed.
Mobilization is complete when 
the distal esophagus is entirely free 
and the proximal four or five short 
gastric vessels have been divided. In 
dissecting out the previous fundo- 
plication the surgeon must ensure 
that there is no damage to stomach 
or vagi and the curve is intact with 
peritoneal covering.
A first step in the revised repair is 
careful placement of crural sutures 
which should include the peritoneal 
covering of the muscle. In our 
experience crural breakdown is the 
commonest cause of anatomic re­
currence after gastroplasty.
The gastroplasty tube is fash­
ioned in continuity from the lesser 
curvature of the stomach over a no. 
60 French Maloney bougie. It is 
closed in two layers with a locking 
Dexon and an invaginating 000 silk 
suture. In most patients the tube is 
5 cm long, but this length is in­
creased when there is major eso­
phageal shortening. Once the tube 
has been created, posterior crural 
sutures are tied and fundoplication 
commences (Fig. 1). The newly cre­
ated fundus of stomach is rotated
T a b le  1 -  S y m p to m s  in 168 P a tie n ts  W ith
R e cu rre n t H iata l H ern ia
S ym p tom %
H e a rtb u rn 9 8 .8
R e flu x 79 .2
A s p ira tio n 53
E ru c ta tio n 70 .8
H ic co u g h s 28
W a te rb ra s h 25
N ausea 7 6 .2
V o m itin g 3 3 .9
T o ta l d ys p h a g ia 8 7 .5
S tr ic tu re 9 .5
C rico p h a ryn g e a l 4 1 .7
G a s tro eso p ha g e a l 73 .2
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clockwise behind the esophagus 
and gastroplasty; it is positioned so 
that the tip is exposed in the lesser 
sac opening above the hepatic 
branch of the vagus. It is anchored 
to the distal 1.5 cm of esophagus 
and the gastroplasty tube with five 
mattress sutures of 00 silk (Fig. 2). 
The fundoplication is now comple­
ted by approximating medial and 
lateral aspects of fundus for 1 to 
1.5 cm, using three mattress su­
tures of 00 silk (Fig. 3), positioned 
carefully to avoid excessive tight­
ness of the fundoplication, as this
FIG. 1 — Esophagogastric junction is 
exposed following thoracic and abdom­
inal mobilization. Proximal short 
gastric vessels are divided. Window is 
created on medial side in lesser sac 
above hepatic branch of vagus nerve, 
exposing caudate lobe of liver and 
right crus of diaphragm. Gastroplasty 
tube 5 cm long is cut over bougie.
FIG. 2 — Fundus is rotated behind 
gastroplasty tube and distal 1.5 cm of 
esophagus. Medial tip of fundus is held 
well posterior, and fundus is sutured 
to distal 1.5 cm of esophagus and 
through suture line of gastroplasty 
tube.
might produce symptomatic over­
competence. Two final mattress su­
tures of 00 silk are placed from 
fundus to diaphragm.
When the pylorus is intact a 
pyloromyotomy is added. In 11 of 
the 43 patients with previous gas­
tric surgery, the gastric procedure 
was modified. In 4 of the 20 with 
vagotomy and drainage the proce­
dure was further modified in 2 by 
conversion from a gastroenterosto­
my to a vagotomy, in the third by 
adding a gastroenterostomy and in 
the fourth by adding an enteroen- 
terostomy to a gastroenterostomy. 
Six patients with a previous eso- 
phagogastrostomy had this conver­
ted to a TFG. One other patient, 
with a superior mesenteric artery 
syndrome and obstruction to the 
third part of duodenum, had a 
duodenojejunostomy.
The thoracoabdominal incision is 
closed using continuous interlock­
ing Dexon suture invaginated with 
000 silk. The abdomen is usually 
not drained and a chest tube is 
placed in the left thorax.
Postoperative Results
There was one postoperative 
death (0.6%) from a mesenteric ar-
FIG. 3 — Lateral aspect of fundus is 
lifted medially and sutured to medial 
fundus with three sutures of 00 silk. 
This fundoplication is very loose. Sin­
gle suture is also placed to esophagus 
medially and two are placed from fun­
dus to diaphragm.
tery occlusion, unrelated to surgical 
technique. Four patients (2.4%) had 
wound infections. One had an em­
pyema and one a subphrenic ab­
scess, more than 30 days postopera- 
tively; neither of these had evidence 
of a fistula. Two patients required 
splenectomy for surgical injury. 
One patient had bowel obstruction 
which resolved spontaneously. Two 
patients had a fistula, one from 
revision gastric surgery and one 
from the TFG. Both fistulas were 
drained and closed spontaneously 
within 10 days.
Follow-up Evaluation
Follow-up, available for 5 or 
more years after surgery, was by 
radiologic studies in 146 (86.9%), 
manometric studies in 114 (67.9%) 
and by history in 163 (97%) pa­
tients.
Most of the initial radiologic fol­
low-up examinations were carried 
out 3 or 5 months after surgery and 
were repeated when indicated clini­
cally. The water siphon test was 
used routinely. Of the 146 patients, 
142 showed no evidence of anatom­
ic recurrence or reflux. One patient 
had a diverticulum, one obstruction 
and mucus retention and two pa­
tients had anatomic recurrence.
In the 114 patients followed up 
by manometric studies, the mean 
postoperative HPZ tone was 16.9 
cm H20, an increase of 33.1% over 
the mean preoperative HPZ tone 
which was 12.7 cm H20. We stud­
ied the effect of surgery on the 
preoperative tone and found that in 
those with a low tone the increase 
was marked,11 whereas in those 
with a normal or high preoperative 
level, surgery did not affect or actu­
ally reduced the HPZ tone (Fig. 4). 
The average postoperative tone in 
all groups was within the normal 
range of 15 to 20 cm H20. The 
mean lower esophageal disordered
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motor activity postoperatively was 
30% in these patients — a mean 
decrease of 34.5% from the preop­
erative rate of 45.8%.
Comfort and enjoyment of food 
are clearly tied to indications for 
surgery. A classification by symp­
toms was used as follows: group A 
— asymptomatic, no evidence of 
recurrence or reflux; group B — 
minor residual symptoms, no evi­
dence of recurrence or reflux; 
group C — persistence or recur­
rence of symptoms with or without 
anatomic recurrence or reflux; 
group D — intraoperative or post­
operative death. Using this classifi­
cation in the 168 patients, we found 
that 148 (88.1%) were asymptomat­
ic (group A), 11 (6.5%) had minor 
residual symptoms (group B), 8 
(4.8%) had serious residual or re­
current symptoms (group C) and 1 
(0.6%) died in hospital (group D) 
(Table II).
The major cause of operative 
failure was analysed and compared 
in those who previously underwent 
esophageal surgery only and those 
who had both esophageal and gas­
tric surgery. Of 125 patients with 
esophageal surgery, 6 were in 
group B; 3 of them had scleroderma 
with some residual dysphagia, 2 
had recurrent gastritis and 1 a 
diaphragmatic hernia. Two of the 
six patients had some emotional 
difficulties. There were six failures
(group C); three had an anatomic 
and symptomatic recurrence and 
three had residual motor dysphagia.
Of the 43 patients who had had 
previous gastric surgery, 5 were 
classified as group B; 4 had gastri­
tis and 1 had dumping. In addition 
to gastritis one had psychiatric 
problems. Two classified as group C 
had esophageal diverticula pro­
duced by intraoperative muscle in­
jury. The one death in the study 
was from a small-bowel vascular 
occlusion.
Discussion
Reports on the surgical manage­
ment of hiatal hernia recurrence are 
sparse and none have documented a 
follow-up of 5 years or more. In this 
study we examined two aspects — 
the effect of one technique of surgi­
cal correction and the effect of 
preoperative disease on the results 
achieved. Some aspects of the pre- 
and postoperative findings merit 
discussion. In the preoperative in­
vestigation it is important to obtain 
a thorough history, particularly of 
the initial operation, as this helps to 
recognize subsequent motor prob­
lems and may indicate the effective­
ness of reflux control.
Radiologic investigations were of 
value in only 73.7% of our cases, 
distortion from previous surgery 
making interpretation difficult.
Preoperative manometric studies 
are valuable in assessing the severi­
ty of reflux and previous operative 
trauma. Comparison between the 
pre- and postoperative HPZ tone 
shows that there is a greater aver­
age increase in tone postoperatively 
in patients with a low preoperative 
tone (Fig. 4) and a tone decrease in 
those with a hypertonic preopera­
tive HPZ. The tone change is useful 
in understanding the reflux control 
mechanism present in a TFG. Since 
tone returns to normal and postop-
FIG. 4 — Comparison of preoperative (dotted bars) and postoperative (hatched 
bars) high pressure zone (HPZ) tones show return to normal range of 15 to 20 cm 
H20 . Patients with low preoperative tone have major tone increase and those with 
hypertonic HPZ preoperatively have tone decrease postoperatively.
T a b le  II  - R esu lts  o f  S u rg e ry  fo r  R ecurrence
P re v io u s  e s o p h a g e a l P re v io u s  e s o p h a g e a l
A ll p a t ie n ts , s u r g e r y  o n ly , a n d  g a s tr ic  s u rg e ry ,
G ro u p n o . ( % ) n o . ( % ) no. ( % )
A 148  (8 8 .1 ) 1 1 3 (9 0 .4 ) 3 5  (8 1 .4 )
B 11 (6 .5 ) 6  (4 .8 ) 5 ( 1 1 .6 )
C 8 (4 .8 ) 6  (4 .8 ) 2 (4 .7 )
D 1 (0 .6 ) 0  (0 ) 1 (2 .3 )
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eratively an increase or decrease 
depends on preoperative tone, this 
effect is best explained by transmis­
sion of gastric tone through the 
fundoplication. If the gastric wrap 
were to cause the increase this 
should be equal in each case, rather 
than showing a strong relationship 
to the preoperative tone.
In this study, all patients with an 
intact pylorus had a pyloromyoto- 
my.8 The theoretical rationale for 
pyloromyotomy is that vagal func­
tion is unlikely to be normal after 
two mobilization procedures, even if 
the nerves are intact. Poor gastric 
emptying is a potential risk of hiatal 
hernia surgery, and pyloromyotomy 
is used to avoid this. There have 
been no operative or postoperative 
complications of this procedure.
Our study has considered two 
major factors — hernia recurrence 
and previous gastric surgery. The 
results achieved are not as good as 
previously reported10 in an overall 
review of TFG for primary and 
secondary repair; 355 patients were 
reported 5 years postoperatively. In 
that study, group A results were 
present in 93.1%, group B in 4.0% 
and group C in 2.9%. The preopera­
tive pathologic condition affects the
quality of the results and reopera­
tive surgery gives poorer results 
than primary surgery. Previous 
gastric surgery exposes the esopha­
gus to biliary and pancreatic secre­
tions which can produce major re­
flux injury.7’12
Despite these difficulties, the re­
sults obtained in our group of 168 
patients have been good. Since this 
is the first 5-year review, the results 
obtained in comparable groups of 
patients subjected to other surgical 
techniques must be evaluated to 
determine the optimal approach to 
the management of recurrent hiatal 
hernia with or without previous 
gastric surgery.
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ITEM 136
The systemic septic response involves abnormalities of virtually every organ system, due to ill-understood cell 
membrane abnormalities. Pulmonary dysfunction characterized by hypoxemia; disseminated intravascular 
coagulation (DIC) causing an increase in serum fibrin split products; deranged glucose metabolism resulting in 
hyperglycemia, and increased cardiac output due to decreased vascular resistance are all common during severe 
sepsis. Thrombocytopenia resulting from DIC, rather than thrombocytosis, is a feature o f sepsis.
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Evaluation of Delivery Systems 
Oxygenated Cardioplegia
Roderick W. Landymore, MD, FRCSC; Gerard Myers, RRT, CCP
The oxygen-carrying capacity of four delivery systems for blood and crystalloid 
cardioplegia was evaluated: nonoxygenated crystalloid cardioplegia, crystalloid 
cardioplegia oxygenated with a bubbler system and with a membrane system and, 
finally, blood cardioplegia delivered by the Shiley-Buckberg system. The 
nonoxygenated crystalloid cardioplegic solution delivered 0.56 ml of oxygen/dl of 
solution, the bubbler oxygenating system delivered 3.2 m l/dl and the membrane 
oxygenating system made available 3.7 ml/dl. Blood cardioplegia delivered 4.2 
m l/dl when oxygen-carrying capacity was corrected for the shift in the 
oxyhemoglobin dissociation curve that occurs with hypothermia. There appears to 
be no advantage between blood and oxygenated crystalloid cardioplegia with respect 
to the ability of these solutions to provide oxygen to the myocardium during 
ischemic arrest. However, the bubbler oxygenating system is superior to the 
membrane and blood delivery systems in that it could administer cold cardioplegia at 
any time during the operation. In contrast, the membrane and blood cardioplegia 
delivery systems both depend on integral heat exchangers which limit the delivery of 
cold cardioplegia to the period of hypothermia.
On a evalue la capacite de transport d’oxygene de quatre systemes de cardioplegie 
sanguine ou par cristalloide: la cardioplegie par cristalloide non oxygene, la 
cardioplegie par cristalloide oxygene a l’aide d’un bulleur ou d’un systeme a 
membrane, et, finalement, la cardioplegie sanguine produite a l’aide d’un systeme 
Shiley-Buckberg. La solution cardioplegique de cristalloide non oxygene a trans­
ports 0.56 ml d’oxygene/dl de solution, l’oxygenateur a bulk, 3.2 ml/dl et le 
systeme d’oxygenation a membrane, 3.7 ml/dl. La cardioplegie sanguine a donne 
une capacite de transport d’oxygene de 4.2 ml/dl, apres correction pour le decalage 
de la courbe de dissociation de l’oxyhemoglobine qui survient avec l’hypothermie. II 
ne semble pas y avoir d’avantage pour la cardioplegie sanguine par rapport a la 
cardioplegie par cristalloide, en ce qui concerne leurs capacites respectives de 
fournir de l’oxygene au myocarde durant un arret ischemique. Neanmoins, 
l’oxygenateur a bulle est preferable aux systemes sanguin et a membrane, car il est 
capable de fournir une cardioplegie froide en tout temps durant l’operation. Au 
contraire, les systemes de cardioplegie sanguine ou par membrane dependent tous 
deux d’un echangeur de chaleur qui limite la cardioplegie froide a la periode 
d’hypothermie.
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C linical investigations1-3 have suggested that, during pro­
longed ischemic arrest, blood cardi­
oplegia may provide better myocar­
dial preservation than asanguineous 
solutions because the former can 
oxygenate the ischemic myocardi­
um. However, Digerness and col­
leagues4 indicated that the affinity 
of oxygen for hemoglobin increases 
with hypothermia, and oxyhemoglo­
bin dissociation does not readily 
take place in cold sanguineous solu­
tions. This concept has led to the 
use of oxygenated crystalloid solu­
tions as an alternative to blood 
cardioplegia. In this study we evalu­
ated a number of delivery systems 
for oxygenated blood and asan­
guineous cardioplegia, measured 
the oxygen availability of these so­
lutions and discussed the relative 
merits of each delivery system.
Patients and Methods
Oxygen-carrying capacity was de­
termined for blood and crystalloid 
cardioplegia in 32 patients, ranging 
in age from 22 to 77 years (mean 
60.5 years), who underwent cardiac 
operations. The patients were divid­
ed into four equal groups of eight 
patients each. Group 1 patients re­
ceived nonoxygenated crystalloid 
cardioplegia and served as controls 
(Table I). Group 2 received crystal­
loid cardioplegia oxygenated with a 
bubbler oxygenating system (Ameri­
can Bentley Inc., Irvine, Calif.). 
Group 3 received crystalloid cardio­
plegia oxygenated with a membrane 
oxygenating system (Terumo Corp., 
Piscataway, NJ) and group 4 re-
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ceived blood cardioplegia infused 
with a Shiley-Buckberg system 
(Shiley Inc., Irvine, Calif.) which 
delivered blood cardioplegia in a 
ratio of 1 to 4.
Patients who received nonoxy- 
genated crystalloid cardioplegia 
(group 1) and crystalloid cardio­
plegia oxygenated with a bubbler 
system (group 2) were cooled by 
means of a recirculation line that 
was passed through an aluminum 
coil immersed in a bucket of ice. 
The cardioplegic solution was 
cooled by an integral heat exchan­
ger for the membrane crystalloid 
oxygenating system in group 3 pa­
tients and the Shiley-Buckberg sys­
tem in group 4.
The crystalloid and blood cardio­
plegic solutions were delivered into 
the ascending thoracic aorta by a 
roller pump, and cardioplegic tem­
perature was monitored by a therm­
istor positioned in line with the 
delivery system. Samples for oxy­
gen saturation were drawn directly 
from the cardioplegia infusion cir­
cuit during each administration and 
every 20 to 30 minutes during
Table 1 -  C o m p o s it io n  o f th e  E x tra ce llu la r 
C rys ta llo id  C a rd iop leg ia
Component Volume
R in g e r 's  s o lu tio n , m l 800
L o w -m o le c u la r-w e ig h t d e x tra n , 180
m l
P o ta s s iu m  c h lo r id e , m m o l/L 25
H eparin , U /L 200 0
S o d iu m  b ica rb o na te , m l 24
T o ro n to  in s u lin , m l 0 .04
ischemic arrest. Hemoglobin con­
centration was used to calculate 
oxygen availability in patients re­
ceiving blood cardioplegia. Mean 
oxygen-carrying capacities for both 
blood and crystalloid cardioplegia 
were corrected for pH and tempera­
ture as previously described by Kel- 
man and Nunn.5
Surgical Technique
The ascending aorta was can- 
nulated with a no. 24 Argyle cannu­
la (Sherwood Medical, Saint Louis, 
Mo.); in most cases venous return 
was provided with a no. 51 two- 
stage Sams cannula (Sarns Inc., 
Ann Arbor, Mich.). Bicaval cannula- 
tion was carried out only during 
mitral valve replacement or for re­
pair of congenital cardiac defects. 
Core temperature was lowered to 
between 25° and 30°C (mean 
25.2°C). Initial cardiac arrest was 
induced with an infusion of 10 
m l/kg of either crystalloid or blood 
cardioplegic solution, which was ad­
ministered at 20- to 30-minute in­
tervals or in the event of rewarming 
or the presence of electromechani­
cal activity. Myocardial protection 
was augmented in each case with 
topical iced saline, and myocardial 
temperature was monitored contin­
uously with a plunge electrode. Dis­
tal and proximal anastomoses were 
performed during a single aortic 
cross-clamping in patients undergo­
ing myocardial revascularization.
Statistical Analysis
The results were reported as the 
arithmetic mean ± the standard 
error. Statistical comparisons were 
made with the unpaired f-test.
Results
In group 1, nonoxygenated crys­
talloid cardioplegia provided 0.56 ±  
0.6 ml of oxygen/dl of solution 
(Table II). In group 2, crystalloid 
cardioplegia oxygenated with a bub­
bler system increased dissolved oxy­
gen to 3.2 ± 0.2 ml/dl and the 
membrane system for oxygenating 
crystalloid cardioplegia in group 3 
made available 3.7 ± 0 . 1  ml/dl. 
The membrane system provided sig­
nificantly (p < 0.02) more dissolved 
oxygen than the bubbler system. 
The oxygen-carrying capacity for 
blood cardioplegia administered to 
group 4 patients measured 11.3 ± 
0.5 ml/dl, but when corrected to 
take into account the reduced oxy­
hemoglobin dissociation that occurs 
with hypothermia the actual oxygen 
availability was 4.2 ± 0.2 ml/dl. 
The blood cardioplegic solution was 
significantly (p < 0.0001) more 
acidic than the crystalloid solution, 
probably reflecting the effects of 
carbon dioxide pressure as blood 
cardioplegic solution was drawn di­
rectly from the oxygenator. The 
delivery systems for oxygenated 
crystalloid cardioplegia lowered the 
temperature of the cardioplegic so-
Table II -  O xygen  A v a ila b il ity  o f  C a rd io p le g ic  S o lu t io n s
Crystalloid cardioplegia
Measurement
Unoxygenated 
(group 1)
Bubbler 
oxygenated 
(group 2)
Membrane 
oxygenated 
(group 3)
Blood
cardioplegia 
(group 4)
pH 7 .9  ±  0 .0 4 8 .3  ±  0 .0 6 8 .3  ±  0 .0 4 7 .5  ±  0 .01
P0 2 , m m  Hg 9 0 .4  ±  1.2 5 7 7  ±  2 7 6 6 5  ±  15 2 5 9  ±  2 5
P co 2 , m m  Hg 8 .9  ±  0 .8 4 .5  ±  0 .5 3 .5  ± 0 .4 5 2  =t 2 .6
M y o c a rd ia l te m p e ra tu re , °C 9 .6  ± 1.4 1 0 .5  ±  1.1 9 .6  ± 1 .3 1 2 .5  ± 0 .4
C a rd io p le g ia  te m p e ra tu re , °C 5.1 ± 0 .2 7 .4  ± 0 .6 7 .6  ± 0 .3 1 2 .8  ±  0 .8
O x yg e n -ca rry in g  ca p a c ity , m l 0 2 / d l 0 .5 6  ±  0.61 3 .2  ±  0 .2 3 .7  ±  0 .0 8 1 1 .3  ±  0 .5  
4 .2  ±  0 .2 *
*0 x y g e n -c a r ry in g  ca p a c ity  o f b lo o d  ca rd io p le g ia  w h e n  co rre c te d  fo r  th e  s h if t  in  o x y h e m o g lo b in  d is s o c ia t io n  c u rv e  th a t  o c c u rs  w ith  h y p o th e rm ia .
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lution more effectively (p < 0.0001) 
than the Shiley-Buckberg system 
for blood cardioplegia. Myocardial 
temperature also tended to be lower 
after delivery of crystalloid cardio­
plegia and was substantially lower 
(p < 0.06) with the membrane 
delivery system.
Discussion
Blood cardioplegia has been 
shown1' 3 to provide better myocar­
dial protection than crystalloid car­
dioplegia during prolonged hypo­
thermic arrest. Its superiority is 
thought to be an ability to provide 
sufficient oxygen for oxidative me­
tabolism. Although this concept is 
theoretically attractive, the capabili­
ty of sanguineous solutions to deliv­
er oxygen during hypothermic ar­
rest is considerably reduced because 
oxygen binding for the hemoglobin 
molecule increases with hypo­
thermia, thus preventing oxyhemo­
globin dissociation.4 Furthermore, 
the oxygen-carrying potential is di­
rectly related to the hemoglobin 
concentration, which may vary con­
siderably with hemodilution. Boden- 
hamer and colleagues6 found that 
blood cardioplegia was capable of 
delivering 2.4 ± 0.15 ml of ox- 
ygen/dl of solution but asanguine- 
ous crystalloid solutions delivered 
4.1 ± 0.1 ml/dl at 10°C. Coetzee 
and associates7 reported similar 
findings and indicated that oxygen­
ated crystalloid solutions can deliv­
er 4 ml/dl at 10°C. Digerness and 
associates4 found that blood cardio­
plegia released only 2.4 ml of oxy­
gen at 10°C compared with 4 ml/dl 
released by crystalloid cardioplegia.
Hypothermia reduces myocardial 
oxygen demand. Hearse and col­
leagues8 have indicated that at 
15°C the oxygen demand is in the 
range of 0.3 to 0.4 ml/min for 
every 100 g of left ventricle. Similar 
results have been reported by Guy­
ton and colleagues9 who indicated
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that the oxygen demand per 100 g 
of left ventricle at 15°C was 0.27 
ml/min. The nonhypertrophied 
heart, therefore, requires approxi­
mately 30 ml oxygen every 30 
minutes. Our data indicate that oxy­
genated crystalloid cardioplegia and 
blood cardioplegia can provide oxy­
gen between 3 and 4 ml/dl. Thus, 
either solution could provide suffi­
cient oxygen for oxidative metabo­
lism, as long as the multidose car- 
dioplegic technique was used dur­
ing the period of hypothermic ar­
rest.
Comparison of the delivery sys­
tems for both solutions suggested 
distinct advantages in using the 
bubbler oxygenating system. The 
cooling system for bubble oxygen­
ated crystalloid cardioplegia con­
sists of a recirculation line passed 
through an aluminum coil and im­
mersed in a bucket of ice. It could 
provide cold oxygenated crystalloid 
cardioplegia at any time during the 
operation. In contrast, the Terumo 
membrane system for oxygenated 
crystalloid cardioplegia and Shiley- 
Buckberg blood cardioplegia system 
depended upon an integral heat 
exchanger which required continu­
ous cold water cooling. Cold cardio­
plegia was, therefore, not available 
once the rewarming phase had 
started; this is a serious disadvan­
tage if the heart has to be rearrest­
ed in order to place additional su­
tures in an arterial anastomosis.
The temperature of the cardiople- 
gic solution and the final myocardi­
al temperature after its delivery was 
lower for oxygenated crystalloid 
than for blood cardioplegia, because 
the Shiley-Buckberg system for 
blood cardioplegia employs a pediat­
ric cooling system which is less 
efficient than that used for oxygen­
ated crystalloid cardioplegia. The 
lower cardioplegia and myocardial 
temperatures obtained with crystal­
loid solutions offer a distinct advan­
tage over the blood delivery system,
considering that optimal myocardial 
temperatures are often more diffi­
cult to maintain in patients with 
critical coronary artery disease.
In summary, all the oxygenating 
systems evaluated can provide suffi­
cient oxygen as long as the mul­
tidose cardioplegia technique is uti­
lized during ischemic arrest. Re­
sults indicate that the cardioplegia 
temperature and final myocardial 
temperature is lower with crystal­
loid delivery systems, and that the 
bubble oxygenating system is the 
only one capable of providing cold 
oxygenated crystalloid cardioplegia 
at any time during the surgery.
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A n  Unusual Facial Injury Highlighting 
the Basics of Diagnosis in Maxillofacial 
Trauma: a Case Report
Robert Cartotto, MD;* Ronald M. Zuker, MD, FRCSC, FACS
The authors present an unusual and bizarre missile type of maxillofacial injury in a 
7-year-old girl, who was struck in the middle of her face by an iron hook. The area 
between her forehead and upper lip was obliterated, making a clinical and radiologic 
diagnosis impossible. The authors review the current diagnostic methods used in 
maxillofacial trauma, including standard and computed tomography, to emphasize 
the importance of a correct preoperative diagnosis in the management of 
maxillofacial injuries.
Les auteurs decrivent un cas curieux et inhabituel de blessure maxillofaciale par 
projectile, subie par une fillette de 7 ans qui fut frappee au milieu du visage par un 
crochet de fer. L’espace compris entre le front et la levre superieure etait 
litteralement oblitere, ce qui rendait impossible un diagnostic clinique et radiologi- 
que. Les auteurs passent en revue les methodes actuelles de diagnostic des 
traumatismes maxillofaciaux, dont la tomographie conventionnelle ou assistee par 
ordinateur, et ils soulignent l’importance d’un diagnostic preoperatoire adequat 
dans le traitement des blessures maxillofaciales.
A ccurate documentation of inju­ries sustained in maxillofacial 
trauma is often difficult. Clinical 
examination may be impaired by 
swelling, bleeding, pain, fear and 
the patient’s state of conscious­
ness.1 Radiologic techniques, in­
cluding standard and computed to­
mography, may be required to dis­
cover the nature and extent of 
injury.
We present an unusual case of 
facial trauma in which the clinical 
and radiologic diagnosis was ob­
scured. Although the outcome was 
favourable, this case serves as a 
reminder of the value of a correct 
preoperative diagnosis in similar 
cases.
Case Report
A transport trailer travelling 
downhill at 90 k m /h  lost a frag­
ment of an iron hook from its load. 
The hook, weighing 400 g and 
measuring 25 X 15 X 15 cm,
smashed through the windshield of 
a car passing uphill at the same 
speed and struck a 7-year-old girl, 
riding in the back seat, in the 
middle of her face. On arrival at a 
nearby hospital the girl was found 
to have the majority of the hook 
embedded in her face, obliterating 
the region between her forehead 
and upper lip. Her airway was pa­
tent, her vital signs were stable and 
there was no external hemorrhage. 
She was alert, not disoriented, 
speaking clearly and moving all 
four limbs. Her medical history in­
cluded a tracheostomy for tra­
cheomalacia, but was otherwise un­
remarkable.
Although the large radiopaque 
hook made interpretation of plain 
x-ray films difficult, it did not ap­
pear to penetrate the cranial cavity 
(Fig. 1). However, there was de­
struction of the nasoethmoid com­
plex, displacement of the cribriform
FIG. 1 — Embedded hook with no 
obvious intracranial extension.
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plate and disruption of the left 
orbital roof. The cervical spine ap­
peared normal.
The girl was given a general 
anesthetic, intubated and ventilated; 
she was paralysed with pancuroni­
um bromide and an orogastric tube 
inserted. Ringer’s lactate solution 
was given intravenously and 4 mg 
of morphine, 200 mg of phenytoin 
and 500 mg of cefazolin were ad­
ministered. She was then trans­
ferred to Toronto by air ambulance.
Examination of the central ner­
vous system on her arrival at the 
Hospital for Sick Children (Fig. 2) 
was impossible because of the ef­
fects of the pancuronium bromide. 
There was no otorrhea, hemotym- 
panum or rhinorrhea. The chest, 
cardiovascular system, abdomen 
and extremities were normal. The 
globe of the left eye was disrupted 
superiorly and displaced temporally 
out of the orbit. The right eye had 
periorbital swelling, a chemotic con­
junctiva and a pharmacologic mio­
sis of the pupil. The cornea was 
clear and there was a good red 
reflex. Fundal examination revealed 
retinal hemorrhages and edema of 
the nasal retina and optic nerve 
head. The fate of the optic nerve 
was considered uncertain at this 
point.
Fearing hemorrhagic shock on 
removal of the hook, we started two 
further intravenous infusions, 
placed an arterial line, catheterized 
the bladder and typed and cross- 
matched her blood. Since her im­
munization status was unknown we 
gave 5 ml of tetanus toxoid and 
250 units of tetanus immune globu­
lin. She also received 200 000 units 
of aqueous penicillin G.
The hook created too much ar­
tefact to interpret the computed 
tomogram of the face. However, 
axial scans of the brain showed no 
intracranial injury.
In the operating room, we easily 
rotated the hook out of its cavity in
a direction opposite to the one by 
which it entered, suggesting that 
the hook had been spinning on 
impact (Fig. 3). The defect was 
thoroughly irrigated, fortunately 
without major hemorrhage.
The nasoethmoid complex, floor 
of the nose, maxillary sinuses and 
nasal septum were completely de­
stroyed. The left frontal sinus had 
been penetrated, the right zygoma 
and maxilla were fractured outward 
and there were bilateral comminut­
ed fractures of the anteromedial 
orbital walls.
The left eye was enucleated and a 
plastic conformer placed in the con­
junctival sac, which was then closed 
with a running 6-0 catgut suture. 
Indirect ophthalmoscopy of the 
right eye revealed medial commotio 
retinae, a few small retinal hemor­
rhages and mild swelling of the 
optic nerve head.
The right maxillary fracture, 
which ran in the direction of a Le 
Fort II, was approached from above 
through the wound and from below 
through a superior buccal sulcus 
incision. The fracture was reduced 
and fixed with intraosseous wire 
loops. The fractures in the right
FIG. 2 — Large iron hook embedded 
in midface. Note intact right eye and 
displaced left eye.
medial orbital wall were dealt with 
in a similar fashion.
Numerous bony fragments in the 
bottom of the cavity were retrieved 
and wired together with no. 28 and 
no. 30 wires to recreate a nasal 
bone. This refashioned nasal bone 
was then bridged with intraosseous 
wires to the frontal bone using a 
bone fragment that must have been 
the frontal process of the maxilla 
since it fitted perfectly. This scaf­
fold was then built up on both sides 
by wiring remaining bone fragments 
into place (Fig. 4). The mucosal 
remnants of the frontal and maxil­
lary sinuses were then excised. Two 
larger bone fragments, likely from 
the bony nasal septum, were placed 
as free bone grafts to cover defects 
to the right of the nose and in the 
right orbital floor.
Both medial canthal tendons 
were avulsed from their bony ori­
gins and reattached with wire su­
tures to the reconstructed nasal 
complex.
A viable skin flap based on the 
middle segment of the nose was 
positioned over the new bony skele­
ton. The subcutaneous layers were 
approximated with interrupted 4-0
FIG. 3 — Hook removed from midface.
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Dexon sutures and the skin was 
closed with interrupted 6-0 Prolene 
sutures.
The girl was transferred to the 
intensive care unit and extubated 
the following day. Dexamethasone 
(25 mg/d) was given for 1 week to 
reduce swelling of the optic nerve. 
Cefoxitin (2 g/d) was given for 5 
days intravenously followed by 
cephalexin (1.5 g/d) orally for 2 
weeks.
Postoperative computed tomo­
grams showed Le Fort I and II
FIG. 4 — Bony architecture recon­
structed.
FIG. 5 — Postoperative direct coronal 
computed tomogram. Note Le Fort I 
and II fractures.
fractures, a displaced fracture of the 
cribriform plate and total destruc­
tion of the nasoethmoid complex 
and maxillary sinuses (Fig. 5).
Over the next few days she 
showed steady improvement with 
no neurologic deficits except for 
anosmia. Her midface was stable 
but there was a mild degree of 
malocclusion. There was also a 
steady serosanguineous rhinorrhea
Fig. 6b
FIG. 6 — Appearance 2 weeks postop- 
eratively. (a) Frontal view, (b) lateral 
view.
which was thought to contain cere­
brospinal fluid. This drainage 
ceased by day 14 and a radionucleo­
tide scan at that time was negative.
The right eye gradually opened 
as the swelling diminished. The 
retina was intact and the edema of 
the optic nerve head slowly re­
solved. Her visual acuity was per­
fect, colour discrimination was nor­
mal and there were no visual field 
defects or limitations of gaze (Fig. 
6)
Plans for follow-up include fur­
ther ophthalmologic examination, 
placement of a left eye prosthesis, 
orthodontic and dental work and 
possible craniofacial surgery if the 
midface fails to grow with the rest 
of the face and head.
Discussion
The diagnosis of maxillofacial in­
jury is clinical and radiologic. Al­
though the clinical diagnosis is im­
portant, its accuracy is reduced by 
edema, pain, lacerations and altered 
states of consciousness.1 Therefore, 
radiologic investigations are crucial 
in planning surgical reconstruction. 
Standard and computed tomogra­
phy may be required in addition to 
plain films.
Clinical Diagnosis
Injuries to the brain, cervical 
spine, chest, cardiovascular system 
and abdomen take precedence over 
maxillofacial injuries.2 Injuries may 
be classified as soft tissue (lacera­
tions, abrasions, punctures, edema 
and burns) or bony.3 Bony injuries 
can be approached systematically by 
routinely examining four regions: 
eyes, nose, face and mouth.
The eyes are inspected for ocular 
disparity, subconjunctival hemorrh­
age, periorbital ecchymosis and 
swelling. The orbital rims are then 
palpated for step deformities. The
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eyes are tested for limitation of 
gaze and diplopia. Finally the in­
fraorbital skin is tested for anesthe­
sia. Any positive finding suggests 
injury to the orbit or its rim.
The nose is then inspected for 
deformity, epistaxis and septal he­
matomas and palpated for defects 
and tenderness.
The face is assessed for asymme­
try and palpated for deformity and 
tenderness. Midface stability is eval­
uated by grasping the upper central 
incisors and attempting to move the 
middle third of the face.
Finally, the mouth is inspected 
for ecchymosis, malocclusion and 
loss of dentition. Sensation in the 
mental nerve distribution is exam­
ined, and the mandible should be 
palpated both externally and intra- 
orally. By following this protocol 
important injuries will not be 
missed.
Radiologic Diagnosis
Plain views of the face will pro­
vide much information. 4 They in­
clude the posteroanterior view 
(Caldwell) to show the frontal sinus­
es, the ethmoid air cells and orbital 
margins; the oblique posteroanteri­
or view (Waters) to demonstrate the 
orbits, maxillary sinuses, zygomatic 
and maxillary bones; the lateral 
view to show the frontal sinuses, 
the lateral orbital walls, maxillas 
and mandible; and either the sub- 
mentovertex or Towne’s view to 
assess the zygomatic arches. The 
panorex view of the mandible is 
used to examine this structure.3
Simple isolated fractures are best 
evaluated with plain films. Multiple 
complex injuries may require fur­
ther study with tomography.5
In linear and pluridirectional to­
mography, the x-ray tube and film 
move in opposite directions with 
respect to a plane in the object, 
leaving that plane in focus and all 
others blurred. As a result, tomo­
grams give good spatial resolution 
and show bony detail well. Howev­
er, tomography does not show soft- 
tissue detail as well and this is 
important when orbital injuries ex­
ist. Also, in complex injuries the 
blurred images of multiple fracture 
fragments outside the plane of in­
terest may accumulate and obscure 
that plane.6-8 Although maxillary 
fractures and orbital wall fractures 
(including blowout fractures) are 
easily seen on coronal tomograms, 
fractures of the zygomatic arches 
and anterior maxillary sinus walls 
may not be identified. 16
Computed tomography is useful 
in the diagnosis of traumatic facial 
injuries.59 Direct axial or coronal 
scanning may be performed or com­
puter-reformatted coronal images 
constructed using information from 
direct axial scans. Only computed 
tomography accurately demon­
strates soft-tissue injuries, includ­
ing those to the globe, optic nerve 
and extraocular muscles. With little 
extra delay, additional scans of the 
brain can be made to rule out any 
associated intracranial injury.5' 10-11
Computed tomography does have 
some disadvantages. Fractures par­
allel to the plane of scanning are 
frequently not seen, therefore, scan­
ning in two perpendicular planes is 
usually necessary. In particular, 
axial scans may miss orbital floor 
and inferior orbital rim fractures. 12 
Direct coronal scanning requires 
that the patient hyperextend the 
neck while lying prone or supine. 
This is impractical in the intubated 
or unconscious trauma patient with 
a cervical spine injury. Direct coro­
nal scanning may have to be done 
later when the patient is stable. 
Direct coronal scans may also be 
obscured by artefact from dental 
fillings. Although reformatted coro­
nal scans avoid these problems, 
their images lack sharp definition 
and they can be difficult to inter­
pret.
Computed tomography is most 
helpful when direct axial and coro­
nal scans are used in a complemen­
tary fashion or when axial comput­
ed tomograms are used in conjunc­
tion with coronal tomograms if di­
rect coronal tomography is not pos­
sible. In this way most fractures will 
be identified and injuries to the 
orbit and its contents will be opti­
mally shown. 12
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Penile Corporeal Disproportion: 
Long-Term Results of Surgical Treatment
Michael P. Leonard, MD; Alvaro Morales, MD, FRCSC
Penile corporeal disproportion (PCD) is frequently confused with the more prevalent 
Peyronie’s disease, with which it shares the characteristic feature of penile 
curvature on erection. The authors report on 13 patients with PCD, 9 of whom were 
treated surgically, using Nesbit’s technique to correct the curvature. Results were 
good to excellent in 89%, with a mean long-term follow-up of 6 years. The 
diagnostic process is simple and accurate but requires participation by the patient. 
Surgical treatment is indicated when the penile curvature is so severe that it 
interferes with sexual intercourse.
La disproportion corporeale penienne (DCP) est frequemment confondue pour la 
maladie de Peyronie, laquelle est plus frequente. Les deux partagent une caracteris- 
tique commune, soit une courbure prononcee du penis a l’erection. On decrit 13 cas 
de DCP, dont 9 patients qui furent traites chirurgicalement a l’aide de la technique 
de Nesbit pour corriger la courbure. Les resultats vont de bons a excellents dans 
89% des cas apres une periode d’observation moyenne de 6 ans. La procedure 
diagnostique est simple et precise, mais elle necessite la participation du patient. Le 
traitement chirurgical devient indique quand la courbure du penis devient assez 
prononcee pour nuire aux relations sexuelles.
Penile corporeal disproportion (PCD), a developmental defi­
ciency involving either the corpora 
cavernosa or the corpus spongosi- 
um, results in a deviation of the 
erect penis toward the affected side 
(laterally or downward). An abnor­
mal erection is also characteristic of 
Peyronie’s disease, but this condi­
tion can be distinguished from PCD 
by a fibrous plaque that develops in 
the tunica albuginea producing a 
painful erection in addition to the 
penile curvature. Furthermore, pa­
tients with PCD give a history of
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curvature dating back to adoles­
cence, but Peyronie’s disease ap­
pears typically during middle age or 
beyond.
Patients and Methods
From January 1979 to June 1986 
we investigated 13 patients with 
PCD. All were assessed by history, 
physical examination, autophotog­
raphy,1 cavernosography and the 
induction of an artifical erection by 
intracavernosal saline injection.
Home autophotography, a tech­
nique popularized by Kelami1 most 
readily demonstrated the penile cur­
vature. Three positions (superior, 
lateral, anterior) were used (Fig. 1).
Cavernosography, dorsolateral 
puncture of one of the corpora 
cavernosa with a butterfly needle 
and injection of 50 to 70 ml of 
diluted contrast medium followed 
by an x-ray film was used to show 
the corporeal disproportion.
With the same butterfly needle, 
an artificial erection was induced by 
injecting normal saline with a pump 
at a rising flow rate (60 to 150 
ml/min). The dorsal, ventral or 
lateral aspects were photographed. 
With PCD the deviation is usually 
lateral or ventral (Fig. 2).
Four patients did not require im­
mediate surgical intervention two 
because they were preadolescents 
and two adults because they had 
only moderate curvature, not seri­
ously interfering with sexual perfor­
mance. The abnormality was cor­
rected surgically in nine patients 
using the technique described by 
Nesbit.2
Patients were followed up at reg­
ular intervals ranging from 6 
months to 8 years (mean 59 
months) and autophotography was 
done at least once postoperatively.
Surgical Technique
Nesbit’s procedure2 is as follows. 
A circumcoronal incision is used. 
Penile skin is retracted to its base
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and the penis insufflated with nor­
mal saline to induce an artificial 
erection. One or more ellipses are 
then excised from the tunica al­
buginea of the corpus on the con­
vex portion of curvature (Fig. 3). 
The resulting defects are then 
closed with interrupted absorbable 
sutures (Fig. 4). Depending on the 
site of the excision, the dorsal neu­
rovascular complex or the urethra 
may need to be isolated and mobi­
lized. A pressure dressing and a 
urethral or suprapubic catheter are 
left in place for 48 hours.
Results
The results (Table I) were classi-
Fig. la
fied as excellent if, on erection, the 
penis was straight and the patient 
able to have satisfactory inter­
course, good if there was residual 
penile curvature but intercourse 
was satisfactory and poor if penile 
curvature was the same or worse, if 
there was penile sensory deficit or if 
intercourse was not possible for 
mechanical or psychologic reasons.
Six of the nine patients were 
considered to have an excellent out­
come and two were classified as 
good. Of the latter group one had 
an excellent initial result but several 
months later scarring developed at 
the operative site and the curvature 
returned with features of Peyronie’s 
disease. He is currently being fol- 
lowed-up at another institution and
Fig. lb
FIG. 1 — Penile corporeal disproportion (PCD) demonstrated by home autophotog­
raphy using technique described by Kelami.1
Fig. 3a Fig. 3b
FIG. 3 — Ellipse excised from tunica albuginea of corpus on convex side of 
curvature.
is receiving treatment with vitamin 
E; the second patient had an excel­
lent result after his operation, but 6 
years later presented with a slight 
penile deviation on the opposite 
side, characteristic of Peyronie’s 
disease. The one patient with a poor 
result had good straight erections 
initially; however, 1 year later he 
complained of short duration of 
erections, decreased libido and in-
FIG. 2 — Lateral deviation in PCD 
demonstrated by induction of artifical 
erection.
FIG. 4 — Defect closed with interrupt­
ed absorbable sutures.
Table 1-Outcome of Surgical 
Treatment for Penile 
Corporeal Disproportion*
Result No. (%)
Excellent 6 (67)
Good 2 (22)
Poor 1(11)
*Mean follow-up was 59 mo.
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ability to perform with a “mutilated 
tool”. On further assessment psy­
chologic problems were found to be 
mainly responsible for his dysfunc­
tion.
Discussion
Congenital corporeal dispropor­
tion is an uncommon cause of sexu­
al dysfunction. However, it is im­
portant that the physician be aware 
of its occurrence since it is easily 
confused with the more common 
Peyronie’s disease. In the differen­
tial diagnosis, a long history of 
penile curvature on erection likely 
indicates PCD, but a history of 
acquired penile curvature with pain 
on erection and no history of trau­
ma or surgery is more in keeping 
with Peyronie’s disease, particularly 
beyond the fifth decade of life.
No physical defects are noted on 
the flaccid penis in cases of PCD, 
but in Peyronie’s disease or post- 
traumatic curvature, a plaque or 
skin tethering are frequently pres­
ent; the plaque can readily be dem­
onstrated by ultrasonography. On 
cavernosography a disparity in the 
length of the corpora may be clearly
FIG. 5 — Dorsal deviation of penis 
typical of Peyronie's disease.
shown in patients with PCD, but in 
those with Peyronie’s disease an 
area of corporeal irregularity or a 
filling defect may be detected. In­
duction of an artificial erection 
shows typically lateral or ventral 
deviation of the penis and curvature 
is most frequently in a dorsal direc­
tion (Fig. 5).
Use of Nesbit’s technique usually 
results in some loss of penile length 
and often leaves a depression at the 
site of excision (Fig. 6). To avoid 
these residual defects Saalfeld and 
colleagues3 used transverse ellipses 
on the shorter corpus. The ellipses 
are closed longitudinally in Heine- 
ke-Mikulicz fashion to obtain addi­
tional length, compensating for the 
shortening of the corpus. More re­
cently Kelami4 has advocated the 
use of continuous folding sutures 
to prevent the appearance of a 
depression where the segment of 
tunica has been removed. We re­
cently treated a patient in this fash­
ion but follow-up has been too 
short to assess the final result.
Utilizing the Nesbit2 procedure or 
one of its variants, eight of nine 
patients in our series obtained good 
to excellent results. These compare 
well with the results of one of the
FIG. 6 — Depression of penis at site of 
excision of ellipse of tunica albuginea.
most recent reports5 which indi­
cates an 80% to 90% success rate in
the surgical correction of PCD.
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Association of Breast Cysts and Breast 
Cancer
J.E. Devitt, MD, FRCS(Edin), FRCSC
A review of 915 consecutive patients with breast cancer and 812 with breast cysts 
showed that an association between the two is uncommon — 5% of breast cancers 
were associated with cysts and 4% of cysts were associated with breast cancer. Four 
types of association were identified: (a) cystic cancers — easily diagnosed because of 
the characteristic features of the aspirate, failure of the mass to disappear and early 
recurrence in a patient whose age and menstrual status were not usually associated 
with cysts; (b) cancers occurring simultaneously with breast cysts — recognized 
because they did not contain cyst fluid; (c) cysts occurring after breast cancer — 
diagnosed by aspiration of the mass in premenopausal women; (d) cancers in 
patients who have had breast cysts — usually occurring many years after the cyst 
aspiration when menses had ceased. These associations were not sufficiently 
frequent to justify specific follow-up, but all suspected cysts should be successfully 
aspirated to confirm the clinical diagnosis.
delay diagnosis or to use excessive 
intervention.
The purpose of this study was to 
find out if there was an association 
between breast cysts and breast 
cancer. It was hoped that such a 
review would not only reveal epide­
miologic information of interest but 
identify certain diagnostic features 
of breast cancer associated with 
breast cysts that would lead to 
confident, prompt and appropriate 
management.
L’etude de 915 patientes consecutives souffrant de cancer du sein et de 812 
patientes ayant des kystes mammaires a revele qu’une association entre kystes et 
cancer est peu frequente — 5% des cancers du sein ont ete associees a des kystes et 
4% des kystes a un cancer du sein. Quatre types dissociations ont ete releves: a) les 
cancers kystiques — facilement diagnostiques grace aux caracteristiques particu- 
lieres de la ponction-biopsie, a la persistance de la masse et a la recidive precoce 
chez une personne dont l’age et l’etat menstruel ne sont pas generalement relies a 
des kystes; b) les cancers qui surviennent concomitamment avec des kystes 
mammaires et que l’on peut reconnaitre du fait que la ponction-biopsie ne ramene 
pas de liquide kystique; c) les kystes qui surviennent apres un cancer du sein et qui 
sont diagnostiques par ponction-biopsie de la masse chez des femmes qui ont un 
cycle menstruel; d) les cancers vus chez des femmes qui ont deja eu des kystes 
mammaires et qui surviennent habituellement plusieurs annees apres une biopsie du 
kyste et apres l’arret des menstruations. Ces associations ne semblent pas etre assez 
frequentes pour justifier une surveillance periodique specifique. Neanmoins, tout 
kyste suspect doit faire l’objet d’une ponction-biopsie pour confirmer le diagnostic 
clinique.
B reast cysts are easily diagnosed and treated in the office by 
simple aspiration.1 Although breast 
cysts and breast cancer each occur
in about 9% of Canadian women, 
their association in the same patient 
is uncommon, so lack of experience 
may cause the surgeon either to
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Patients and Method
The charts of all patients with 
new breast cancers (915) and all 
patients with a breast cyst (812) 
seen for the first time in a consult­
ing practice during the years 1971 
to 1986 inclusive were reviewed. 
The cancers were diagnosed histo­
logically. Most cysts were diag­
nosed by simple aspiration, the re­
mainder at biopsy. Each new breast 
cancer, whether ipsilateral or con­
tralateral, was counted separately, 
but, because of multiplicity and re­
peated recurrence, breast cysts were 
only counted once — at the time 
the patient was first treated. Some 
of the breast cancer patients 
claimed to have had previous breast 
“ cysts” , but because the diagnosis 
was usually not verifiable, this in­
formation was not considered.
Follow-up
Reprint requests to: Dr. J.E. Devitt, Ste. 310, 1081 Carling Ave., Ottawa, Ont. K1Y4C 2 The 812 patients with cysts were
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followed up from 1 to 16 years, 
451 for 5 or more years and 192 
for 10 or more years. There were 
over 5000 patient-years of follow­
up.
Observations
There were four ways in which 
breast cysts and breast cancers were 
associated.
Cystic Carcinomas
Of the 915 patients, 11 (1.2%) 
had cystic neoplasms, that is, fluid 
could be aspirated from the mass. 
The patients ranged in age from 30 
to 80 years but nine were aged 52 
years or older. Only two patients, 
aged 30 and 35 years were men­
struating. The size of the lesion 
varied from 0.5 to 15 cm; in all but 
one patient the lesions were 4 cm or 
smaller.
The aspirate was bloody in 8 of 
the 11 patients; in 7 of them there 
was a residual mass after aspiration 
and in the other the cyst recurred 
promptly. In the three patients 
without a bloody aspirate, two had 
a residual mass after aspiration, and 
in the third the aspirate was unusu­
ally thick and the mass recurred 
quickly. Cytologic examination of 
the aspirate in seven patients was 
suggestive of or positive for malig­
nancy in only three.
Nine of the patients had no can­
cerous nodes, one had axillary 
lymph-node metastases and one had 
distant metastases.
Simultaneous Cysts and Cancer
There were 10 patients with si­
multaneous cysts and cancers (1.2% 
of those with cysts and 1.1% of 
those with cancer). In 6 of the 10 
patients the lesions were ipsilateral. 
The patients ranged in age from 40 
to 83 years and eight were 53 years
or younger; six of the eight were 
menstruating, one had had an 
ovary-preserving hysterectomy and 
the last patient was taking a hor­
monal supplement.
Tumour size varied from 0.6 to 
10 cm, but in nine instances it was 
3 cm or smaller (one patient had 
two simultaneous cancers).
In two of the patients there was a 
mass clinically suggestive of cancer 
(5 and 10 cm in diameter) and a 
coincidental cyst was recognized, 
which was aspirated and did not 
recur. In the remainder, the mass 
could not be aspirated, although in 
one blood was obtained.
Cytologic examination of aspirate 
gave negative results in three of the 
six patients in whom it was per­
formed. In six patients there were 
no cancerous cells in the nodes, 
in three patients there were axillary 
lymph-node metastases and in one 
other the tumour was locally ad­
vanced.
Cysts Appearing After a Breast 
Cancer
In six patients a breast cyst devel­
oped after diagnosis of breast can­
cer. These patients ranged in age 
from 44 to 52 years and all were 
menstruating. The cysts were diag­
nosed from 2 months to 20 years 
after the diagnosis of breast cancer; 
four were diagnosed by aspiration 
and two by biopsy.
Breast Cancer Appearing A fte r a 
Breast Cyst
In 20 of the patients with breast 
cysts, 21 cancers subsequently de­
veloped. Twelve cancers were ipsi­
lateral and 9 contralateral (one pa­
tient had bilateral breast cancers 
and two patients had bilateral 
cysts). The cancers were recognized 
from 6 months to 13 years (median 
78 months) after the first diagnosis 
of a cyst.
Discussion
In spite of the uncommon associ­
ation of breast cancers and breast 
cysts, the observations reported 
herein allow a confident clinical 
diagnosis to be made in the office. 
Most authorities2' 6 are prepared to 
diagnose cysts by aspirating them, 
without the unnecessary cost or 
delay incurred by cytologic exami­
nation or imaging procedures.
This study has confirmed an ear­
lier report7 that cystic carcinomas 
can be diagnosed with ease clinical­
ly. They usually occur in women 
past the age at which cysts are 
expected, who are postmenopausal. 
The aspirate is generally bloody or 
differs from the usual thin, watery, 
green, brown, yellow or grey cyst 
fluid. Frequently, there is either a 
residual mass after aspiration or 
prompt recurrence. This combina­
tion of clinical observations will 
allow a confident diagnosis. Unfor­
tunately, the results of cytologic 
examination are often negative,7 
presumably because cystic degener­
ation results in an absence of recog­
nizable cells in the fluid.
The rarity of simultaneous cysts 
and breast cancer must be appreci­
ated.8 Only 10 of the 812 patients 
with cysts had such an association 
even though in 75% of 812 patients 
further cysts developed, in many 
cases being multiple. Simultaneous 
cysts and breast cancers were rec­
ognized usually when another ap­
parent cyst did not contain fluid on 
attempted aspiration. Although cy­
tologic examination of the aspirate 
may be helpful, it will not always be 
so. Thus, all suspected cysts should 
be aspirated for diagnosis, and a 
localized mass that cannot be made 
to disappear by aspiration should be 
formally biopsied.
Cysts after breast cancer are un­
common2’8 but happy occurrences. 
It is usually assumed that the pa­
tient has a new breast cancer. If she
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is premenopausal, aspiration should 
always be done because occasional­
ly the lesion will be a cyst and not a 
carcinoma; thus, anxiety and mor­
bidity can be prevented.
There are reports3'58’9 claiming 
that in patients with breast cysts, 
breast cancer is two to four times 
more likely to develop. The ultimate 
incidence of cancers developing 
after breast cysts is, of course, a 
function of the length of follow-up 
and is the major purpose of this 
ongoing study. To date, the rela­
tively small number of cancers 
found (21) in the 812 patients with 
breast cysts militates against any 
special follow-up of patients in 
whom breast cysts are diagnosed. It 
may be that these patients will 
eventually be found to be at higher 
risk for breast cancer than others
but it appears now that the risk and 
the yield are not sufficient to justify 
a long follow-up. Fortunately, the 
recognition of subsequent cancers 
is facilitated because they occur 
years after the cysts have stopped 
forming when menstrual cycles 
have ceased.5
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Announcing a 
transform ation 
of parenteral antibiotic
* PRTMAXIN,
(imipenem and cilastatin sodium for injection)
*®  Trademark the first carbapenem antibiotic
PRIMAXIN
(imipenem and cilastatin sodium for injection)
LV
*  4 1
A carbapenem, representing a totally new class of antibiotics
The broadest spectrum  
single-agent antibiotic
possessing bactericidal activity against a great 
majority of clinically significant pathogens
PRIMAXIN* offers the activity of
<r w
the penicillins against gram-positive aerobes -  
including coverage of Streptococcus faecalis
plus
the aminoglycosides and 3rd generation cephalosporins w v
against gram-negative aerobes -
including coverage of Pseudomonas aeruginosa *4
i
plus
the antianaerobic agents -  
including coverage of Bacteroidesfragilis
PRIMAXIN* is not active against Corynebacterium group JK, Fusobacterium varium, Mycobacterium spp., 
Chlamydia spp, Streptococcus faecium, Pseudomonas maltophilia, and some strains of: P. cepacia,
P. pseudomallei, methicillin-resistant staphylococci, and Plavobacterium spp.
Single-agent antibiotic for 
documented and empiric 
therapy in many importan 
infections'
including
□ infections usually treated with combination 
therapy
□ infections complicated by underlying 
disease
□ nosocomial infections
Imipenem and cilastatin sodium are present in a 1:1 ratio in PRIMAX1N* I.V. 
Imipenem is the sole antibacterial component. The role of cilastatin sodium is to 
prevent the inactivation of imipenem in the kidney and obtain antibacterial 
concentrations of imipenem in the urine.
+Caused by organisms susceptible to PRIMAXIN* I.V.
FMMAXIN iv
(im ipenem  and cilastatin  sodium  for injection)
1
i
Clinical efficacy in many 
im portant infections
EFFICACY IN INTRA-ABDOMINAL INFECTIONS
91% cure or improvement
in  164  evaluable patients
1. Kager, L., Nord, C.E.: Imipenem/ 
cilastatin in the treatment of intra­
abdominal infections: A review of 
worldwide experience, Rev Infect Dis 
7 (Suppl 3): S518-S521, July-August 
1985.
EFFICACY IN LOWER RESPIRATORY TRACT 
INFECTIONS2
85% cure or improvement
in 2 0 4  evaluable 
patients
2. Acar, J.F.: Therapy for lower 
respiratory tract infections with 
imipenem/cilastatin: A review of 
worldwide experience, Rev Infect Dis 
7 (Suppl 3): S513-S517, July-August 
1985.
v
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fCaused by organisms susceptible to PRIMAXIN* IV.
EFFICACY IN BACTERIAL SEPTICEMIA
90%  cure or 
improvement
in 135 evaluable 
patients
3. Eron, L.J.:
Imipenem/ cilastatin 
therapy of bacteremia,
Am J Med 78 (Suppl 6A):
95-99, June 7, 1985.
patients
4. Sweet, R.L.: Imipenem/ 
cilastatin in the treatment 
of obstetric and gynecologic 
infections: A review of 
worldwide experience,
Rev Infect Dis 7 (Suppl 3): 
S522-S527, July-August 1985.
EFFICACY IN GYNECOLOGICAL
INFECTIONS4
97%  cure or 
improvement
in 72 evaluable
PRIMAXIN
(imipenem and cilastatin sodium for injection)
IV u
PRIMAXIN* I.V offers management 
advantages over combination ibeiapy 
that includes an aminoglycoside
Generally well tolerated -  
safety profile 
sim ilar to cefazolin 3
□ 1723 patients, including the severely ill, have received therapy in clinical trials. 
The incidence of the most common adverse experience (nausea) was no greater 
than 2%.
□ Avoids the potential nephrotoxicity or ototoxicity experienced with 
aminoglycosides.
□ Avoids the potential hypoprothrombinemia and clinical bleeding experienced 
with cephalosporins with M TT side chain.
□ Avoids the potential disulfiram-like effect experienced with metronidazole and 
cephalosporins with MTT side chain.
Convenience of a single agent
The broadest spectrum single­
agent antibiotic representing 
a transformation of parenteral 
antibiotic therapy
5. Calandra G.B., Ricci F.M., Wang C., Brown K.R.: Safety and 
tolerance comparison of imipenem/cilastatin to cephalothin and 
cefazolin, J  Antimicrob Chemother 12 (suppl D): 125-131,1983.
+ Certain antibiotics which possess, as part of their molecular structure, the l-methyl-5-thiotetrazole (MTT) 
group have been associated with hypoprothrombinemia (and in some cases, clinical bleeding) and with 
a disulfiram-like effect.
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PRIMAXIN*
(imipenem and cilastatin sodium 
for injection)
Antibiotic
CNS adverse experiences such as myoclonic 
activity, confusional states, or seizures have 
been reported with PRIMAXIN* especially when 
recommended dosages based on renai function 
and body weight were exceeded. These exper­
iences have occurred most commonly in patients 
with CNS disorders (e.g., brain lesions or 
history of seizures) and/or who have compro­
mised renal function. However, there were rare 
reports in which there was no recognized or 
documented underlying CNS disorder. Close 
adherence to recommended dosage schedules 
is urged, especially in patients with known factors 
that predispose to seizures.
ACTION
Imipenem exerts a bactericidal action by inhibiting 
cell wall synthesis in aerobic and anaerobic gram­
positive and gram-negative bacteria.
PRIM AXIN* consists o f tw o com ponents: 
(1) imipenem, a derivative of thienamycin, a 
carbapenem antibiotic; and (2) cilastatin sodium, a 
specific inhibitor of dehydropeptidase-l a renal 
enzyme w hich metabolizes and inactivates 
imipenem. Cilastatin blocks the metabolism of 
imipenem in the kidney, so that concomitant 
administration of imipenem and cilastatin allows 
antibacterial levels of imipenem to be attained in the 
urine.
Inhibition of cell-wall synthesis is achieved in gram­
negative bacteria by the binding of imipenem to 
penicillin binding proteins (PBPs). In the case of 
E s c h e r ic h ia  c o li and se lec ted  s tra in s  o f 
Pseudomonas aeruginosa, imipenem has been 
shown to have highest affinity for PBP-2, PBP-1a 
and PBP-1 b, with lower activity against PBP-3. The 
preferential binding of imipenem on PBP-2 and 
PBP-1 b leads to direct conversion of the individual 
cell to a spheroplast resulting in rapid lysis and cell 
death without filament formation. When imipenem 
is removed prior to complete killing of gram­
negative species, the remaining viable cells show a 
measurable lag, termed a "post-antibiotic effect” 
(PAE), prior to resumption of new growth.
INDICATIONS AND CLINICAL USE
PRIMAXIN* (imipenem and cilastatin sodium for 
injection) may be indicated in the treatment of 
serious infections when caused by sensitive strains 
of bacteria. Where considered necessary, therapy 
may be initiated on the basis of clinical judgment 
before results of sensitivity testings are available. 
Continuation of therapy should be reevaluated on 
the basis of bacteriological findings and of the 
patient’s clinical condition.
Imipenem is active in vitro against a wide range of 
gram-positive and gram-negative aerobic and 
anaerobic bacteria, including most strains which 
are beta-lactamase producing. Patients have 
responded while under treatment with PRIMAXIN* 
for single or mixed infections of the following body 
systems, when they were associated with a number 
of pathogenic species and strains of the genera 
listed:
1. Lower Respiratory Tract Infections
2. Urinary Tract Infections
3. Intra-Abdominal Infections
4. Gynecological Infections
5. Septicemia
6. Endocarditis caused by Staphylococcus 
aureus
7. Bone and Joint Infections
8. Skin Structure Infections
Gram-positive Aerobes
•  Listeria monocytogenes
• Nocardia asteroides
•  Staphylococcus (excluding many strains 
which are methicillin resistant)
•  Streptococcus (excluding S. faecium)
Gram-negative Aerobes
•  Acinetobacter
•  Citrobacter
•  Enterobacter
•  Escherichia coli
•  Haemophilus influenzae
•  Haemophilus parainlluenzae
•  Klebsiella
•  Morganella morganii
•  Neisseria
• Proteus (indole positive and indole negative 
strains)
•  Providencia
•  Pseudomonas aeruginosa
•  Serratia marcescens
Gram-positive Anaerobes
•  Clostridium (excluding C. difficile)
•  Peptococcus
•  Peptostreptoccus
Gram-negative Anaerobes
• Bacteroides fragilis
•  Bacteroides (non-fragilis)
CONTRAINDICATIONS
PRIMAXIN* (imipenem and cilastatin sodium for 
injection) is contraindicated in patients who have 
shown hypersensitivity to either component of this 
product.
WARNINGS
PRIMAXIN* (imipenem and cilastatin sodium for 
in jec tion) SHOULD BE ADMINISTERED WITH 
CAUTION TO ANY PATIENT WHO HAS DEMONS­
TRATED SOME FORM OF ALLERGY, PARTICULARLY 
TO STRUCTURALLY-RELATED DRUGS. IF AN 
ALLERGIC REACTION TO PRIMAXIN* OCCURS, 
DISCONTINUE THE DRUG. SERIOUS HYPER­
SEN SITIVITY  REACTIONS MAY REQUIRE 
EPINEPHRINE AND OTHER EMERGENCY 
MEASURES.
Pseudomembranous colitis
Pseudomembranous colitis has been reported with 
the use of PRIMAXIN*. Therefore it is important to 
consider this diagnosis in patients who develop 
diarrhea during or after therapy. This colitis may 
range from mild to life threatening in severity.
Mild cases of pseudomembranous colitis may 
respond to drug discontinuance alone. In more 
seve re  cases, m anagem ent may in c lu d e  
s igm oidoscopy, appropriate bacte rio log ica l 
studies, fluid, electrolyte and protein supple­
mentation, and the use of a drug such as oral 
vancomycin, as indicated. Other causes of colitis 
should also be considered.
PRECAUTIONS
General
Prolonged use of PRIMAXIN* (imipenem and 
cilastatin sodium for in jection) may result in 
overgrowth of resistant organisms. Repeated 
evaluation of the patient's condition is essential. If 
superinfection occurs during therapy, appropriate 
measures should be taken.
CNS adverse experiences such as myoclonic 
activity, confusionaTstates, or seizures have been 
reported with PRIMAXIN* especially when recom­
mended dosages based on renal function and body 
weight were exceeded. These experiences have 
occurred most commonly in patients with CNS 
disorders (e.g., brain lesions or history of seizures) 
and/or who have compromised renal function. 
However, there were rare reports in which there was 
no recognized or documented underlying CNS 
disorder. Close adherence to recommended dosage 
schedules is urged especially in patients with 
known factors that predispose to seizures (see 
DOSAGE AND A D M IN IS TR A TIO N ). A n t i­
convulsant therapy should be continued in patients 
with a known seizure disorder. If focal tremors, 
myoclonus, or seizures occur, patients should be 
evaluated neurologically and placed on a n ti­
convulsant therapy if not already instituted. If CNS 
symptoms continue, the dosage of PRIMAXIN* 
should be decreased or discontinued.
Use in Patients with Impaired Renal Function
Dosage in patients with impaired renal function is 
based on the severity of infection but the maximum 
daily dose varies with the degree of renal functional 
im pa irm en t (see DOSAGE AND A D M IN IS ­
TRATION - Dosage in Patients with Renal 
Insufficiency).
Use in Pregnancy
The use of PRIMAXIN’ in pregnant women has not 
been studied, therefore, PRIMAXIN* should be used 
during pregnancy only if clearly needed. Use of this 
drug in women of childbearing potential requires 
that the anticipated benefits be weighed against 
possible hazards.
Reproduction studies with bolus I.V. doses suggest 
an apparent intolerance to PRIMAXIN* (including 
emesis, inappetence, body weight loss, diarrhea
and death) at doses equivalent to the average 
human dose in pregnant rabbits and cynomolgus 
monkeys that is not seen in non-pregnant animals in 
these or other species. In other studies, PRIMAXIN* 
was well tolerated in equivalent or higher doses (up 
to 11 times the average human dose) in pregnant 
rats and mice (see REPRODUCTION STUDIES 
under TOXICOLOGY in the complete monograph).
Nursing Mothers
It is not known whether PRIMAXIN* is excreted in 
milk. If the use of PRIMAXIN* is deemed essential, 
the patient should stop nursing.
Pediatric Use
Efficacy and tolerability in infants under the age of 
3 months have not yet been established; therefore, 
PRIMAXIN* is not recommended in the pediatric 
age group below the age of 3 months.
Drug Interactions
Concomitant administration of PRIMAXIN* and 
probenecid results in only minimal increases in 
plasma levels of imipenem and plasma half-life. It is 
not recommended that probenecid be given with 
PRIMAXIN*.
PRIMAXIN* should not be mixed with or physically 
added to other antibiotics. PRIMAXIN* has been 
administered concomitantly with some antibiotics, 
such as aminoglycosides.
There is no evidence to suggest that association of 
PRIMAXIN* with any other beta-lactam antibiotics 
has any therapeutic advantage.
ADVERSE REACTIONS
PRIMAXIN* (imipenem and cilastatin sodium for 
injection) is generally well tolerated. The following 
adverse reactions were reported on 1,723 patients 
treated in clinical trials. Many of these patients were 
severely ill and had multiple background diseases 
and physiological impairments, making it difficult to 
determ ine causal re la tionsh ip of adverse ex­
periences to therapy with PRIMAXIN*.
local Adverse Reactions
Adverse local clinical reactions that were reported 
as possibly, probably or definitely related to therapy 
with PRIMAXIN* were:
Incidence (%)
Phlebitis/thrombophlebitis 1.7
Infused vein pain 0.6
Vein induration 0.2
Infused vein infection 0.1
Systemic Adverse Reactions
Adverse clinical reactions that were reported as 
possib ly , p robab ly , or d e fin ite ly  re la ted to 
PRIMAXIN* were:
Incidence (%)
Gastrointestinal
nausea 2.0
diarrhea 1.7
vomiting 1.6
tongue papillar hypertrophy 0.2
pseudomembranous colitis
(see WARNINGS) 0.1
hemorrhagic colitis <0.1
gastroenteritis <0.1
abdominal pain <0.1
glossitis <0.1
heartburn <0.1
pharyngeal pain <0.1
increased salivation <0.1
CNS
fever 0.4
dizziness 0.3
seizures 0.2
(see PRECAUTIONS)
somnolence 0.2
confusion 0.2
myoclonus 0.1
vertigo 0.1
headache 0.1
encephalopathy <0.1
paresthesia <0.1
Special Senses
transient hearing loss in 
patients with impaired hearing <0.1 
tinnitus <0.1
Respiratory TABLE 1 Dosage in Infants and Children
dyspnea 0.1
hyperventilation <0.1
thoracic spine pain <0.1
Cardiovascular
hypotension 0.4
palpitations 0.1
tachycardia <0.1
Renal
oliguria/anuria <0.1
polyuria <0.1
Skin
rash 0.9
pruritus 0.3
urticaria 0.2
skin texture changes 0.1
candidiasis 0.1
erythema multiforme <0.1
facial edema <0.1
flushing <0.1
cyanosis <0.1
hyperhidrosis <0.1
pruritus vulvae <0.1
Body as a whole
polyarthralgia <0.1
asthenia/weakness <0.1
Adverse Laboratory Changes
Adverse laboratory changes, without regard to drug 
relationship, that were reported during clinical trials 
were:
Hepatic: Increased SGPT, SGOT, alkaline phospha­
tase, bilirubin and LDH.
Hemic: Increased eosinophils, positive Coombs 
test, decreased WBC and neutrophils, increased 
WBC, increased platelets, decreased platelets, 
decreased hemoglobin and hematocrit, increased 
monocytes, abnormal prothrombin time, increased 
lymphocytes, increased basophils.
Electrolytes: Decreased serum sodium, increased 
potassium, increased chloride.
Renal: Increased BUN, creatinine.
Urinalysis: Presence of urine protein, urine red 
blood cells, urine white blood cells, urine casts, 
urine bilirubin, and urine urobilinogen.
TREATMENT OF OVERDOSAGE
There are no data available on overdosage.
PRIMAXiN' (imipenem and cilastatin sodium for 
injection) is cleared by hemodialysis.
DOSAGE AND ADMINISTRATION
The dosage recommendations for PRIMAXIN* 
(imipenem and cilastatin sodium for injection) 
represent the quantity of imipenem to be ad­
ministered by I V. infusion only. An equivalent 
amount of cilastatin is also present in the solution.
The dosage of PRIMAXIN* should be determined by 
the severity of the infection, renal function, body 
weight, the antibiotic susceptibility of the causative 
organism(s) and the condition of the patient. Doses 
cited are based on body weight of 70 kilos.
The median duration of treatment with PRIMAXIN* 
in clinical trials for infections of the various body 
systems ranged from 6 to 10 days except for 
endocarditis and bone and joint infections for which 
the median duration of treatment was 4 weeks.
Dosage in Adults
The recommended daily dose is 1 to 2 g adminis­
tered in equally divided doses every 6 to 8 hours 
(see Table 1).
Dosage in Elderly Patients
The recommended dosage of PRIMAXIN* in elderly 
patients with normal renal function is the same as 
given for adults above. Renal status of elderly 
patients may not be accurately portrayed by 
measurement of BUN or creatinine alone. Deter­
mination of creatinine clearance is suggested to 
provide guidance for dosing in such patients.
ADULT DOSAGE OF PRIMAXIN*
I.V. Adm inistration
Severity  
of infection
Dose
(m g of im ipenem )
Dosage
Interval
Daily
Dose
Mild 250 mg 6  h 1.0 g
Moderate 500 mg 8 h 1.5 g
Severe (fully 
susceptible)
500 mg 6 h 2.0 g
Severe* infections
due to less
susceptible
organisms
or life threatening
conditions
1000 mg 
1000 mg
sz c. 
CO CO
3.0 g
4.0 g
* Primarily some strains of Ps. aeruginosa.
The recommended total daily dosage of PRIMAXIN* 
in children and infants 3 months of age and older is 
60 to 100 mg/kg of body weight divided into 4 equal 
doses given at six hour intervals. The higher 
dosages should be used for infants and young 
children. The total daily dosage should not exceed 
2 gram s. C lin ic a l data are in s u ff ic ie n t to 
recommend an optimum dose for infants and 
children with impaired renal function.
Administration
CAUTION: CONTENTS OF VIALS NOT FOR 
DIRECT INFUSION.
Each reconstituted 250 mg or 500 mg dose should 
be given by intravenous infusion over twenty to 
th irty minutes. Each 1000 mg dose should be 
infused over 40 to 60 minutes. In patients who 
develop nausea during the infusion, the rate of 
infusion may be slowed.
RECONSTITUTION
The maximum daily dose should not exceed 4 g or 
50 mg/kg, which ever is less.
Contents of the 13 mL vials must be suspended and 
transferred to 100 mL of an appropriate infusion 
solution.
Dosage in Patients with Renal Insufficiency
P a tie n ts  w ith  c re a t in in e  c le a ra n c e s  o f 
<5 mL/min/1.73 m* (<0.08 mL/s/1.73 m*) should 
not receive PRIMAXIN* unless hemodialysis is 
instituted within 48 hours. Both imipenem and 
cilastatin are cleared from the circulation during 
hem od ia lys is . The pa tien t shou ld  receive 
PRIMAXIN* after hemodialysis and at 12 hour 
intervals timed from the end of that hemodialysis 
session. Dialysis patients, especially those with 
background CNS disease, should be carefully 
m o n ito re d ; fo r pa tien ts  on hem od ia lys is , 
PRIMAXIN* is recommended only when the benefit 
outweighs the potential risk of seizures (see 
PRECAUTIONS). Currently, there are inadequate 
data to recommend the use of PRIMAXIN* in 
patients undergoing peritoneal dialysis.
TABLE 2
MAXIMUM DOSAGE OF PRIMAXIN* 
IN RELATION TO RENAL FUNCTION
RENAL
FUNCTION
CREATININE
CLEARANCE
mL/min/1.73 m* 
(mL/s/1.73 m^)
DOSE
(9)
DOSAGE
INTERVAL
(h)
MAXIMUM
TOTAL
DAILY
DOSAGE
(9)
Mild
impairment 3 1 -7 0
(0 .52-1 .17 )
0.5 6 - 8 1 .5 -2
Moderate
im pairm ent 2 1 -3 0  
(0.35 -  0.50)
0.5 8 -1 2 1 -1 .5
Severe*
im pairm ent 0 - 2 0  
(0 -  0.33)
0 .2 5 -0 .5 12 0 .5 -1 .0 * *
Patients w ith  creatin ine  clearance of 6 to  
20 mL/min/1.73 m2 (0.1 - 0.3 mL/s/1.73 m2) should 
be treated with 250 mg (or 3.5 mg/kg whichever is 
lower) every 12 hours for most pathogens. When 
the 500 mg aose is used in these patients, there may 
be an increased risk of seizures.
A suggested procedure is to transfer approximately 
10 mL from the 100 mL of the appropriate infusion 
solution to the vial (see list of diluents under 
COMPATIBILITY AND STABILITY). Shake well. 
Return the resulting 10 mL of suspension to the 
remaining 90 mL of the infusion solution.
Repeat, using 10 mL of the diluted suspension, to 
ensure complete transfer of the contents of the vial 
to the infusion solution.
CAUTION: CONTENTS OF VIALS NOT FOR 
DIRECT INFUSION.
COMPATIBILITY AND STABILITY
List of diluents
0.9% Sodium Chloride Injection 
5% or 10% Dextrose Injection 
5% Dextrose Injection with 0.02% sodium 
bicarbonate solution
5% Dextrose and 0.9% Sodium Chloride 
Injection
5% Dextrose Injection with 0.225% or 0.45% 
saline solution 
NORMOSOL-M in D5-W 
5% Dextrose Injection with 0.15% potassium 
chloride solution 
Mannitol 2.5%, 5% and 10%
Reconstituted solutions
Solutions of PRIMAXIN* range from colourless to 
yellow. Variations of colour within this range do not 
affect the potency of the product.
PRIMAXIN*, as supplied in vials and reconstituted 
as above maintains satisfactory potency for four 
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Rectovaginal Fistula: Initial Experience
H. Stern, MD, FRCSC;* Z. Gamliel, MD;* T. Ross, MD, FRCSC;t Z. Dreznik, MD$
Rectovaginal fistulas are not common, but the associated symptoms can be 
emotionally and physically disabling. The authors report their experience of 10 
patients with a diagnosis of rectovaginal fistula, seen between December 1982 and 
July 1986. The women ranged in age from 28 to 74 years. All complained of passing 
feces or flatus, or both, through the vagina. In the majority of cases, fistulas were 
present for longer than 6 months before surgical repair. The fistulas were due 
mainly to trauma. Endorectal advancement flaps were used in seven patients with 
excellent results. Small fistulas due to obstetric trauma may heal spontaneously, so 
in these cases a 6-month waiting period before operation is recommended. However, 
fistulas due to inflammatory bowel disease will not heal spontaneously and should 
be repaired as soon as the patients’s condition is optimal.
Les fistules recto-vaginales ne sont pas frequentes, mais les symptomes qui leur 
sont associes peuvent toutefois etre emotionellement et physiquement invalidants.
Les auteurs font etat de leur experience aupres de 10 patientes souffrant de fistules 
recto-vaginales, qui ont ete vues entres decembre 1982 et juillet 1986. Leur age 
variait de 28 a 74 ans. Toutes se plaignaient du passage de matiere fecales ou de 
l’expulsion de gaz intestinaux par le vagin. Dans la majorite des cas, les fistules 
etaient presentes depuis plus de 6 mois au moment de la reparation chirurgicale.
Les fistules etaient principalement dues a des traumatismes. Des lambeaux 
d’avancement endorectaux ont ete utilises chez sept patientes avec d’excellents 
resultats. Les petites fistules dues a un traumatisme obstetrical peuvent guerir 
spontanement. Dans de tels cas, on recommande une periode d’attente de 6 mois 
avant d’operer. Toutefois, les fistules dues a une maladie inflammatoire intestinale 
ne guerissent pas spontanement et doivent etre reparees aussitot que l’etat de la 
patiente s’y prete.
Rectovaginal fistulas constitute less than 5% of anorectal fistu­
las.1 They may be congenital or 
acquired. Although it is difficult to 
determine the precise incidence of 
rectovaginal fistulas due to any sin­
gle cause, most result from obstetri­
cal injuries, inflammatory bowel dis­
ease and pelvic irradiation. Al­
though these fistulas are not com-
Accepted for publication Feb. 16, 1988
mon, they can be physically and 
emotionally disabling.
We present our experience in 
managing rectovaginal fistulas.
Patients and Method
We reviewed the charts of 10 
women with a diagnosis of rec­
tovaginal fistula, operated upon be­
tween December 1982 and July 
1986. The mean age at the time of 
repair was 39.7 years (ranging from 
28 to 74 years). The timing of 
repair varied from 1 month to 14 
years after the onset of symptoms; 
of the 10 fistulas, 8 were present 
for more than 6 months and 1 for 5 
months before operative repair was 
attempted. (One fistula, present for 
3 months, healed spontaneously but 
sphincteroplasty was required for 
persistent anal incontinence.) Fol­
low-up after successful repair 
ranged from 8 to 46 weeks (mean 
20.4 weeks).
The chief presenting complaint 
was passage of feces and flatus 
through the vagina. Several pa­
tients noted that their symptoms 
worsened when they had diarrhea. 
One woman noted passage of men­
strual blood through her rectum. In 
all cases, the fistula was demon­
strated by proctosigmoidoscopy 
and, when the fistula was low, its 
course was outlined by passage of a 
probe through the vaginal orifice 
and by digital palpation (Fig. 1). 
The locations and sizes of the fistu­
las are listed in Table I.
In 6 of the 10 patients the fistula 
developed as a result of obstetrical 
trauma. One of them had a medium­
sized fistula for 5 years during 
which time repair was attempted 
four times before referral to our 
centre. Barium studies of the large 
and small bowel were done to rule 
out Crohn’s disease. Another pa­
tient had a small fistula for 14 years 
with only one previous attempt at 
repair.
Pelvic surgery was the cause of
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the fistula in two patients. One 
fistula developed after posterior col- 
potomy for tubal ligation, and the 
patient had a diverting colostomy 
for the next 17 months before 
being referred to us. The other 
patient had a fistula associated with 
strictures for 9 years after surgical 
correction of rectal prolapse.
In one woman a fistula developed 
just before she underwent subtotal 
colectomy for Crohn’s disease. She 
had an ileostomy for 7 months 
before entering our study. In anoth­
er patient a fistula developed after 
frequent use of progesterone sup­
positories for premenstrual syn­
drome; two attempts at repair had 
failed. Barium enema examination 
demonstrated the fistula but no 
other related disease. The cause of 
the fistula was presumed to be 
traumatic due to repeated insertion 
of the suppositories.
Treatment
Our approach to small or medi­
um-sized low rectovaginal fistulas is 
endorectal advancement of an ano­
rectal flap, consisting of mucosa, 
submucosa and circular muscle as 
described by Goldberg’s group2 (Fig. 
1). Repair is deferred until local
inflammatory reaction has subsided 
(usually 6 months) and is then 
performed only with suitable bowel 
preparation, which includes the in­
travenous administration of broad- 
spectrum antibiotics. To ensure ad­
equate blood supply to the rectal 
flap, its base is maintained at least 
4.0 cm proximal to the fistula and 
approximately twice the width of 
the apex. The rectal mucosa and 
submucosa are elevated laterally 
(Fig. 2) so that the cut edges of the 
underlying internal sphincter mus-
FIG. 3 — Reapproximation of internal 
sphincter.
Table 1-Patients Treated for Rectovaginal Fistula, December 1982 to July 1986
Patient
no.
Age,
yr
Cause of 
fistula
Fistula
type
Size,
mm
Duration of 
symptoms Investigations
Previous
repairs
Mode of 
repair Outcome
Duration of 
follow-up, wk
1 28 Obstetric Low 10 1 mo EUA - Transanal flap Healed 15
2 31 Obstetric Low 15 5 yr UGI & FT, 
Barium enema
4 Transanal flap Healed 11
3 30 Obstetric Low 3 6 mo - - Transanal flap Healed 46
4 60 Rectal
surgery
High/
complex
10 9 yr EUA Transanal suture 
(incomplete)
Unsatisfactory 14
5 36 Posterior
colpotomy
High/
complex
10 17 mo Barium enema ~ Transabdominal +  
colostomy
Healed 16
6 34 Obstetric Low 4 14 yr - 1 Transanal flap Failed 20
7 32 ? traumatic 
(unproven)
Low 5 18 mo Barium enema 
Small-bowel 
enema
2 Transanal flap + 
colostomy
Healed 32
8 47 Ulcerative
colitis
Low 5 9 mo “ Transanal flap +  
ileostomy*
Healed 24
9 34 Obstetric Low 2 13 mo “ Transanal flap + 
sphincteroplasty
Healed 8
10 31 Obstetric Low 2 3 mo None. Sphincteroplasty 
for persistent anal 
incontinence
Healed
spontaneously
13
*ln site before repair. EUA = examination under anesthesia, UGI =  upper gastrointestinal, FT =  follow though.
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cle may be mobilized and approxi­
mated in the midline without ten­
sion (Fig. 3). In patients with anal 
incontinence, a concomitant plica­
tion external sphincteroplasty is 
performed (Fig. 4). The rectal flap 
is advanced over the repaired area, 
the excess trimmed and the flap 
sutured in place with 2-0 or 3-0 
Dexon (Fig. 5). The vaginal mucosa 
is left open for drainage. Postopera- 
tively, the patient is given analge­
sics and warm sitz baths as needed, 
as well as bulk laxatives to avoid 
constipation.
Results
There were no operative deaths 
or serious complications. Seven pa­
tients had their fistula repaired by 
endorectal flap advancement; one of 
them also required a colostomy and 
one already had an ileostomy in 
place following subtotal colectomy 
(Table I). One patient had a con­
comitant sphincteroplasty. Six of 
the seven flap advancements were 
successful; in the other the fistula 
recurred 20 weeks postoperatively 
but a second repair 4 weeks later,
FIG. 4 — Advancement of flap of mucosa and internal sphincter.
which included a colostomy and 
sphincteroplasty, was successful.
One high, complex fistula, which 
lay between two rectal strictures, 
could not be adequately repaired by 
the transanal route. Only the distal 
portion of the fistula was closed 
using interrupted sutures, since in­
struments could not be passed 
proximal to the stricture. One very 
small, low fistula caused by obstet­
rical trauma closed spontaneously 3 
months post partum. In this case, 
persistent anal incontinence was 
corrected by anterior sphinctero­
plasty.
One medium-sized high fistula 
was managed by the transabdominal 
route. The fistula was repaired with 
a colostomy by mobilizing the rec­
tovaginal septum, dividing the fistu­
la, closing the rectal defect and 
interposing a pedicle of omentum 
between the rectum and vagina. A 
Penrose drain was passed through 
the open vaginal defect.
Most patients reported resolution 
of their symptoms, although one 
(patient no. 2, Table I) complained 
of a sensation of gas in the vagina, 
which persisted for several weeks.
Discussion
The symptoms of rectovaginal 
fistulas depend on their size, loca­
tion and cause. While small ones 
may be asymptomatic, larger ones 
are associated with passage of fla­
tus or stool through the vagina.3 
These distressing symptoms cause 
varying degrees of social and sexual 
problems.
Most fistulas are palpable and 
easily visualized by rectovaginal ex­
amination or proctoscopy. Occa­
sionally, more involved techniques 
such as methylene blue4 or barium 
studies are necessary for diagnosis. 
Rectovaginal fistulas may be classi­
fied anatomically by location and 
size. Rosenshein and colleagues5
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described four types occurring in 
three zones. Daniels6 classified 
them as small, medium or large. 
Although a number of classifica­
tions have been proposed, we be­
lieve these fistulas can most practi­
cally be considered as low (anal) or 
high (complex or rectal).
Many approaches have been de­
scribed for the correction of rec­
tovaginal fistulas. The high type 
can usually be approached transab- 
dominally, and low fistulas by rec­
tal, vaginal, perineal, trans-sphinct- 
eric and trans-sacral routes. Re­
gardless of the approach used, the 
main principle of repair is to create 
maximal strength without tension 
at the site.7 Complete removal of 
the fistula is not necessary, as long 
as the tract is adequately drained 
and the rectal defect covered by a 
flap of healthy rectal mucosa and 
muscle. Excellent drainage is 
achieved by leaving the vaginal de­
fect open. The vaginal mucosa 
heals readily once drainage has 
ceased.
Timing of the repair is important. 
In small fistulas due to obstetrical 
trauma, Mattingly8 recommended 
waiting at least 6 months before 
operative intervention because half 
will heal spontaneously; there may 
be residual anal incontinence that 
requires sphincteroplasty. Con­
versely, fistulas due to inflammato­
ry bowel disease seldom heal spon­
taneously9-10 and the underlying dis­
ease should be treated aggressively 
so that the patient’s condition is 
optimal when operative repair is 
attempted. Patients with fistulas 
due to pelvic irradiation may require 
a defunctioning colostomy for over 
1 year before local tissue pliability 
allows surgical repair.11
Opinions differ widely about the
need for a temporary colostomy 
with surgical repair of rectovaginal 
fistulas.11-13 We believe that a colos­
tomy is not needed for the majority 
of uncomplicated rectovaginal fistu­
las. However, for more complex 
fistulas due to inflammatory bowel 
disease, irradiation or cancer, colos­
tomy may be useful either as part of 
a staged procedure or at the time of 
definitive repair. In this series, four 
fistulas were successfully repaired 
transanally and one transabdominal- 
ly without a colostomy.
After successful repair, patients 
generally report complete resolution 
of their symptoms. However, at 
least one of our patients reported a 
feeling of gas in the vagina, a 
feeling that persisted for several 
weeks postoperatively, even though 
there was no evidence of fistula 
recurrence. This phenomenon "has 
been reported by Hoexter and asso­
ciates14 but lacks a clear explana­
tion. We recommend that these 
women abstain from sexual inter­
course for 3 months after fistula 
repair. If sphincteroplasty has been 
performed, consideration should be 
given to cesarean section for subse­
quent deliveries, although no con­
clusive data are available on this 
issue.
The illustrations have been adapted and 
are reproduced by permission from 
Goldberg SM, Gordon PH, Nivatvongs 
S: Essentials o f Anorectal Surgery, Lip- 
pincott, Philadelphia, 1980: 326, 327
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Liver Blood Flow After Major Hepatic 
Resection
Sherif S. Hanna, MB, BCh, FRCSC, FACS; Giuseppe Pagliarello, MD, FRCSC; Alan Ing, MD, FRCSC
The factors involved in liver regeneration are poorly understood, but it has been 
suggested that blood flow plays a role. This paper documents the changes in liver 
blood flow (LBF) that occur after major hepatic resection. Eight patients, ranging in 
age from 37 to 76 years, underwent liver resection. Liver blood flow was measured 
preoperatively and on days 1, 4 and 7 postoperatively by low-dose galactose 
clearance.
There was a significant (p < 0.01) fall in LBF on day 1 compared with the 
baseline value, followed by a significant (p < 0.01) rise from the baseline value by 
day 4. By day 7, LBF had returned to baseline levels and was significantly (p < 0.01) 
lower than on day 4. These changes in LBF may be related to the stimulus for liver 
regeneration and increased functional demands during the early regenerative phase.
The changes in flow have not been 
studied clinically in humans.
Using low-dose galactose clear­
ance (LDGC) we measured LBF 
postoperatively in patients who un­
derwent major liver resection. As a 
noninvasive technique we hoped 
that it would be useful in monitor­
ing regeneration after hepatic fail­
ure or resection.
Les facteurs participant a la regeneration hepatique sont mal connus. II a toutefois 
ete suggere que le debit sanguin y jouait un role. Cet article montre les 
changements du debit sanguin hepatique (DSH) qui surviennent apres une resection 
hepatique importante. Huit patients ages de 37 a 76 ans ont subi une resection 
hepatique. Des determinations du DSH ont ete pratiquees par mesure de la clairance 
du galactose a faible dose, avant l’operation, et 1, 4 et 7 jours apres l’intervention.
On a constate une baisse significative (p < 0.01) du DSH au jour 1 par rapport a 
la valeur de depart, suivie d’une augmentation significative (p < 0.01) au jour 4. Au 
jour 7, le DSH etait retourne a son point de depart et il etait significativement plus 
faible (p < 0.01) qu’au jour 4. Ces changements de DSH peuvent etre relies a la 
stimulation du processus de regeneration hepatique et a l’augmentation de la 
demande fonctionnelle durant la phase precoce de regeneration.
The ability of the liver to regen­erate after major resection has 
been studied extensively, but the 
factors responsible for regeneration 
are not well understood.
The role of hepatic blood flow in 
liver regeneration is also poorly
understood, but an association be­
tween flow and regenerative re­
sponse has been suggested. Liver 
blood flow (LBF) after hepatic re­
section has been studied in small 
and large animal models using sev­
eral methods of flow measurement.
Methods
Eight patients, ranging in age 
from 37 to 76 years, underwent 
major liver resection. Indications 
for resection are listed in Table I 
and operations performed in Table 
II. Anatomical resections were per­
formed, first controlling hilar ves-
T a b le  1—Indications fo r  Liver Resection
In d ic a t io n
N o .  o f  
p a t ie n t s
Metastatic co lorectal cancer 4
Metastatic carcinoid 1
Locally invasive renal cell 
carcinoma 2
Hemangioma 1
T a b l e  ll-O pe ra tions  Perform ed
O p e r a t io n
N o .  o f  
p a t ie n t s
Extended right hepatic 3
lobectom y 
(right hepatic 
trisegm entectom y) 
Extended le ft hepatic 1
lobectom y 
(le ft hepatic 
trisegm entectom y) 
Right hepatic lobectom y 2
Left hepatic lobectom y 2
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sels then dividing liver tissue by 
finger fracture and ligation of ves­
sels or bile ducts as they were 
encountered. Thorough drainage of 
the right upper quadrant was pro­
vided. Resected specimens were ex­
amined for adequacy of resection 
and weighed. Early postoperative
FIG. 1 — Mean liver blood flow (LBF) 
after partial hepatectomy in eight pa­
tients. Note significant decrease (*) in 
LBF from baseline to postoperative 
day 1 and significant return of LBF to 
baseline levels by postoperative day 4.
T a b le  Ill-Operative Data (Mean ± SEM)
Operative time,
min 459.0 ± 24.7
h 7.65 ± 0.41
Anesthesia time,
min 564.0 ± 26.4
h 9.40 ± 0.44
Blood loss, ml 14 750 ±3180
Packed red cells given,
units 23.4 ± 4.90
Platelets given, units 7.0 ± 2.00
Fresh frozen plasma
given, units 8.75 ± 1.96
Crystalloids given, ml 21 090 ± 3780
care was carried out in the surgical 
intensive care unit. The LBF was 
measured preoperatively for a base­
line value and again on days 1, 4 
and 7 postoperatively using Hender­
son’s method1 of LDGC. When 
blood samples were drawn for base­
line measurements a 10-ml bolus of 
5% galactose (500 mg) was injected 
intravenously, followed by a contin­
uous infusion at 50 m l/h (42 
mg/min). Samples were withdrawn 
from a peripheral vein at 60, 70, 
80, 90 and 100 minutes. The blood 
was centrifuged at 1000 rpm for 10 
minutes. The plasma was separated 
and frozen and then assayed for 
galactose by continuous-flow fluo- 
rometry.
Liver blood flow was calculated 
from the blood clearance of galac­
tose, a simple sugar, 96% of which 
is metabolized in the liver. When 
infused continuously at a very low 
dose, its elimination from the liver 
is dependent only on blood flow;2 
thus, the LDGC closely approxi­
mates LBF. Plasma concentration 
of galactose is converted to blood 
concentration by multiplying by 
1 — (0.5 X  hematocrit). Blood clear­
ance can then be calculated as the 
rate of elimination divided by blood 
galactose concentration. A steady 
state is reached when the rate of 
elimination equals the rate of infu­
sion; galactose clearance then 
equals the infusion rate divided by 
the blood concentration.3
Calculation of galactose clear­
ance is based on the steady state 
concentration of galactose and ex­
pressed as millilitres per minute.
Results are expressed as the 
mean ± standard error for the eight 
patients on each day studied. Statis­
tical analysis was by the paired 
(-test for the mean differences be­
tween blood flows on different days.
Results (Fig. 1)
Operative data are shown in 
Table III. All patients were hemody- 
namically stable when studied post­
operatively, but one later died of 
complications. The mean weight of 
resected specimens was 904 ± 227 
g-
Cardiac output measurements 
were only available for day 1, when 
the mean value was 6.29 ± 0.49 
L/min. Liver function (Table IV) 
was monitored at intervals corre­
sponding to the time of the LBF 
measurements and also on the day 
of operation and 3 weeks later 
when the surviving patients were 
ambulatory and were discharged. 
The patterns of change are illustrat­
ed in Figs. 2 and 3 and correlated 
with the changes in measured LBF. 
Gross abnormalities were recorded 
for postoperative day 1 but a rapid 
return toward normal values was 
noted by day 4, a trend that contin­
ued toward full normalization by 
the third postoperative week. An 
interesting exception to these pat­
terns was the serum alkaline phos­
phatase. Markedly elevated preoper­
atively, it started to fall on the day 
of operation toward normal values
T a b le  IV-Liver Function Test Values After Hepatic Resection (Mean
LUCO-H
A lka lin e A spartate A lan ine P artia l
B ilirub in p h osph atase a m in o tran s fe rase am in o tra n s fe ra s e A lbum in P rotein P ro th rom bin  th rom bop lastin
T im e (2  -  2 0  Mm o l/L * )  (3 0  -  9 0  U /L ) (0  -  3 0  U /L) (0  -  30  U /L ) (3 5  -  50  g /L ) (60  -  80  g /L ) tim e , s tim e , s
Preop 8.6 ± 1.5 150.4 ±54.1 21.9 ± 1.8 15.0 ±2.3 34.8 ± 3.9 70.7 ± 2.3 11.5 ±0.3 30.8 ± 0.9
Day of operation 63.0 ± 12.9 46.8 ± 13.3 131.4 ±28.5 120.0 ± 40.8 26.2 ± 3.1 44.6 ± 5.5 12.8 ±0.4 34.9 ± 1.9
Postop day 1 113.8 ±34.0 42.0 ±11.0 182.8 ±52.9 125.5 ± 46.1 28.3 ± 2.1 47.5 ±  2.8 13.7 ±0.6 31.8 ± 1.5
Postop day 4 64.9 ± 13.7 63.7 ±11.0 35.6 ± 6.4 29.0 ±12.4 25.0 ±1.1 46.9 ± 2.2 13.1 ± 0.4 32.6 ± 2.0
Postop day 7 46.2 ± 10.4 100.7 ± 19.0 35.0 ± 2.9 29.6 ± 5.4 23.0 ± 1.6 47.8 ± 0.8 12.3 ± 1.0 30.6 ± 0.8
3 wk postop 14.8 ± 2.7 163.5 ±34.6 26.8 ± 0.9 22.6 ± 3.3 27.8 ± 4.4 64.0 ± 6.7
'Normal ranges.
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on day 1, then rose steadily thereaf­
ter toward preoperative levels.
The baseline LBF was 1978 ± 
141 ml/min. On postoperative day
FIG. 2 — Liver function tests after 
major hepatic resection. Note that 
serum bilirubin (dotted line), alanine 
aminotransferase (dashes) and aspar­
tate aminotransferase (dots and dash­
es) rise after liver resection but alka­
line phosphatase (solid line) falls. Al­
kaline phosphatase begins to return to 
normal at about same time as LBF 
returns to normal on postoperative day 
4.
1 it was 1025 ± 94 ml/min (52% 
of baseline). The mean difference in 
blood flow from baseline to day 1, 
— 930 ± 134 ml/min, was statisti­
cally significant (p = 0.0004). On 
postoperative day 4, the LBF had 
rebounded to 2157 ± 288 ml/min, 
an increase from day 1 of 1323 ± 
174 ml/min (p = 0.0047). The 
mean difference from baseline to 
day 4 was not significant.
On day 7 the mean LBF was 
1899 ± 314 ml/min, which is 
similar to baseline levels and the 
LBF on day 4, indicating a return 
to baseline levels.
Discussion
These studies are a first attempt 
at quantifying changes in LBF after 
liver resection in humans. Blood 
flow can be estimated noninvasively 
by clearance of indocyanine green 
or galactose.3-5 Reliable measure­
ment requires almost complete 
clearance of the indicator in one 
pass through the liver. When this 
criterion is fulfilled and the indica­
tor is administered at sufficiently 
low dose, the rate of elimination is 
dependent only on blood flow per­
fusing the organ.6 The extraction of 
galactose by the liver is approxi­
mately 96% complete in one pass, 
making it an ideal indicator,7 and is 
higher than indocyanine green.8 
Low-dose galactose clearance has 
been used to estimate hepatic blood 
flow in both experimental and clini­
cal settings, mainly in the study of 
portal hypertension.9' 12 In healthy 
dogs, galactose extraction is 84% 
and in cirrhotic dogs it is still 
relatively high at 75%.12
Because galactose is metabolized 
almost exclusively by the liver, its 
elimination depends on effective 
flow perfusing functional hepato- 
cytes. This flow differs from ana­
tomic LBF in that a portion of the 
latter is shunted away from hepato- 
cytes and appears unchanged in the 
hepatic veins (intrahepatic shunt­
ing). This functional or effective 
flow, perfusing hepatocytes, is what 
we wished to measure in studying 
the response to subtotal hepatecto- 
my. Because LDGC is a noninvasive 
technique and is based on an indica­
tor that is highly extracted and 
metabolized completely, it closely 
approximates effective LBF. This 
makes it an ideal test for repeated 
measurements of LBF in the clinical 
setting.
Hemodynamic changes in the 
liver have been studied in the set­
ting of hepatic resection and regen­
eration in experimental models.13' 16 
Rabinovici and Wiener13 studied 
partial hepatectomy in rats by clear­
ance of albumin labelled with io­
dine-131. Almost immediately post- 
operatively the LBF rose, then de­
creased by day 2, returning to base­
line levels in 1 week. Restrepo and 
Warren14 studied a canine model of 
70% hepatectomy. The LBF, as 
measured by colloid clearance post- 
operatively, was 62% of baseline 
flow but quickly returned to base-
FIG. 3 — Liver function tests after major hepatic resection. Note initial fall in 
protein and albumin with gradual return toward normal.
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line levels. Kahn and associates15 
studied a porcine model of 70% 
hepatectomy using flow probes. 
These have the drawbacks, particu­
larly in humans, of requiring repeat­
ed laparotomy and measuring com­
plete anatomic blood flow rather 
than effective hepatocyte perfusion. 
Blood flow was elevated postopera- 
tively, rising to maximum (300% of 
baseline) on day 1, then returning 
to baseline levels on day 6. The 
LBF was reported at intervals after 
hepatectomy in millilitres per min­
ute per gram of liver, calculated 
from the weight of remaining liver. 
In our study, LBF dropped to 52% 
of the baseline level on postopera­
tive day 1, returning to the baseline 
level by day 4 and remaining at that 
level on day 7. The decrease in LBF 
on day 1 was not likely the result of 
a decrease in cardiac output. Unfor­
tunately, cardiac output measure­
ments were only available on day 1, 
but at that time the mean level was 
elevated to 6.29 ± 0.49 L/min. 
Thus, the decrease in LBF repre­
sents a true decrease in absolute 
and relative blood flow to the liver.
Does the rising serum alkaline 
phosphatase noted after hepatecto­
my (Figs. 2 and 3) parallel increas­
ing regeneration and improving he­
patic function? Biochemical and his­
tologic events in liver regeneration 
have been studied extensively by 
experimental models of liver resec­
tion. In addition to hemodynamic 
studies, Rabinovici and Wiener13 re­
ported on regeneration as measured 
by the proportion of liver weight to 
percentage body weight. Preopera- 
tively the rate was 3.47 g liver per 
100 g body weight; it declined to 
1.31 g/100 g postoperatively, ris­
ing gradually to 3 g /100 g over the 
next 6 weeks. Better indices of 
regeneration are provided by mea­
surements of DNA synthesis, either 
directly17 or indirectly by enzyme 
assays.18 In both 44% and 72% 
hepatectomy models, DNA synthe­
sis began rising at 24 hours, peaked 
at 3 days, then remained elevated 
over baseline levels.
Using thymidine kinase, the peak 
in regenerative activity in a pig 
model occurred on postoperative 
day 3.18 On the basis of these 
observations of animal models, it 
can be assumed that enhanced syn­
thetic activity paralleling liver re­
generation occurs after approxi­
mately 3 days. The timing of 
changes in blood flow after partial 
hepatectomy is not as consistent. 
The measurements were made in 
different models, using different 
techniques to measure LBF. Liver 
blood flow was reported to increase 
progressively in one model;1519 in 
another model it decreased early 
postoperatively but returned to 
baseline levels within a week.13'14 
Our findings are consistent with the 
latter results. The relation between 
changes in LBF and regeneration 
can be viewed in two ways. The 
increases in LBF postoperatively 
may simply reflect perfusion de­
mands due to increased synthetic 
activity during regeneration; sus­
tained increases have been docu­
mented by some investigators.15 Al­
ternatively, the abrupt decreases in 
postoperative LBF observed during 
this study and documented by oth­
ers13'14 using animal models may be 
interpreted as a stimulus to regen­
eration in itself or may be seen as 
an indicator of another humoral 
factor which stimulates regenera­
tion. The peak in regenerative activ­
ity occurs approximately 3 days 
after resection, the most notable 
changes in LBF precede the onset 
of this peak. One may hypothesize 
that the decrease in LBF stimulates 
or signals the onset of stimulation 
in regenerative activity.
Our study does not purport to 
explain mechanisms and interrela­
tionships of the hemodynamic and 
regenerative responses to partial he­
patectomy. It does demonstrate that
changes in blood flow can be mea­
sured noninvasively in the human 
after hepatic resection. We mea­
sured galactose clearance and, by 
inference, liver blood flow. The par­
allel changes in regenerative activi­
ty cannot be followed clinically. 
Noninvasive, clinically applicable 
methods of following the biochemi­
cal, histologic and anatomic 
changes with regeneration are not 
readily available. The demonstration 
that changes in blood flow, as mea­
sured noninvasively using LDGC, 
parallel the regenerative activity 
would allow for noninvasive moni­
toring of liver regeneration. Thus, 
LDGC may be useful in assessing 
various therapies in cases of liver 
failure, after hepatic resection and 
possibly after hepatic transplanta­
tion.
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represents the culmination of two dec­
ades of continuing interest and acquired 
expertise in this field within the Depart­
ment of Anesthesia at the Vancouver 
General Hospital. This hard-cover text 
is divided into nine chapters and forms 
a comprehensive review of the multidis­
ciplinary approach to the perioperative 
assessment and management of patients 
who undergo carotid artery surgery.
Topics discussed include the patient 
profile, diagnostic procedures and con­
troversies in patient selection, anesthet­
ic management, surgical techniques and 
optimum monitoring of cerebral perfu­
sion and intervention modalities for 
brain protection. A review of the Van­
couver General Hospital experience 
from 1974 to 1984 provides a reference 
point for comparison with other cen­
tres. Each chapter includes an extensive 
bibliography covering all relevant publi­
cations up to 1984.
The best chapters are those on moni­
toring during carotid endarterectomy 
and postoperative complications. Both 
are comprehensive and unlikely to be 
discussed in more detail elsewhere. The 
most disappointing feature is the brevi­
ty with which introperative manage­
ment is discussed. Despite a clear de­
scription of potential perioperative
problems, few practical suggestions are 
made, and the reader is left with a 
disjointed and incomplete account of 
“how to do it”. Examples of omissions 
include: the use of intermittent systemic 
heparinization, pharmacologic pressure 
manipulation, biochemical monitoring 
and an updated management guide for 
the treatment of postoperative hyper­
tension. For the academic, a discussion 
of the use of isoflurane and critical 
cerebral blood flow, new pharmacologic 
agents offering potential cerebral pro­
tective effects, and the effects of anes­
thetic agents on cerebrovascular he­
modynamics could have been included. 
Anesthetic considerations for neuroradi- 
ologic investigations or extracranial- 
intracranial arterial anastomosis are not 
discussed.
For the most part the book is well 
written and easily read in an evening. 
Unfortunately there is some repetition 
and numerous spelling and typographic 
errors.
This publication represents an ambi­
tious achievement by two authors who 
have successfully compiled a state-of- 
the-art review of perioperative medical, 
surgical and anesthetic considerations 
in patients who undergo carotid endar­
terectomy. I would recommend this
17. Francavilla A, Porter KA, Benichou J, 
et al: Liver regeneration in dogs: mor­
phologic and chemical changes. J Surg 
Res 1978; 25: 409-419
18. Kahn D, Stadler J, Terblanche J, et al: 
Thymidine kinase: an inexpensive index 
of liver regeneration in a large animal 
model. Gastroenterology 1980; 79 (5 pt 
1): 907-911
19. Rice GC, Leiberman DP, Mathie RT, et 
al: Liver tissue blood flow measured by 
85Kr clearance in the anaesthetized rat 
before and after partial hepatectomy. Br 
J Exp Pathol 1977; 58: 243-250
book as a valuable reference acquisition 
for a departmental library.
K.M. Robertson, MD, FRCPC
Department o f Anesthesia,
University Hospital,
University o f Western Ontario,
PO Box 5339, Station A,
London, Ont.
N6A 5A5
DIAGNOSTIC IMAGING: AN AL­
GORITHMIC APPROACH. 2nd ed. Ed­
ited by Ronald L. Eisenberg, with 76 
contributors. 713 pp. Illust. J.B. Lip- 
pincott Company, Philadelphia, 1987. 
$79.50 (US). ISBN 0-397-58300-1.
An algorithm is a “step-by-step problem 
solving procedure”. In medicine, algo­
rithms or critical diagnostic pathways 
hold the promise of helping clinicians to 
deal with the explosive growth of diag­
nostic imaging by depicting the optimal 
sequence of investigative procedures for 
the patient’s clinical problem. In this 
textbook, Dr. Eisenberg has enlisted 76 
radiologists and internists, many of in-
continued on page 371
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Management of Acute Postoperative 
Occlusion of an Internal Carotid Artery
Thomas M. Egan, MD, MSc, FRCSC; Paul M. Walker, MD, PhD, FRCSC
Complete occlusion of an endarterectomized internal carotid artery in the early 
postoperative period is uncommon. In a series of 325 consecutive carotid 
endarterectomies, the authors recognized this complication on five occasions. In 
each instance, early reoperation resulted in neurologic improvement of the patient. 
Awareness of the condition is important in making the diagnosis; in two patients the 
deficit was mild, despite complete occlusion of the endarterectomized artery. 
Therefore, the authors believe that any neurologic deficit early after endarterectomy 
of an internal carotid artery should be aggressively investigated and patency of the 
affected segment re-established.
II est peu frequent d’observer l’occlusion complete d’une carotide interne endarterec- 
tomisee durant la periode post-operatoire immediate. Sur une serie de 325 
endarterectomies carotidiennes consecutives, les auteurs ont reconnu cette complica­
tion en cinq occasions. Dans chaque cas, une reintervention precoce a amene une 
amelioration neurologique. Le diagnostic exige de toujours avoir cette complication 
a l’esprit, puisque, chez deux patients, le deficit etait leger en depit d’une 
obliteration complete de Tartere endarterectomisee. Les auteurs croient qu’il y a lieu 
d’etudier a fond tout deficit neurologique survenant tot apres l’endarterectomie 
d’une carotide interne, afin de retablir la permeabilite du segment affecte.
Over the last three decades the role of surgery in the treat­
ment of extracranial atherosclerotic 
disease has been controversial. Sur­
gery is now generally accepted as 
being contraindicated in patients 
with a massive completed stroke 
because it is associated with a high 
incidence of operative complications 
and bestows little benefit.12 Some 
surgeons have advocated carotid 
endarterectomy for selected asymp­
tomatic bruits3 or acute occlusion.4 
The occurrence of transient isch­
emic attacks (TIAs) is considered an 
indication for surgery when there is 
an extracranial lesion in the appro­
priate internal carotid artery.3-5 
Even in this setting, there is a wide 
range of morbidity and mortality.6 
With the advent of newer antiplate­
let agents7 the role of surgery has 
been further challenged.
The most serious complication of 
carotid endarterectomy is stroke, 
which may be due to acute occlu­
sion of the internal carotid arte­
ry.8-10 The hazards of primary sur­
gery after such occlusion have been 
elucidated.3-5 The role of reopera­
tion for acute occlusion after endar­
terectomy is unclear. In this paper 
we describe our experience with 
occlusion of endarterectomized in­
ternal carotid arteries. On the basis 
of this experience, we have adopted 
an aggressive approach to the diag­
nosis and management of any neu­
rologic deficit in the period immedi­
ately after endarterectomy.
Patients and Findings
The data on 325 consecutive pa­
tients who underwent carotid endar­
terectomy between July 1980 and 
June 1987 on the vascular service 
at the Toronto General Hospital 
were analysed. The indications for 
surgery were: TIAs (214 patients), 
reversible ischemic neurologic de­
fects (RINDs) (26), small completed 
strokes (36), asymptomatic severe 
stenosis in the artery opposite a 
surgically corrected lesion (21) and 
opposite an occlusion (5) and for 
vertebral basilar insufficiency (23). 
When general anesthesia was used 
a temporary indwelling shunt was 
placed to provide cerebral protec­
tion. Two patients had temporary 
global dysfunction which resolved 
in less than 24 hours. Acute focal 
neurologic deficit developed in five 
patients all of whom were investi­
gated and managed promptly. Pre- 
operatively, each had severe inter­
nal carotid artery stenosis ipsilateral 
to the symptomatic hemisphere.
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One had an occluded contralateral 
internal carotid artery, two had 
moderate contralateral stenosis and 
two had no contralateral stenosis. 
Notable contralateral disease was 
present in 46% (146 patients) of the 
whole group. Each of the five pa­
tients with acute postoperative oc­
clusion of an endarterectomized in­
ternal carotid artery are briefly re­
viewed.
Case Reports
Case 1
A 53-year-old, non-insulin- 
dependent, diabetic man suffered a 
right-sided stroke and had mild re­
sidual impairment. Cerebral angiog­
raphy demonstrated a 95% steno­
sis, 1 cm long, of the left internal 
carotid artery and a 70% stenosis of 
the right carotid siphon.
Left internal carotid endarterecto­
my was performed. Approximately 9 
hours later, the patient had a dimin­
ished level of consciousness, was 
unable to speak or move his right 
arm and was incontinent. At reoper­
ation the left internal carotid artery 
was found to be blocked with plate­
let aggregates. Thrombectomy was 
performed and the artery closed 
using a saphenous vein patch. Post- 
operatively, he had mild residual 
weakness in the right hand, un­
changed from his initial preopera­
tive status. Three years later, his 
condition remains stable.
Case 2
For 2 years this 66-year-old man 
had episodic weakness of the right 
arm and increasingly frequent brief 
episodes (2 to 3 minutes) of disori­
entation. Digital intravenous angi­
ography demonstrated a 99% steno­
sis in the left internal carotid artery 
and a moderate stenosis of the right 
internal carotid artery. The left ver­
tebral artery was occluded and the 
right vertebral artery had a severe 
stenosis at its origin.
A left internal carotid endarterec­
tomy was performed. Two hours 
postoperatively, the patient had a 
dense right hemiplegia with facial 
droop; he became disoriented and 
difficult to rouse. At reoperation, 
the lumen of the internal carotid 
artery was found to be completely 
occluded with white thrombus; this 
was removed and the arteriotomy 
closed using a saphenous vein 
patch. His neurologic function im­
proved over the next 24 hours, and 
only minimal weakness in the grip 
of his right hand remained. At 
discharge he had no notable neuro­
logic deficit. Follow-up 4 years later 
demonstrated no neurologic deficit.
Case 3
A 58-year-old insulin-dependent 
woman had a 2-year history of 
episodic weakness of right arm and 
right lower limb lasting up to 1 
hour. A digital subtraction angio­
gram demonstrated a completely oc­
cluded right internal carotid artery 
with a severe stenosis of the left 
internal carotid artery and stenosis 
at the origin of the left subclavian 
artery.
A left internal carotid endarterec­
tomy was performed, and saphe­
nous vein patch was used to close 
the vessel. Ninety minutes postop­
eratively she was found to have a 
paralysed right hand and weakness 
of flexion and extension at the wrist 
and elbow. At reoperation an area 
of thrombus formation was identi­
fied on the intimal surface of the 
patch. A second saphenous vein 
patch was fashioned for carotid ar­
tery closure. Postoperatively she re­
gained function in her right elbow 
and wrist, but at discharge had little 
function in the fingers of the right 
hand and no sensation in the sec­
ond and fourth digits. Residual defi­
cit 4.5 years later consisted of re­
duced fine motor function and de­
creased sensation in the fingers.
Case 4
This 70-year-old man experienced 
episodes of weakness of the right 
leg, clumsiness of the right arm and 
numbness of the right side of his 
face. His symptoms occurred two to 
three times weekly and lasted 15 to 
20 minutes. He had had a complet­
ed stroke in the identical distribu­
tion 3 years before, but the symp­
toms had resolved. A digital sub­
traction angiogram showed a 90% 
stenosis of his left internal carotid 
artery.
Endarterectomy of the stenotic 
artery was performed. One hour 
postoperatively he was found to 
have loss of extension at the right 
wrist, decreased flexion of the right 
digits and severely decreased exten­
sion of the digits; there was no 
sensory loss. In addition his blood 
pressure was labile, ranging from 
140/60 mm to 90 /50  mm Hg. 
Cerebral angiography demonstrated 
a complete occlusion of his left 
internal carotid artery.
At reoperation his internal carot­
id artery contained fresh red throm­
bus. A no. 3 Fogarty catheter, 
passed cephalad, retrieved a large 
amount of red clot from the vessel. 
Good back bleeding was established 
and the artery was closed using a 
saphenous vein patch. After this 
procedure, his right hand grip was 
improved. Four years later his fine 
motor function was intact.
Case 5
A 67-year-old man suffered a 
TIA, noted clinically as tingling in 
the right hand. An intravenous digi­
tal subtraction angiogram revealed 
a severe stenosis in the left internal 
carotid artery and an absent left 
vertebral artery.
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He underwent a left internal ca­
rotid endarterectomy with primary 
closure of the artery. In the recov­
ery room, no neurologic deficit was 
noted initially, but 90 minutes post- 
operatively weakness in the right 
hand was noted, progressing over 
15 minutes to paralysis. He also 
became aphasic. At reoperation, the 
internal carotid artery was found to 
be kinked at the distal junction of 
the endarterectomy and the normal 
internal carotid artery. A saphenous 
vein patch angioplasty was per­
formed. Postoperatively he had 
slight lack of coordination of his 
right hand, which resolved com­
pletely over the next 2 weeks. Two 
and a half years later he had no 
neurologic deficit.
Discussion
The true incidence of occlusion 
early after endarterectomy is diffi­
cult to establish. Obviously, the 
condition will be recognized only in 
patients with symptoms. Asymp­
tomatic postoperative thrombosis of 
an internal carotid artery has been 
documented by digital subtraction 
angiography in 1.2% of patients 
after endarterectomy.11 Six patients 
had strokes postoperatively but the 
angiogram was normal in four.11 In 
another series,12 postoperative oc­
clusion was documented by angiog­
raphy in 2 of 48 patients.
The presence of only a mild neu­
rologic deficit in two of our patients 
(cases 3 and 4) underlines the im­
portance of acute awareness of the 
possibility of carotid occlusion after 
endarterectomy of that vessel. Al­
though the published experience 
with this complication is scanty, it 
appears that if surgeons elect to 
reoperate they should do so without 
delay.1314 Angiography may be of 
value when the diagnosis is not 
clearly established, but we believe it 
is not required in the presence of an
extensive, new, appropriately dis­
tributed, neurologic deficit.
The cause of early occlusion of 
the endarterectomized carotid ar­
tery is unclear. Spasm of the distal 
extracranial vasculature has been 
documented angiographically and 
associated with occlusion.15 Embol­
ic events have also been document­
ed16 in the early postoperative peri­
od and could predispose to throm­
bosis. Also, technical problems and 
perioperative hypotension have 
been implicated.17
Our experience supports the poli­
cy of monitoring patients in a surgi­
cal intensive care unit after endar­
terectomy; there, neurologic status 
and blood pressure can be closely 
monitored. In one instance (case 4), 
untreated hypotension may have 
contributed to subsequent occlusion 
at the endarterectomy site.
When surgery was performed 
under general anesthesia a tempo­
rary indwelling shunt was routinely 
employed to provide cerebral pro­
tection and minimize ischemia;918 if 
regional anesthesia was used a 
shunt was placed only when neces­
sary. No patient suffered a focal 
neurologic deficit related solely to 
the operative period.
Since each of our patients im­
proved following re-exploration, it 
is our opinion that an aggressive 
surgical approach is warranted. A 
recent report19 of improved neuro­
logic function in four or five pa­
tients re-explored for occlusion 
after endarterectomy supports our 
position. We did not subject our 
patients to follow-up arteriography 
as a study of long-term patency, so 
our assumption that re-establishing 
internal carotid flow was beneficial 
is open to challenge. Nevertheless, 
the prompt reversal of profound 
ischemic neurologic symptoms in 
three of our patients after throm­
bectomy supports our contention 
that patients who experience neuro­
logic symptoms in the first 12
hours after endarterectomy should 
be re-explored or investigated by 
carotid angiography.
The beneficial effects of carotid 
endarterectomy in reducing subse­
quent strokes depend on low peri­
operative morbidity and mortality. 
Although original operative compli­
cation rates reached 18%, more re­
cent reports20 indicate that they 
may be reduced to the 2% level. 
Despite attempts to reduce this rate 
even further, there is an inevitable 
occurrence of sudden internal caro­
tid artery occlusion after endarte­
rectomy of that vessel. Since the 
incidence of this potentially devasta­
ting problem is low, the individual 
surgeon’s experience in its man­
agement is limited. We suggest 
that careful postoperative moni­
toring and early reoperation for 
any new neurologic deficit may fur­
ther reduce operation-related 
complications.
References
1. McDowell H A jr: S troke and occlusive 
cerebrovascular disease: review of surgi­
cal results in 383 patients. Am Surg 
1971; 37: 5 9 4 -5 9 9
2. Nunn DB: Carotid endarterectomy: an 
analysis of 234 operative cases. Ann 
Surg 1975; 182: 733-738
3. Batson RC, Sottiurai VS: Management 
of asymptomatic carotid artery stenosis. 
Int Surg 1984; 69: 239-246
4. L indberc B: Acute carotid occlusion. 
Indication for surgery? J Cardiovasc 
Surg (Torino) 1980; 21: 315-320
5. P istolese GR, Ventura M, Speziale F, 
et al: Emergency carotid surgery. Int 
Surg 1984; 69: 231-234
6. Easton JD, S herman DG: Stroke and 
mortality rate in carotid endarterectomy: 
228 consecutive operations. Stroke 
1977; 8: 565-568
7. F indlay JM, Lougheed WM, Gentili F, 
et al: Effect of perioperative platelet 
inhibition on postcarotid endarterectomy 
mural thrombus formation. Results of a 
prospective randomized controlled trial 
using aspirin and dipyridamole in hu­
mans. J Neurosurg 1985; 63: 693-698
8. Imparato AM, Riles TS, Ramirez AA, et 
al: Early complications of carotid sur­
gery. Int Surg 1984; 69: 223-229
9. Lees CD, Hertzer NR: Postoperative
370 VOL. 31, NO. 5 SEPTEMBER 1988/CIS
POSTOPERATIVE CAROTID ARTERY OCCLUSION
w
stroke and late neurologic complications 
after carotid endarterectomy. Arch Surg 
1981: 116: 1561-1568
10. Idem: Fatal myocardial infarction and 
late neurologic complications following 
carotid endarterectomy. Curr Surg 
1982; 39: 408-410
11. Hertzer NR, Beven EG, Modic MT, et 
al: Early patency of the carotid artery 
after endarterectomy: digital subtraction 
angiography after two hundred sixty- 
two operations. Surgery 1982; 92: 
1049-1057
12. Diaz FG, Patel S, Boulos R, et al: Early 
angiographic changes after carotid en­
darterectomy. Neurosurgery 1982; 10: 
151-161
13. Kwaan JH, Connolly JE, S harefkin JB: 
Successful management of early stroke 
after carotid endarterectomy. Ann Surg 
1979; 190: 676-678
14. Treiman RL, Cossman DV, Cohen JL, et 
al: Management of postoperative stroke 
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1981; 142: 236-238
15. Lye CR, Morrow IM, Downs AR: Carot­
id artery spasm. A cause of postendar­
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ternational stature, to discuss 47 clini­
cal problems ranging from abdominal 
abscess to pulmonary embolism to loss 
of vision. One chapter is devoted to 
each problem, and the chapters are 
organized into seven sections — chest, 
gastrointestinal tract, genitourinary 
tract, musculoskeletal system, head and 
neck, cancer staging and miscellaneous. 
For each problem a differential diagno­
sis is presented, followed by a discus­
sion of the available diagnostic modali­
ties, including their sensitivities and 
specificities, advantages and disadvan­
tages, complications and relative cost. 
Each chapter ends with a graphic depic­
tion of the algorithm or decision tree 
recommended to deal with the problem.
The authors stress the need for radi­
ologists and clinicians to work together 
to develop algorithms that are flexible 
and relate to local expertise and equip­
ment. Such cooperative effort provides 
our best hope of keeping abreast of 
technical advances and containing cost 
without sacrificing the quality of medi­
cal care.
This book should be in the library of 
every hospital that trains clinical or 
radiology residents. Most of its 47 
chapters are directly relevant to the 
surgical resident since almost all of the
algorithms have surgery as an end­
point. Established surgeons (and radiol­
ogists) who are bewildered or intimidat­
ed by the rapid pace of technical ad­
vance will also benefit from the wealth 
of information that Dr. Eisenberg has 
assembled in this timely and compre­
hensive text.
D. Ian Hammond, MD, FRCPC
Associate Professor,
University o f  Ottawa.
Department o f Radiology.
Ottawa General Hospital,
Ottawa, Ont.
TRAUMA. Edited by Kenneth L. Mat­
tox, Ernest Eugene Moore and David 
V. Feliciano. 944 pp. Illust. Appleton 
& Lange, East Norwalk, Conn., 1987. 
$125.00 (US). ISBN 0-8385-9004-7.
In my opinion this is the most compre­
hensive, best organized and written text 
on the subject. It is current and has 
been written by numerous authorities 
each representing their field of special­
ty. Every aspect from field triage, resus­
citation, surgery, intensive care and 
rehabilitation is included. Current scor­
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17. Dunsker SB: Complications of carotid 
endarterectomy. Clin Neurosurg 1976; 
23:336-341
18. Browse NL, Ross-Russell R: Carotid 
endarterectomy and the Javid shunt: the 
early results of 215 consecutive opera­
tions for transient ischaemic attacks. B r 
J Surg  1984; 71: 53-57
19. S imma W, Hesse H, Gilhofer G, et al: 
Management of immediate occlusion 
after carotid-reconstruction. J Cardi- 
ovasc Surg (Torino) 1987; 28: 176-179
20. Hertzer NR: Carotid endarterectomy — 
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ing systems, crash models, missile bal­
listics and military surgery are dis­
cussed. Anyone called upon to deal with 
injured patients — the trauma surgeon, 
the rural physician or the medical stu­
dent — will find the text an invaluable 
reference.
The contributors discuss controver­
sial treatment, giving divergent opin­
ions and expressing their preference in 
conclusion. For readers wishing even 
greater detail, the references with each 
chapter contain the significant contribu­
tions to the literature.
Dr. Walt's foreword highlights the 
major trauma statistics, which unfortu- 
ately place trauma as the major killer of 
young adults and the cause of untold 
economic loss from morbidity. The 
chapters on injury statistics and history 
are interesting. The frustrations associ­
ated with attempts to develop injury 
countermeasures are well supported. 
The value of seat-belt and helmet legis­
lation is clearly documented. The dis­
cussion of the importance of the trauma 
centre registries emphasizes that with­
out such data it is impossible to develop 
treatment protocols and planning effi-
continued on page 372
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ciently and appropriately for a large 
region. Fortunately, the large Canadian 
health care data banks give us the 
opportunity to be leaders in this field.
The authors of the Advanced Trauma 
Life Support Course are the contribu­
tors to the chapters on “golden hour” 
patient management, which provide an 
excellent overview of the subject. Trau­
ma, radiologic and anesthetic manage­
ment are presented in a fashion that 
emphasizes the need for a team ap­
proach. These chapters are particularly 
well illustrated.
The management of head injuries is a 
major concern to non-neurosurgeons. 
Intracranial, facial, spinal and neck in­
juries are described in sufficient detail 
to provide satisfying isight.
The several hundred pages devoted 
to injuries of the chest and abdomen 
are invaluable references to specific 
management protocols and are support­
ed by detailed reviews and excellent 
illustrations and diagrams.
The trauma team, intensive care, des­
ignated “captain” approach to decision­
making and organization are outlined in 
the chapters dealing with critical care 
management. The life-threatening com­
plications resulting from trauma, inten­
sive resuscitation, sepsis and multior­
gan failure — their monitoring and 
management — are described nicely in 
the final chapters.
Trauma is a major contribution to 
the literature. It is a library in itself. It 
should be required reading for all sur­
geons and intensivists, and is a superb 
reference for those likely to be called 
upon to treat an injured patient. At a 
cost of $125.00, it replaces the need to 
attend many expensive meetings and 
symposia.
Charles M. Burns, MD, FRCSC
Director,
Trauma Services,
Department o f Surgery,
Health Sciences Centre,
University o f Manitoba,
Winnipeg, Man.
TUMORS OF THE KIDNEY. Interna­
tional Perspectives in Urology, Vol­
ume 13. Edited by Jean B. deKernion 
and M. Pavone-Macaluso. 339 pp. II- 
lust. Williams & Wilkins, Baltimore, 
1986. Price not stated. ISBN 
0-683-02426-4.
In this volume, international experts 
review recent advances in the manage­
ment of renal tumours. They describe 
and evaluate the available methods for 
early diagnosis and staging, and they 
present techniques that have been de­
veloped to deal with difficult surgical 
urologic problems. In addition, the 
book focuses on research into the treat­
ment of metastatic disease which re­
mains a challenge.
The early chapters deal with current 
issues in the diagnosis of renal tu­
mours. One conclusion is that comput­
ed tomography compares favourably 
with other techniques, although it has 
limited application to nodal disease or 
localized spread. At a practical level, a 
cost-effective work-up is presented for a 
patient with an asymptomatic renal 
mass. This provides a particularly use­
ful diagnostic guideline to the practis­
ing urologist. One of the more informa­
tive chapters deals with paraneoplastic 
syndromes, providing insight on how 
they may affect diagnosis.
The surgical treatment of complex 
lesions is the subject of several chap­
ters, and extensive justification is given 
for the use of modified lymph-node 
dissection, a practice that is not univer­
sally accepted. The technical problems 
of bilateral renal tumours and tumours 
in solitary kidneys are dealt with sepa­
rately and thoroughly. This section is 
augmented by data on tumours that 
extend into the vena cava. Such tu­
mours can evidently be treated success­
fully unless there is actual infiltration 
into the caval wall or distinct metastatic 
disease.
Much attention is paid to metastatic 
renal cell carcinoma. The authors of 
this section discuss their indications for
angioinfarction before nephrectomy. Al­
though this technique is not widely 
accepted, the authors state their case 
for its use, at the same time acknowl­
edging that the results of their studies 
are inconclusive.
The clinical findings on the efficacy 
of chemotherapy are consistent with 
past experience, namely, that the re­
sults are disappointing. Vinblastine, 
chloroethyl-cyclohexy-nitrosourea and 
methyl-glyoxal bisgnanylhydrazone ap­
pear to give the best palliative results in 
terminal cases. Researchers in this field 
will be interested in the comprehensive 
technical review of experimental chemo­
therapy and in-vitro chemotherapy test­
ing that is provided. In-vitro testing 
with soft agar colonies has given some 
useful information on chemotherapy 
sensitivity, but practical application of 
this method is limited.
New experimental and clinical infor­
mation on hormonal therapy is present­
ed. There are indications that research 
into hormone receptors, analogous to 
research relating to breast cancer, may 
produce good results. The principal 
shortcoming of this volume is the ab­
sence of current data relating to immu­
notherapy; it includes only a brief his­
torical review of the subject.
Although this book is a collection of 
articles written by authors with differ­
ent perspectives and styles, the editing 
has made it into a coherent entity. The 
information is presented with scientific 
detachment so that the reader is given a 
balanced view of the management of 
patients with renal cancer. Particularly 
helpful are the numerous illustrations 
of the technical aspects of surgery that 
most residents, and even experienced 
surgeons, rarely see. Consequently, this 
book can serve as an invaluable refer­
ence in hospital and university libraries.
Colin Dinney, MD 
Said Awad. MD, FRCSC
Department o f Urology,
Dalhousie University,
Halifax, NS
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This list is an acknowledgement of 
books received. It does not preclude 
review at a later date.
Acute Pancreatitis. Experimental and 
Clinical Aspects of Pathogenesis and 
Management. Edited by G. Glazer and 
John H.C. Ranson. 456 pp. Illust. Bal- 
liere Tindall, London; W.B. Saunders 
Company Canada Limited, Toronto, 
Ont., 1988. $95.00. ISBN 0-7020- 
1248-3.
Clinical Imperatives in Surgery and 
Orthopaedics. Edited by G.F. Dommisse 
and B.G.P. Lindeque. 450 pp. Illust. 
Haum Educational Publishers, Pretoria, 
1988. Price not stated. ISBN 
0-7986-1876-0.
Controversies in Breast Disease. Diag­
nosis and Management. Edited by Shar­
on Grundfest-Broniatowski and Cald­
well B. Esselstyn, Jr. 514 pp. Illust. 
Marcel Dekker, Inc., New York, 1988. 
$150.00 (US). ISBN 0-8247-7880-4.
NOTICE OF CHANGE OF ADDRESS/
AVIS DE CHANGEMENT D’ADRESSE
To ensure that you continue to receive the Canadian Journal o f Surgery 
without interruption, please fill in this form before you move.
Avant de demenager, assurez-vous de recevoir sans interruption le Journal 
canadien de chirurgie en completant le formulaire suivant.
Please print /  en lettres moulees, svp
Name /  nom .........................................................................................................
Royal College member number /  numero d'identite .........................................
Old address /  ancienne adresse ...........................................................................
New address /  nouvelle adresse
Postal code /  code postal.....................................................................................
D ate........................................................................................................................
Royal College fellows please mail to: Royal College of Physicians and 
Surgeons of Canada, 74 Stanley Ave., Ottawa, Ont. KIM 1P4.
Membres du College royal, veuillez expedier a: College royal des medecins et 
chirurgiens du Canada, 74 Stanley Ave., Ottawa, Ont. KIM 1P4.
Subscribers please mail to: Information Systems, Canadian Medical Associa­
tion, PO Box 8650, Ottawa, Ont. K1G 0G8.
Abonnes, veuillez expedier a: Systeme de diffusion d’informations, l’Associa- 
tion medicale canadienne, CP 8650, Ottawa, Ont. K1G 0G8.
I Don’t Know What To Say. How to
Help and Support Someone Who Is 
Dying. Robert Buckman. 195 pp. Key 
Porter Books Limited, Toronto, Ont., 
1988. $19.95. ISBN 1-55013-070-6 
(hardcover), ISBN 1-55013-092-7 (pa­
perback).
Perspectives in Colon and Rectal Sur­
gery. Edited by Theodore R. Schrock. 
152 pp. Illust. Quality Medical Publish­
ing, Inc., St. Louis, Missouri, 1988. 
Price not stated. ISSN 0894-8054.
Rush University Review of Surgery.
Steven G. Economou, Steven D. Bines, 
Daniel J. Deziel and Thomas R. Witt. 
426 pp. Illust. W.B. Saunders Compa­
ny, Philadelphia, 1988. $35.75. ISBN 
0-7216-2070-1.
Canadians all over are 
waiting for the gift of a 
life-saving transplant.
The Kidney 
Foundation of Canada 
urges you to sign an 
organ donor card.
ORTHOPAEDIC
SURGEON
The Manpower Committee and the four Or­
thopaedic Surgeons of Burnaby Hospital invite 
applications for an additional Orthopaedic 
Surgeon to join the Medical Staff as a consul­
tant.
The new individual would be expected to share 
general trauma on-call and be ATLS certified. 
An area of sub-specialization would be an 
asset.
Fellowship candidates as well as those with a 
Canadian Fellowship are encouraged to apply.
Burnaby Hospital is a 386 acute bed community 
hospital situated in Greater Vancouver with a 
catchment area of approximately 200,000 peo­
ple.
Direct written inquiries by October 1,1988 to:
Chapin Key, M.D., M.H.A. 
Vice President - Medicine 
Burnaby Hospital
3935 Kincaid Street 
Burnaby, B.C. V5G 2X6
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NOTICES CLASSIFIED ADVERTISING
British Columbia Surgical 
Society Meeting
Vancouver’s Four Seasons Hotel will be 
the setting for the British Columbia 
Surgical Society’s fall dinner meeting 
on Nov. 25, 1988. Dr. Michael Walker, 
founder and director of the Fraser Insti­
tute, will be the guest speaker. In 
conjunction with the dinner, “Trauma 
Update 88’’ will be held on Nov. 24 and 
25 at the hotel. Further information 
can be obtained by calling Ms Tanyss 
Noftle (604)736-5551.
Percutaneous Gallbladder 
Surgery
A 1-day course concerning a new one- 
stage technique to remove gallstones 
percutaneously will be held in London, 
England, Oct. 17, 1988. Recent radi­
ologic developments will be summarized 
and the new technique demonstrated 
using live closed-circuit television ses­
sions. Please contact: BDI Conferences 
Ltd, 9-11 Kensington High St., London 
W8 5NP, England.
ADVERTISERS’ INDEX
Davis & Geek
Outside Back Cover
Impra International, Inc.
Inside Back Cover
Johnson & Johnson Inc.
Nu Gauze
Inside Front Cover
Merck Sharp & Dohme Canada
Mefoxin
302, 303, 322, 323 
Primaxin
358 A,B,C,D,E,F,G,H 
Merrell Dow Pharmaceuticals
Citrucel 
298 ,355
Parke-Davis Canada Inc.
Anusol-HC
300
Roussel Canada Inc.
Claforan 
326 A,B
Upjohn Company of Canada, The
Dalacin C 
296, 312
Week
306
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable 
classified advertisements. The deadline is 1 month before issue date. Regular classified rates 
(for each insertion): $42.00 for the first 40 words or less, additional words 55<f each 
(additional $16.00 for frame). Special Display under 75 words, 2V4 in. X 2 in., $105.00. $6.00 
charge (first insertion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario 
K1G0G8.
RESEARCH ASSOCIATE: AB -  The joint 
unjury and diseases research group at the 
university of Calgary is seeking a biomechanics 
research associate with expertise in biome­
chanical testing of ligaments. This individual 
must have a PHD or equivalent in biomechanical 
engineering and must have experience with 
multidisciplinary bench research in the field of 
mechanical testing of connective tissues. This 
term position is funded from external sources 
and is not a university support staff position. In 
accordance with Canadian immigration require­
ments, priority will be given to Canadian citi­
zens and permanent residents of Canada. The 
closing date for applications is September 30, 
1988. Address all correspondence to: Dr. C. 
Frank, Dept, of Surgery, University of Calga­
ry, 13 Heritage Medical Research Building, 
3330 Hospital Drive NW, Calgary, AB T2N 
4M 1. -S88-30
GENERAL SURGEON: ON -  An opportunity 
exists for a general surgeon to join the staff of 
the Oakville-Trafalgar Memorial Hospital. At 
present there are 4 general surgeons in this fully 
accredited 330-bed hospital. Applications to: 
Dr. G. Lloyd, Dept, of Surgery, Oakville-Tra­
falgar Memorial Hospital, 327 Reynolds 
Street, Oakville, ON L6J 3L7. -S88-36
CHIEF, DIVISION OF GENERAL SURGERY:
ON -  The Children's Hospital of Eastern Ontar­
io, a bilingual and progressive tertiary care 
facility affiliated with the University of Ottawa, 
invites applications for this position which be­
comes available following the retirement of the 
present incumbent on June 30, 1989. This 
should be of particular interest to specialists in 
pediatric surgery. In accordance with Canadian 
immigration requirement, this advertisement is 
directed to Canadian citizens and permanent 
residents of Canada. Other candidates will be 
considered if no suitable Canadian is found. 
Send application with curriculum vitae to: Dr. 
Hans Heick, Chairman of the Medical Advi­
sory Committee, Children's Hospital of East­
ern Ontario, 401 Smyth Road, Ottawa, ON 
K1 H 8L1. -S88-34
CHEF DE LA SECTION DE CHIRURGIE 
GENERALE: ON — Ce poste, qui devient di- 
sponsible a la retraite du chef actuel le 30 juin, 
1989, sera d'interet aux specialistes en chirur- 
gie pediatrique a I'hopital pour enfants de Test 
de I'Ontario un hdpital bilingue de soins ter- 
tiaires affilie a I'universite d'Ottawa. Aux termes 
de reglements canadiens sur I'immigration, 
cette annonce s'adresse aux personnes de 
nationalite canadienne et aux residents perma­
nents. D'autres candidatures pourraient etre 
considerees si on ne peut trouver de candidat 
canadien repondant aux exigences. Veuillez en- 
voyer votre curriculum vitae au: Dr Hans 
Heick, president du Comite consultatif 
Medical, Hdpital pour enfants de Test de 
I'Ontario, 401, chemin Smyth, Ottawa, ON 
K1H8L1. -S88-35
BIOGRAPHY: — Material for biography of the 
late Professor J. C. B. Grant required. Personal 
memoirs, anecdotes, photographs, welcome. 
Information treated with discretion and material 
returned promptly. Reply to: Dr. Clayton Rob­
inson, 808 - 750 West Broadway, Vancou­
ver, BC V5Z 1 H7. -S88-31
GENERAL SURGEON: NWT -  The board is 
seeking a general surgeon to join a medical staff 
of 7 physicians, to function as a team member 
in an isolated location. The Baffin Regional 
Hospital is located in Iqaluit (Frobisher Bay) on 
Baffin Island. The hospital acts as a referral 
centre for 12 outlying health centres in the 
eastern arctic and serves a total population of 
10 000. The candidate is required to undertake 
cesarian sections, general surgery, emergency 
trauma and some general practitioner clinical 
sessions. Surgical specialists ENT; GYNE; 
ORTHO visit on a regular basis from McGill 
University affiliated hospitals. Candidates for 
this position will preferably be FRCSC and be 
eligible for licensing in the Northwest Territo­
ries. Competitive salary, generous incentive bo­
nus. Benefits: housing allowance; vacation trav­
el assistance, paid educational leave, relocation 
expenses, dental, pension and insurance plan. 
Furnished accommodation. Closing date: to re­
main until suitable candidate is recruited. Please 
send resume to: Chief executive officer. Head 
Office, Baffin Regional Health, Board, Bag 
200, Iqaluit, NWT, XOA OHO. -S88-37
CHIEF, DEPT. OF SURGERY: ON -  The
Children's hospital of Eastern Ontario, a bilin­
gual and progressive tertiary care facility affiliat­
ed with the University of Ottawa, invites appli­
cations for the position of Chief, Department of 
Surgery. This position which becomes available 
following the retirement of the present incum­
bent on June 30, 1989, will be of interest to 
specialists in pediatric surgery. In accordance 
with Canadian immigration requirements, this 
advertisement is directed to Canadian citizens 
and permanent residents of Canada. Other can­
didates will be considered if no suitable Canadi­
an is found. Send application with curriculum 
vitae to: Dr. Hans Heick, Chairman of the 
Medical Advisory Committee, Children's 
Hospital of Eastern Ontario, 401 Smyth 
Road, Ottawa, ON K1 H 8L1. -S88-32
CHEF, SERVICE DE CHIRURGIE: ON -  Ce
poste, qui devient disponsible a la retraite du 
chef actuel le 30 juin, 1989, sera d'interet aux 
specialistes en chirurgie pediatrique a I'hopital 
pour enfants de Test de I'Ontario un hopital 
bilingue de soins tertiaires affilie d I'universite 
d'Ottawa. Aux termes des reglements canadi­
ens sur I'immigration, cette annonce s'adresse 
aux personnes de nationalite canadienne et aux 
residents permanents. D'autres candidatures 
pourraient etre considerees si on ne peut trouv­
er de candidat canadien repondant aux exi­
gences. Veuillez envoyer votre curriculum vitae 
au: Dr Hans Heick, president du Comite 
consultatif Medical, Hdpital pour enfants de 
Test de I’Ontario, 401, chemin Smyth, Otta­
wa, ON K1 H 8L1. -S88-33
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This PTFE graft w ill be stabbed, 
poked, pierced, pricked, 
pinched and contorted 
6 times a week.
Under the harsh conditions o f
blood access, studies show only I
can m aintain high patency rates beyond 5 years.
Hemodialysis is punishing for a 
vascular graft. Yet the documented 
5-year patency rate of IMPRA® 
grafts in blood access applications 
exceeds 57%.
To put this into perspective, 
IMPRA’s 5 year patency rate is 
superior to what any other graft 
reports at just 3 years.
Furthermore, published studies 
report less infection and 35% fewer 
complications with IMPRA, com­
pared to other PTFE grafts.
How is this high long-term patency 
possible? The reason lies in IMPRA’s 
one-piece wall design. An IMPRA 
graft has no stiff outer wrap to retard 
tissue ingrowth. Healing is faster 
and thrombosis is reduced.
For the surgeon, suture retention 
is greater than natural vein and the 
pliant one-piece graft better con­
forms to host vessels.
For the dialysis technician, the 
IMPRA graft is easy to palpate. 
Needle holes heal fast and of 
course, there is no outer wrap 
to nick or separate.
In Canada: IMPRA International, Inc.
IMPRA International, Inc. 1625 West 3rd Street 
43 Old Maple Lane P.O. Box 1740
Kitchener. Ontario Tempe. Arizona 85281 USA
Canada N2N 2L2 (602) 894-9515
(519) 742-8472 Telex No. 910-950-0122
1-800-321-4254 Cable: IMPRAINC
IMPRA’s one-piece design gives higher 
long-term patency than wrapped grafts.
IMPRA grafts are available in 
11 styles, including Stepped and 
Tapered to help manage Steal 
Syndrome and Center Flex to avoid 
kinking of loop fistulas. For more 
product information, fill out the 
coupon below. For faster response, 
call toll free.
The Fine Line of Excellence
Please send more 
information on:
□  IMPRA grafts
□  Kelly Wick Tunneler
□  NEW! Dialysis Patient 
Handbook
©Copyright 1988 
®IMPRA is a registered 
trademark of IMPRA, Inc.
For faster service call 1 (800) 321-4254.
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Ultra Light Compact 
disposable skin stapler 
Automatically released staples 
Improved staple visibility 
Proven reliability 
Allows for excellent accuracy 
Quality stapler supplied inexpensively
Now a monofilament suture 
that is easy to handle and tie:
Soft, supple, flexible
• Resists kinking
• Yields secure knots 
•Strong
the manageable monofilament.
...now  comes the 
Even Greater Stapler
DEXON* PLUS
Excellent knot security plus superior handling 
and smoother tissue passage.
FORADIFFt:r e n c e
YOUCAN1 FEEL.
N E W PR E f CYDE*
(ChkxheaSnc Qua male)
TV Tew Pre-Cyde is the only IN germicidal antiseptic hand 
wash that combines all the 
effectiveness of chlorhexidine 
with a gentle emollient to 
sooth the skin 1;  I
Pre-Cyde's broad antibacterial 
spectrum makes it an excellent 
bactericidal and fungicidal
Pre-Cyde is safe, virtually 
non-irritating,1 and has a 
pleasant emollient... for a 
difference you can feel
quality professional products from
DAVIS+GECK
Cyanamid Canada Inc.
‘ Registered Trademark of Cyanamid Canada Inc.
A  T R A D I T I O N  O F  I N N O V A T I O N
